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Preface
Echocardiography, despite the huge development of computed tomography and magnetic
resonance imaging, is still the most used imaging technique for the evaluation of cardiac
anatomy and function and today it plays an essential role in daily decision making.
Echocardiography offers a number of advantages over newer and more sophisticated
technologies. First of all echocardiography offers a complete morphological and hemody‐
namic evaluation. Furthermore ultrasounds are radiation and contrast free, they are wide‐
ly available, relatively cheap and they can be performed at the patient’s bed, even to very
critical ones.
Cardiologists face unique challenges interpreting echocardiographic imaging and trough
the integration of these data with other clinical information.
Heart failure is becoming increasingly common and a major clinical and public health
challenge. The prevalence of the disease is rising mainly because the population is getting
older. More people survive myocardial infarction and some of them will develop heart
failure. An increasing fraction, especially older, diabetic, hypertensive patients, and those
with atrial fibrillation, exhibit heart failure with preserved systolic function. Echocardiog‐
raphy meets the growing need for non-invasive imaging in the expanding heart failure
population because of its ability to provide accurate measures of ventricular function, fill‐
ing pressure and to asses causes of structural heart disease. Echocardiography offers also
prognostic information and can guide the therapy.
The echocardiographic technology and its applications have widely developed in the last
years leading to a better diagnostic accuracy. On the other hand echocardiography special‐
ists have new clinical questions to answer.
Since the introduction of percutaneous closure of patent foramen ovale, atrial and ventric‐
ular septal defects, echocardiography has become the imaging technique of choice in selec‐
tion of patients and during the percutaneous procedure in the cath lab.
In the last years new structural heart interventions have become widely available such as,
transcatheter aortic valve replacement, mitral valve repair, mitral valvuloplasty and left
atrial appendage closure. These new percutaneous therapies need, in particular during the
patients selection phase, a precise evaluation of cardiac dimensions and a complete under‐
standing of the spatial relationships between cardiac structures. Echocardiography is of
paramount importance both during the patient evaluation and guiding the procedure.
Three dimensional echocardiography, especially in the transesophageal approach, is a key
technique for a precise localization and an easier definition of cardiac anatomy.
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1. Introduction
The mortality, hospitalization, and prevalence rates of heart failure (HF) are increasing, in spite
of decrease in coronary artery and cerebrovascular disease mortality.[1]
Approximately half of patients with a diagnosis of heart failure have a normal left ventricular
(LV) ejection fraction (EF) without valve disease which is defined as diastolic heart failure
(DHF), because it is attributed to LV diastolic dysfunction.[2] Studies examining prevalence
of diastolic heart failure in hospitalized patients or in patients undergoing outpatient diag‐
nostic screening and prospective community based studies have shown that the prevalence of
diastolic heart failure approaches 50%.[3-5]
They tend to be older and female, and their condition is likely to be associated with hyperten‐
sion, diabetes mellitus and ischemic heart disease. Many reports show that the mortality and
morbidity of DHF is minimal differences from that of HF with a reduced EF. Moreover,
although the mortality and morbidity have improved for patients with HF with a reduced EF,
it has not changed for patients with DHF. So, the Evaluation of LV diastolic function is
important.
LV diastolic function is related to myocardial relaxation and passive LV properties and is
modulated myocardial tone. Myocardial relaxation is an active process, while stiffness is on
the contrary a mechanical property of the myocardial wall.
Echocardiography is useful for the evaluation of LV diastolic function. The points of diastolic
function to be estimated with echocardiography are propagation velocities, pulmonary vein
Doppler, mitral inflow pattern and tissue Doppler imaging. We discuss the estimation of LV
diastolic function with echocardiography.
© 2013 Wake et al.; licensee InTech. This is a paper distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
This book tries to give an in depth evaluation about the specific issues that a modern car‐
diovascular imaging specialist is asked to answer nowadays.
Dr. Angelo Squeri
Cardiology
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2. The mechanism of DHF
Heart failure is a clinical syndrome characterized by symptoms and signs of increased tissue
water and decreased tissue perfusion. Definition of the mechanisms that cause this clinical
syndrome requires measurement of both systolic and diastolic function. When heart failure is
accompanied by a predominant or isolated abnormality in diastolic function, this clinical
syndrome is called diastolic heart failure. The pathophysiology is attributed to LV diastolic
dysfunction, in which LV diastolic chamber size is normal or reduced despite elevated filling
pressures resulting in decreased cardiac output. DHF occurs when the ventricular chamber is
unable to accept an adequate volume of blood during diastole, because of a decrease in
ventricular relaxation and/or an increase in ventricular stiffness,[2] and increased circulating
blood volume is present. Hypertension, ischemia, aging and diabetes mellitus are the major
risk factor of a decrease in ventricular relaxation and/or an increase in ventricular stiffness.
Endocardial biopsies from HF patients without coronary artery disease (CAD) showed
structural and functional differences in cardiomyocytes from patients with diastolic HF
compared to cardiomyocytes from patients with abnormal systolic ejection fraction.[6]
Myocytes from patients with diastolic HF had increased diameter and higher myofibrillar
density and developed greater passive force and had greater calcium sensitivity. Myocardial
collagen volume fraction was equally elevated.
Patients with DHF were shown to have similar pathophysiological characteristics, compared
with HF patients with a reduced EF including reduced exercise capacity and impaired quality
of life. DHF will be present in heart failure with preserved ejection fraction. When it is difficult
with diagnosing HF, it is important to use echocardiography. [7,8]
2.1. The diagnosis of DHF
The diagnosis of heart failure with preserved left ventricular (LV) ejection fraction (HFpEF)
requires the following conditions to be satisfied: (1) signs or symptoms of heart failure; (2)
normal or mildly abnormal systolic LV function; (3) evidence of diastolic LV dysfunction.
Normal or mildly abnormal systolic LV function implies both an LVEF > 50% and an LV end-
diastolic volume index (LVEDVI) < 97 mL/m2. Diagnostic evidence of diastolic LV dysfunction
can be obtained invasively (LV end-diastolic pressure >16 mmHg or mean pulmonary capillary
wedge pressure >12 mmHg) or non-invasively by tissue Doppler imaging (TDI) (E/E’ >15) with
an echocardiography. If TDI yields an E/E’ ratio suggestive of diastolic LV dysfunction ( 8 <
E/E’ < 15 ), additional non-invasive investigations are required for diagnostic evidence of
diastolic LV dysfunction. These can consist of blood flow Doppler of mitral valve or pulmonary
veins, echocardiographic measures of LV mass index or left atrial volume index, electrocar‐
diographic evidence of atrial fibrillation, or plasma levels of natriuretic peptides. If plasma
BNP is more than 200 pg/mL, diagnostic evidence of diastolic LV dysfunction also requires
additional non-invasive investigations.
A similar strategy with focus on a high negative predictive value of successive investigations
is proposed for the exclusion of HFpEF in patients with breathlessness and no signs of
congestion. If a patient with breathlessness and no signs of fluid overload has a BNP of less
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than 100 pg/mL, any form of heart failure is virtually ruled out because of the high negative
predictive value of the natriuretic peptides, and pulmonary disease becomes the most likely
cause of breathlessness. [9, 10]
As far as diastolic dysfunction, in decompensated patients with advanced systolic heart failure
(LVEF≦30%, New York Heart Association class III to IV symptoms), tissue Doppler-derived
with E/E’ ratio may not be as reliable in predicting intracardiac filling pressures, particularly
in those with larger LV volumes, more impaired cardiac indices, and the presence of cardiac
resynchronization therapy. [11]
2.2. Echocardiography in LV diastolic dysfunction
2.2.1. Doppler echocardiographic assessment of diastolic function and filling pressures
Comprehensive Doppler echocardiography is invaluable in the evaluation of HF patients. It
is established that the mitral E wave velocity reflects the LA-LV pressure gradient during early
diastole and is therefore affected by preload and alterations in LV relaxation. Assessment of
diastolic function begins with the transmitral flow velocity profile. Decreases in the ratio of
early to late diastolic filling (E/A), increases in the deceleration time, increases in the isovolumic
relaxation time, or increases in tissue Doppler imagings (E/E’) indicate impaired relaxation.
However, in the presence of impaired relaxation, increases in filling pressure progressively
modify the transmitral gradient and mitral inflow pattern. A comprehensive Doppler assess‐
ment must be used to determine diastolic function from filling pressures and tissue Doppler
imagings. [10] Patients studied at various times during their presentation will display a
spectrum of filling patterns, including abnormal relaxation and psuedonormal or restrictive
patterns. Such a spectrum has also been reported in patients with HF with a depressed EF and
reflects the potent effect of filling pressures and blood pressure and their interaction with
underlying diastolic dysfunction on the Doppler patterns. Thus, depending on their level of
compensation and their filling pressures and whether they have exertional or rest symptoms,
patients with HFpEF may display any of the filling patterns.[12]
2.2.2. Tissue Doppler imaging
Tissue Doppler imaging (TDI) is performed in the apical views to acquire mitral annular
velocities with pulse wave. The sample volume should be positioned at 1 cm within the septal
and lateral insertion sites of the mitral leaflets. It is recommended that spectral recordings be
obtained at a sweep speed of 50 to 100 mm/s at end-expiration and that measurements should
reflect the average of more than 3 consecutive cardiac cycles. Primary measurements include
the systolic and early (e’) and late (a’) diastolic velocities. For the assessment of global LV
diastolic function, it is recommended to acquire and measure tissue Doppler signals at least at
the septal and lateral sides of the mitral annulus and their average. In patients with cardiac
disease, e’ can be used to correct for the effect of LV relaxation on mitral E velocity, and the E/
e’ ratio can be applied for the prediction of LV filling pressures. The E/e’ ratio is not accurate
as an index of filling pressures in normal subjects or in patients with heavy annular calcifica‐
tion, mitral valve disease, and constrictive pericarditis.
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Strain and strain rate can be derived from either tissue Doppler or speckle tracking 2-dimen‐
sional echocardiography. Using tissue Doppler, which is a form of pulsed Doppler, specific
points within the myocardium can be identified. Tracking these Doppler points enables
measurement of strain rate. Because Doppler is velocity or distance divided by time, the initial
measurement is strain rate. Integrating the strain rate gives strain. The estimation of strain in





Figure 1. Normal pattern in LV inflow: Panel A shows long axis view. Panel B shows 4 chamber view. Panel C shows LV
inflow. Panel D shows tissue Doppler imaging.
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Figure 2. Abnormal relaxation pattern in LV inflow: Panel A shows long axis view. Panel B shows 4 chamber view.
Panel C shows LV inflow. Panel D shows tissue Doppler imaging.
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Figure 3. Pseudonormalized pattern in LV inflow: Panel A shows long axis view. Panel B shows 4 chamber view. Panel
C shows LV inflow. Panel D shows tissue Doppler imaging.
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Figure 4. Restrictive pattern in LV inflow: Panel A shows long axis view. Panel B shows 4 chamber view. Panel C shows
LV inflow. Panel D shows tissue Doppler imaging.
2.2.3. Left ventricle in diastolic heart failure
Most patients with HFpEF have normal chamber dimensions, although a small subset may
have variable degrees of LV enlargement.
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Although HF preserved EF has been thought to occur primarily patients with left ventricular
hypertrophy (LVH), studies that have carefully quantified LV mass report that echocardio‐
graphic criteria for LVH are met in less than 50% of patients. [13-16]
2.2.4. Left atrium in diastolic heart failure
Increases in the left atrial dimension or volume are commonly present in patients with HF
preserved EF. [17-19] The left atrium modulates ventricular filling through its reservoir,
conduit, and pump functions. During ventricular systole and isovolumic relaxation, when the
atrioventricular (AV) valves are closed, atrial chambers work as distensible reservoirs
accommodating blood flow from the venous circulation. The atrium is also a pumping
chamber, which contributes to maintaining adequate LV end-diastolic volume by actively
emptying at end-diastole. Finally, the atrium behaves as a conduit that starts with AV valve
opening and terminates before atrial contraction and can be defined as LV stroke volume
minus the sum of LA passive and active emptying volumes.
The measurement of left atrial (LA) volume is highly feasible and reliable in most echocardio‐
graphic studies, with the most accurate measurements obtained using the apical 4-chamber
and 2-chamber views. This assessment is clinically important, because there is a significant
relation between LA remodeling and echocardiographic indices of diastolic function. In the
previous observational studies, patients without baseline histories of atrial fibrillation and
significant valvular heart disease have shown that more than 34 mL/m2 LA volume index is
an independent predictor of death, heart failure, atrial fibrillation, and ischemic stroke.
The dilated left atria may be seen in patients with bradycardia and 4-chamber enlargement,
anemia and other high-output states, atrial flutter or fibrillation, and significant mitral valve
disease, in the absence of diastolic dysfunction. Likewise, it is often present in elite athletes in
the absence of cardiovascular disease. Therefore, it is important to consider LA volume
measurements in conjunction with a patient’s clinical status, other chambers’ volumes, and
Doppler parameters of LV relaxation.
2.2.5. Pulmonary hypertension in diastolic heart failure
Symptomatic patients with diastolic dysfunction usually have increased pulmonary artery
(PA) pressures. [17,20] Therefore, in the absence of pulmonary disease, increased PA pressures
may be used to infer the presence of elevated LV filling pressures. Indeed, a significant
correlation was noted between PA systolic pressure and noninvasively derived LV filling
pressures. The peak velocity of the tricuspid regurgitation (TR) jet by continuous-wave (CW)
Doppler together with systolic right atrial (RA) pressure are used to derive PA systolic
pressure. In patients with severe TR and low systolic right ventricular–RA pressure gradients,
the accuracy of the PA systolic pressure calculation is dependent on the reliable estimation of
systolic RA pressure. Likewise, the end-diastolic velocity of the pulmonary regurgitation (PR)
jet can be applied to derive PA diastolic pressure. Both signals can be enhanced, if necessary,
using agitated saline or intravenous contrast agents, with care to avoid overestimation caused
by excessive noise in the signal. The estimation of RA pressure is needed for both calculations
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and can be derived using inferior vena caval diameter and its change with respiration, as well
as the ratio of systolic to diastolic flow signals in the hepatic veins.
2.2.6. Pulmonary venous flow
Pulse wave (PW) Doppler of pulmonary venous flow is performed in the apical 4-chamber
view and aids in the assessment of LV diastolic function. A 2-mm to 3-mm sample volume is
placed more than 0.5 cm into the pulmonary vein for optimal recording of the spectral
waveforms. Measurements include peak S and D velocities, the S/D ratio, systolic filling
fraction, and peak Ar velocity in late diastole. Another measurement is the time difference
between Ar duration and mitral A-wave duration (Ar - A). With increased LV end-diastolic
pressure, Ar velocity and duration increase, as well as the Ar - A duration. In patients with
depressed EFs, reduced systolic filling fractions (less than 40%) are related to decreased LA
compliance and increased mean LA pressure. Atrial fibrillation results in a blunted S wave
and absence of Ar velocity.
2.2.7. Other echocardiographic findings in diastolic heart failure
Regional wall motion abnormalities with preserved EF and right ventricular dilatation, either
from ischemic disease or secondary to chronic pressure overload from chronic pulmonary
venous hypertension, can also be present at echocardiography in patients with HFpEF.
Additional negative findings at echocardiography include the absence of valvular disease,
pericardial tamponade, pericardial constriction, the presence of congenital heart diseases such
as atrial septal defect, other more extensive structural abnormalities are important enough to
cause the HF symptoms.
3. Conclusions
HFpEF currently accounts for more than 50% of all heart failure patients. The updated
strategies for the diagnosis and exclusion of HFpEF are useful not only for individual patient
management but also for patient recruitment in future clinical trials exploring therapies for
HFpEF. Echocardiography is useful for the diagnosis of HFpEF, noninvasively.
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1. Introduction
The right ventricle (RV) has its own particular morphology and functions, which are different
when compared to the left ventricle (LV). In clinical practice, the right heart chambers are often
overlooked, as most physicians tend to focus more on LV and left atrium (LA) morphology
and functions. However, cardiac pathology is often associated with right chambers impair‐
ment, which can occur as a primary pathophysiological response to elevated pressure in the
pulmonary arterial circulation associated with primary pulmonary artery hypertension [1-2],
in pulmonary diseases associated with pulmonary venous or arterial hypertension [3-4],
pulmonary embolism [5], but also in congenital heart disease [6]. Most often, RV dysfunction
is triggered by left chamber impairment [7-9].
Right cardiac imaging is quite challenging, as there are few validated and reproducible
parameters that can be employed for an accurate right atrium (RA) and RV morphology and
function assessment. However, some imaging techniques are available for this purpose.
Nowadays, cardiac magnetic resonance imaging (MRI) is the golden standard for right
chambers evaluation [10], due to its unlimited imaging planes, higher image resolution, and
the ability to calculate volumes using three-dimensional (3D) measurements. Regrettably, this
type of evaluation is not available in many centres and rather expensive, requiring high quality
equipment and highly trained examiners.
Although cardiac MRI is the preferred method [11], echocardiography remains a valuable
alternative, as it is widely available, non-invasive, and less expensive and can be performed
in all patients oblivious of associated pathology or the presence of metallic devices such as
pacemakers, implanted cardioverter defibrillators, cochlear implants or drug infusion pumps.
© 2013 Agoston-Coldea and Lupu; licensee InTech. This is a paper distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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type of evaluation is not available in many centres and rather expensive, requiring high quality
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Although cardiac MRI is the preferred method [11], echocardiography remains a valuable
alternative, as it is widely available, non-invasive, and less expensive and can be performed
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Some studies seem to suggest that the risk usually associated with cardiac MRI in patients with
pace makers and defibrillators is overestimated and that examination using magnetic fields
up to 1.5 Tesla can be safe [12-13]. However, performing such an examination is not without
risk and should be attempted in selected patients, with several precautions including complete
resuscitation facilities and in the presence of an electrophysiologist [14]. All in all, cardiac MRI
requires many precautions, in such cases, whereas echocardiography is without risk and easier
to perform. Despite its major advantages, echocardiography has its limitations, mainly due to
the particular morphology of the RV. The thin, trabeculated right free wall and the anterior
position in the chest render RV assessment difficult [15]. Moreover, endocardial border tracing
is strenuous due to the presence of trabeculations, which can be a source of error when
attempting to obtain precise dimension assessment. These downfalls are limited when real-
time 3D echocardiography is used, although, for the time being, end-systolic and end-diastolic
RV volumes seem to be underestimated when compared to cardiac MRI measurements [16].
Some studies have shown, however, that, in spite of the difference in volume measurements,
the correlation between 3D echocardiography and MRI assessment of the right ventricle
ejection fraction (RVEF) is quite strong [17]. All in all, echocardiography can be very useful,
provided that a complex standard protocol is followed.
2. Anatomy and physiology of the right ventricle
The RV has an anterior position in the chest and lies immediately behind the sternum. It has
a triangular or crescent shape and three distinct regions with different embryological origin
and electrophysiological properties. The three regions include: 1) the inlet component, 2) the
apical trabecular component and 3) the outlet component [18]. The inlet component extends
from the tricuspid valve insertion to the level of the papillary muscle, surrounding and
supporting the tricuspid valve and the subvalvular apparatus. The trabecular component
extends from the papillary muscles level to the apex and contains coarse trabeculations. The
inlet and trabecular components have a common embryological origin and form a morpho‐
logical and functional structure called sinus. The sinus is the pivot structure for RV contraction.
The outlet component, also called the infundibulum, conus or the RV outflow tract (RVOT)
has its distinct embryological origin and is functionally different from the sinus. This compo‐
nent has a smooth surface and a minute contribution to RV output volume, and is the last
cardiac structure to be activated, at end systole [19]. This region is particularly important in
patients with congenital heart disease [20] and arrhythmias such as the idiopathic outflow
tachycardia [21], as well as for the diagnosis of arrhythmogenic right ventricle dysplasia
(ARVD), for which the left parasternal long-axis view is usually preferred [22]. All in all, each
region of the RV (Figure 1) is essential in patients with cardiopulmonary disorders and should
be analysed in correlation with segmental coronary vascularisation [18, 23].
RV physiology is closely linked to its anatomical properties. The thin, trabeculated free wall
is adapted to the low pressures in the pulmonary circulation, its dynamics being very different
from that of the LV. RV contraction is generated by the progression of a peristaltic wave which
begins at the inlet and moves towards the infundibulum. RV depolarization triggers the
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mechanic activity which consists of inward, longitudinal and circumferential traction; the
systolic function is mainly determined by the longitudinal contraction which causes the
shortening of the ventricle, with equal contribution from the interventricular septum and the
free wall [24]. Several factors contribute to RV global function, namely the preload, afterload
and contractility. The preload is dependant on the volume status, the tricuspid valve gradient
and the venous return from the vena cava. The afterload is determined by the resistance
opposed by the pulmonary valve, the pulsatile flow reflected from the main pulmonary artery,
the impedance of the proximal pulmonary artery and arterioles [25]. Pulmonary vascular
resistance may not, therefore, be used to assess RV total afterload, particularly in patients with
pulmonary hypertension [25]. Due to its thin free wall and high compliance, the RV can easily
adapt to increased preload by dilatation, which can be well tolerated for a long time, although
it eventually leads to RV failure. By contrast, elevated afterload is poorly tolerated from an
early stage, as the RV has little capacity for compensatory hypertrophy, which is quickly
followed by increased stiffness and chamber dilatation [3]. In clinical practice, changes in
preload and afterload alter RV contraction. Other factors that may impair RV systolic function
include abnormal variations of the heart rate, pharmacological agents, or ventricular interde‐
pendence [25]. Ventricular interdependence refers to the fact that the shape, size and compli‐
ance of one ventricle may influence the shape, size or pressures in the other ventricle, an
essential concept for understanding the pathophysiology of RV dysfunction [9].
3. Assessment of right chambers morphology and systolic function
3.1. Echocardiography
Echocardiography can help with qualitative morphological examination by 2D and 3D
echocardiography. Although 2D echocardiography is widely applied in everyday clinical
practice for the morphological and functional assessment of cardiac chambers and valves, 3D
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Figure 1. Segmental anatomy of right ventricle in correlation with segmental coronary vascularisation. Adapted from
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provides a superior view of the valves. 2D echocardiography of the right chambers may
provide diameter, area and volume measurements, which should be indexed to body surface,
and allows the assessment of the systolic pulmonary artery pressure (sPAP) using the tricuspid
regurgitation flow and inferior vena cava (IVC) diameter and its variations during the
respiratory cycle. Newer techniques, such as tissue Doppler and strain-rate imaging, provide
valuable data on the systolic and diastolic functions of the RV.
3.1.1. Right ventricle
A complete evaluation of RV structure should include the study of RV volume, shape and
internal architecture, RV hypertrophy and mass, tissue characterization, assessment for
potential masses [8], and regional wall motion abnormalities [26]. Normally, the RV has a
crescent shape when viewed from the parasternal short-axis incidence; when the RV is
submitted to pressure and volume overload, the crescent shape changes to a D shape, with
subsequent septal flattening, leading to impaired LV filling and decreased output. Septal
movement analysis can help distinguish between RV volume and pressure overload; in the
case of volume overload, septal flattening only occurs during the diastole, whereas, in the
presence of pressure overload, it is persistent throughout the entire cardiac cycle [27-28]. This
phenomenon is quantitatively analyzed by deriving the eccentricity index, calculated as the
RV anteroposterior over the RV septolateral diameter ratio (which may be measured at end-
systole or end-diastole); a value>1 suggests RV overload and was shown to be positively
correlated with pulmonary artery hypertension [29].
a. Acquisition and measurements:
Although qualitative assessment of the RV has its virtues, quantitative assessment provides
more accurate and interpretable data. Morphology assessment may include diameter, area and
volume measurements. RV morphology should be assessed by 2D using several acoustic
windows such as the parasternal long-axis view (which allows RV anterior wall visualisation),
the parasternal short-axis view (to assess the infundibulum and some of the RV anterior wall),
the left parasternal RV inflow window (for the anterior, lateral and inferior RV walls, depend‐
ing on the section level), the subcostal view (for the lateral wall and the infundibulum), the
apical 4-chamber view, and apical 5-chamber view (for assessment of the RV lateral wall) [26]
(Figure 2). Usually, the RV is best measured at end-diastole using the 4-chamber apical view.
From this window, three dimensions can be derived: the basal diameter (the largest diameter
in the basal third of the RV, usually just below the tricuspid annulus); the medial diameter
(measured at the level of the LV papillary muscles); the longitudinal diameter (measured from
the RV apex to the tricuspid annulus plane). RV free wall thickness is best measured from the
subcostal view at the end of the diastole, using either 2D or M-mode imaging techniques;
oblivious of the preferred method, measurements should exclude trabeculations, the papillary
muscle, and the pericardium. RV volume and function may also be assessed by 3D trans‐
thoracic echocardiography using apical and subcostal views. Usually, four-beat images are
necessary to include the entire RV, although newer techniques allow a good evaluation using
a single beat, at the expense of temporal and spatial resolution [26].
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Figure 2. Echocardiography 2D views for right ventricle chamber.
Images are available for off-line analysis, allowing accurate endocardial contours delineation
and RV volumes measurement from sequential long axis planes. End-diastolic measurements
are taken at the peak of the R wave of QRS complexes, while end-systolic volumes are
measured in the first frame before opening of the tricuspid valve [26]. Furthermore, trabecu‐
lations are included in the blood pool. The end-diastolic, end-systolic RV and stroke volume,
as well as RVEF and RV mass are calculated using Simpson’s rule.
b. Qualitative values:
An empirical comparison of LV and RV dimensions allows RV description as (Table 1): normal
(when the RV has smaller dimensions when compared to the LV, with RV apex more basal
than the LV apex); mildly dilated (when the RV is enlarged, but still smaller than the LV);
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moderately dilated (when the RV and LV dimensions are equal); severely dilated (when the
RV is larger than the LV) [30]. However, normal values have been established for quantitative
assessment: a basal diameter >42 mm, a median diameter >35 mm and a longitudinal diameter
>86 mm indicate RV dilatation. The parasternal short-axis view of the great vessels allows
RVOT measurement at the level of the pulmonary valve insertion (the distal diameter) for
which a value of >27 mm signifies RV dilatation. Proximal RVOT diameter can be measured
from either the long or the short-axis parasternal views, with a normal maximum value of 33
mm. However, the former is usually preferred, as it is more reproducible [23]. RV areas are
measured at end-diastole and end-systole, with the following normal values: RV end-diastole
area 20.1 ± 4 cm2 and RV end-systole area 10.9 ± 2.9 cm2 [26, 30]. RV volumes may be calculated
by using either the Simpson method or the area-length method and normal values range
between 63-103 mL for end-diastolic volumes and 22-56 mL for end-systolic volume [31].
However, these 2D echocardiography measurements were proved to be inaccurate by
comparison with 3D echocardiography and cardiac MRI derived volumes. Normal thickness
ranges from 3 to 5 mm [23], and any value surpassing 5 mm suggests RV hypertrophy, which
is usually a response to pressure overload, in the absence of associated pathology, such as










Basal RV diameter (RVD1), mm 20-28 29-33 34-38 "/>39
Mid-RV diameter (RVD2), mm 27-33 34-37 38-41 "/>42
Base-to-apex length (RVL), mm 71-79 80-85 86-91 "/>92
RVOT diameters
Above aortic valve, (RVOT
proximal) mm
25-29 30-32 33-35 "/>36
Above pulmonic valve (RVOT
distal), mm
17-23 24-27 28-31 "/>32
RV area
RV diastolic area, cm2 11-28 29-32 33-37 "/>38
RV systolic area, cm2 7.5-16 17-19 20-22 "/>23
RV volume
RV diastolic volume, mL 63–103
RV systolic volume, mL 22–56
Table 1. Reference limits and partition values of right ventricular size
Hot Topics in Echocardiography16
The lack of accuracy in assessing RV volumes by 2D echocardiography is mainly determined
by the complex RV geometry and the heavily trabeculated inner wall contour. Real 3D
echocardiography overcomes these limitations and provides a superior evaluation of ventric‐
ular volume, mass and function, as well as a more complete view of the valves [26]. Moreover,
3D echocardiography was proved to be a reliable noninvasive modality of directing the
bioptome to the desired site of biopsy within the RV. In one study, 3D echocardiography
provided accurate anatomic details and was proved to allow sufficient pulmonary valve
visualization in 68% of the patients and an excellent RVOT visualisation in 40% [32]. Normal
medium values of RV end-diastolic and end-systolic volumes were established at 49 ± 10 and
16 ± 6 mL/m2 respectively, with a mean RVEF of 67 ± 8% [33]. Another study provided normal
reference ranges of indexed volumes: 38.6 to 92.2 mL/m2 for RV end-diastolic volume, 7.8 to
50.6 mL/m2 for end-systolic volume, 22.5 to 42.9 mL/m2 for stroke volume in women and higher
values in men: 47.0 to 100 mL/m2 for RV end-diastolic volume, 14.2 to 48.4 mL/m2 for end-
systolic volume, and 23.0 to 52.6 mL/m2 for stroke volume [34].
c. Clinical Application
The structural assessment of the RV provides information concerning the pressure and volume
loading conditions which may lead to functional impairment. The RV gradually adapts to
pressure overload by hypertrophy and interventricular septal flattening, with systolic function
impairment, RV and tricuspid annulus enlargement and aggravated tricuspid regurgitation,
which trigger RV diastolic dysfunction. Therefore, RV morphology should be assessed
periodically in patients with acute or chronic respiratory pathology and valvulopathies with
the purpose of identifying early anomalies which might be corrected by a proper therapeutic
approach. Until recently, the eccentricity index was based on measurements made from the
parasternal short-axis view, at the level of papillary muscles. However, one recent study shows
that these measurements were less accurate than those made at the apical level, which was
superior in terms of correlation with aggravated pulmonary hypertension [35], right chamber
dilatation and RV systolic dysfunction [36]. In addition to that, ultrasound imaging techniques
may identify regional morphologic abnormalities that occur in ARVD, provided the area of
dysplasia is large enough. The diagnosis of ARVD is likely in the presence of significant local
wall aneurysm (major diagnostic criterion), trabeculation disarray, increased thickness of the
moderator band, with hyperechogenic appearance and RVOT dilatation [37]. However,
despite the advantages, the diagnosis of ARVD by imaging techniques cannot rely on echo‐
cardiography alone.
3.1.2. Right atrium
The RA has its own complex pathology, as it responds to both RV volume and pressure
overload. In addition to that, RA enlargement was documented in patients with atrial ar‐
rhythmias such as atrial fibrillation by both 2D and 3D echocardiography; moreover, it has
been proven that RA remodelling occurs in atrial fibrillation and regresses if sinus rhythm is
restored and maintained after radiofrequency catheter ablation [38]. However, RA dilatation
is most often encountered in patients with elevated pulmonary hypertension.
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a. Acquisition and measurements:
The RA is most often visualized from the apical 4-chamber view or the subcostal view [23, 26,
39]. However, due to the fact that standardized data concerning RA assessment is scarce,
current evaluation includes exclusively RA minimum and maximum diameter and RA area
estimation. All these measurements are made by planimetry from the apical 4-chamber view,
at the end of the ventricular systole, when the atrium volume is largest (Figure 3). 3D echo‐
cardiography, although time consuming, may also be employed to calculate RA volume, with
the advantage of more accurate endocardial border tracing at end-systole. To this purpose,
two orthogonal planes (two-plane), four equiangular planes (four-plane), and eight equian‐
gular planes (eight-plane) may be used [40]. All the collected data can be analyzed on and off-
line, with cropping and threshold processing. The final result depends on the accurate and
complementary use of these processing tools [41].
Figure 3. Echocardiography 2D views for right atrium.
b. Qualitative values:
The maximal short-axis distance is measured at mid level, with an upper reference limit of 44
mm. The maximal long axis distance is measured from the center of the tricuspid annular plane
to the center of the RA superior wall, describing a straight line parallel to the interatrial septum;
the threshold for the maximal normal value has been established at 53 mm [23] (Table 2). RA
area provides a more accurate assessment, but it is more time-consuming and, thusly, avoided
by most physicians. The upper reference limit has been established at 18 cm2 or at 9 cm2/m2.











RA minor-axis dimension, mm 29-45 46-49 50-54 "/>55
RA minor-axis dimension/BSA, mm/m2 17-25 26-28 29-31 "/>22
Table 2. Reference limits and partition values for right atrium 2D dimensions
Hot Topics in Echocardiography18
In 3D echocardiography, RA volumes are calculated using the following formula: 0.85 (D2)/L,
where D is the area in the four-chamber view and L the vertical long-axis [42]. Images should
be taken from three different beats and the loops and tracings from the first examination should
be available during the second and third examination to improve accuracy (Table 3) [42].
RA 3D echocardiography Men Women
RAEF, % 46-74 48-83
RAVI max, mL/m2 18-50 17-41
RAVI min, mL/m2 7-22 5-18
Table 3. Reference limits and partition values for right atrium 3D dimensions
c. Clinical Application
Real-time 3D echocardiography is believed to be a more reproducible and robust method for
atrial volume measurements than 2D echocardiography [42], particularly in the presence of
pathological conditions such as pulmonary disorders, congenital heart disease, valvular
disease, and heart failure.
3.1.3. Inferior vena cava
Right chamber and pulmonary artery pressure assessment also relies on inferior vena cava
(IVC) diameter measurement and the study of its variation during the respiratory cycle. In
normal subjects, the IVC collapses, reducing its diameter with more than 50% after a sniff [43];
during a spontaneous, normal breathing cycle, changes in pleural pressure occur, which
influence RA pressure; while inbreathing, the intrathoracic pressure becomes lower, allowing
a more significant venous return and a decrease in IVC diameter. Respiratory variations are
abolished in case of cardiac tamponade or severe right heart failure [43].
a. Acquisition and measurements:
The subcostal 4-chamber view is used to measure the IVC at end-expiration, proximal to the
emergence of the hepatic veins, which is usually located at 0.5 to 3 cm of the IVC-RA ostium.
Maximum and minimum diameters should be measured perpendicular to the long axis of the
IVC. Measurements may be facilitated by using M-mode (Figure 4).
b. Qualitative values:
Current guidelines [23] established an upper reference limit of 21 mm for IVC diameter. For
an IVC diameter ≤21 mm and an inbreathe variation of >50%, the RA pressure is estimated at
3 mmHg (range 0 – 5 mmHg). If IVC diameter is >21 mm, and the inbreathe collapse is lower
than 50%, the RA pressure is estimated at 15 mmHg (range, 10 – 20 mmHg). However, some
cases do not fit this paradigm; in that situation, if IVC >21 mm and significant collapse (>50%)
occurs after a sniff, or if IVC ≤21 mm, but there is scarcely any inbreathe diameter variation or
none at all, RA pressure is estimated at 8 mmHg (Table 4). Other authors [44] have previously
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an IVC diameter ≤21 mm and an inbreathe variation of >50%, the RA pressure is estimated at
3 mmHg (range 0 – 5 mmHg). If IVC diameter is >21 mm, and the inbreathe collapse is lower
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suggested a different approach (Table 4). The reference normal value interval for the IVC
diameter was set at 15 – 25 mm; if the measured IVC diameter remained within these limits,
and decreased with >50% after a sniff, the RA pressure was estimated at 5 – 10 mmHg; if
inbreathe variation was <50%, RA pressure was estimated at 10 – 15 mmHg, and at 15 – 20
mmHg if IVC diameter was greater than 25 mm. If IVC was dilated and remained flat during
the respiratory cycle, and dilated hepatic veins were also visualized, RA pressure was
considered to be >20 mmHg.
Figure 4. Measurement and view of the inferior vena cava (IVC) perpendicular to the long axis at end-expiration, just
proximal to the junction of the hepatic veins that lie proximal to the ostium of the right atrium.
IVC diameter Change after “sniff” Estimated right atrium pressure (mmHg)
Estimated right atrium pressure by Rudski [23]
≤ 21 mm Collapse "/>50% 3 mmHg (range 0 – 5 mmHg)
"/> 21 mm Collapse <50% 15 mmHg (range 10 – 20 mmHg)
"/>21 mm Collapse "/>50% 8 mmHg (range 5 – 10 mmHg)
≤ 21 mm Collapse <50% 8 mmHg (range 5 – 10 mmHg)
Estimated right atrium pressure by Otto [43]
Normal range (15–25 mm) Collapse "/>50% 5 – 10 mmHg
Normal range (15–25 mm) Collapse <50% 10 – 15 mmHg
Dilated ("/>25 mm) Collapse <50% 15 – 20 mmHg
Dilated ("/>25 mm) Flat "/> 20 mmHg
Table 4. Right atrium pressure assessment by inferior vena cava collapse and inbreathe variation
Hot Topics in Echocardiography20
c. Clinical Application
Oblivious of the approach, estimated RA pressure is added to the tricuspid regurgitation
gradient in order to calculate the systolic pulmonary artery pressure (sPAP). Usually, IVC
diameter is only used to assess sPAP, and is not interpreted individually. However, one study
focused on idiopathic pulmonary hypertension patients showed that an IVC diameter ≥20 mm,
with respiratory variation <50%, was a prognostic factor for mortality [45]. In some cases, such
as young athletes, dehydrated patients or in the presence of mechanical respiratory assistance
devices, IVC diameter correlates poorly with RA pressure.
3.1.4. Right ventricle systolic function
Assessing RV systolic function can be difficult, due to the particular morphology of the RV.
Geometrical assumptions are based on pyramidal and ellipsoidal models which are not
particularly accurate, as the RV has a rather irregular shape. Moreover, area and volume
estimation can be impaired by the presence of trabeculations in the RV, which should be
excluded from myocardial border tracings. For volume calculation, area-length and disk
summation (Simpson’s) methods are used, the latter being more accurate. However, volumes
are underestimated by 2D echocardiography [46], when compared to 3D echocardiography
[47] and cardiac MRI [34]. Cardiac computed tomography may also be used, but RV volumes
tend to be overestimated using this imaging technique [48], while cardiac MRI remains the
gold standard for RV assessment, although it was shown to correlate very well with real-time
3D echocardiography measurements [11]. These imaging techniques are often unavailable in
most centres, rendering 2D echocardiography quite important, despite its downfalls. A
complete 2D echocardiography examination should include area and volume assessment, as
well as several derived parameters (Table 5), such as right ventricle fractional area change
(RVFAC) and the RVEF, tricuspid annular plane systolic excursion (TAPSE), systolic velocity
of the myocardium (St wave) and right ventricular myocardial performance index (RVMPI).







RVFAC, % 32-60 25-31 18-24 <17
RVEF, % 43–65 40-30 30-20 <20
TAPSE, mm 15-20 13-15 10-12 <10
Table 5. Reference limits and partition values of right ventricular systolic function as measured in the apical 4-
chamber view
a. Right ventricle fractional area change
The RVFAC is estimated using the formula: (end-diastolic area – end-systolic area)/end-
diastolic area x 100, with a lower reference value for normal RV systolic function of 35% [23]
and was previously proved to diminish in primary pulmonary hypertension patients, when
compared to healthy controls [49] (Figure 5). Normal RVFAC and partition values [30] are
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c. Clinical Application
Oblivious of the approach, estimated RA pressure is added to the tricuspid regurgitation
gradient in order to calculate the systolic pulmonary artery pressure (sPAP). Usually, IVC
diameter is only used to assess sPAP, and is not interpreted individually. However, one study
focused on idiopathic pulmonary hypertension patients showed that an IVC diameter ≥20 mm,
with respiratory variation <50%, was a prognostic factor for mortality [45]. In some cases, such
as young athletes, dehydrated patients or in the presence of mechanical respiratory assistance
devices, IVC diameter correlates poorly with RA pressure.
3.1.4. Right ventricle systolic function
Assessing RV systolic function can be difficult, due to the particular morphology of the RV.
Geometrical assumptions are based on pyramidal and ellipsoidal models which are not
particularly accurate, as the RV has a rather irregular shape. Moreover, area and volume
estimation can be impaired by the presence of trabeculations in the RV, which should be
excluded from myocardial border tracings. For volume calculation, area-length and disk
summation (Simpson’s) methods are used, the latter being more accurate. However, volumes
are underestimated by 2D echocardiography [46], when compared to 3D echocardiography
[47] and cardiac MRI [34]. Cardiac computed tomography may also be used, but RV volumes
tend to be overestimated using this imaging technique [48], while cardiac MRI remains the
gold standard for RV assessment, although it was shown to correlate very well with real-time
3D echocardiography measurements [11]. These imaging techniques are often unavailable in
most centres, rendering 2D echocardiography quite important, despite its downfalls. A
complete 2D echocardiography examination should include area and volume assessment, as
well as several derived parameters (Table 5), such as right ventricle fractional area change
(RVFAC) and the RVEF, tricuspid annular plane systolic excursion (TAPSE), systolic velocity
of the myocardium (St wave) and right ventricular myocardial performance index (RVMPI).







RVFAC, % 32-60 25-31 18-24 <17
RVEF, % 43–65 40-30 30-20 <20
TAPSE, mm 15-20 13-15 10-12 <10
Table 5. Reference limits and partition values of right ventricular systolic function as measured in the apical 4-
chamber view
a. Right ventricle fractional area change
The RVFAC is estimated using the formula: (end-diastolic area – end-systolic area)/end-
diastolic area x 100, with a lower reference value for normal RV systolic function of 35% [23]
and was previously proved to diminish in primary pulmonary hypertension patients, when
compared to healthy controls [49] (Figure 5). Normal RVFAC and partition values [30] are




shown in Table 5. In one study, RVFAC was found to be an independent predictor of heart
failure, stroke and higher mortality in patients with prior myocardial infarction [50].
Figure 5. Measurement of the right ventricular fractional area change (RVFAC), views for right ventricle chamber.
b. Right ventricular ejection fraction
The RVEF is derived using the formula: (end-diastolic volume – end-systolic volume)/end-
diastolic volume, for which the minimal normal value was established at 44% (Figure 6).
Although RVEF measurement by echocardiography is impaired by geometrical assumptions,
difficult endocardial border tracing and the fact that the RVOT is not included in area and
volume assessment, it is still a valuable parameter, as some studies showed that RVEF is a
strong and independent predictor of mortality in heart failure [51-52]. Both RVFAC and RVEF
were proved to significantly correlate with other RV function parameters such as the myocar‐
dial performance index [53]. As mentioned above, the RV systolic function is dependent on
the LV function and can be altered in the presence of interventricular septum movement
abnormalities. The LV systolic function is mostly determined by the radial contraction, while
the thin RV free wall systolic movement is predominantly determined by longitudinal
shortening.
c. Tricuspid annular plane systolic excursion
To assess RV free wall systolic shortening, the TAPSE is measured. This parameter is assessed
using the apex-4-chamber view and the M-mode; the cursor is placed at the level of the
tricuspid annular plane, allowing the examiner to assess the base to apex motion of the annular
plane during systole (Figure 7). The minimal reference threshold has been established at 16
mm (normal values ranging around 22 ± 4 mm) and it is inferred that higher TAPSE values
correspond to a better systolic function. TAPSE is easy to measure, reproducible, does not
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require special equipment and is valuable when assessing RV function after myocardial
infarction, but does present with some downfalls, particularly due to the fact that it only reflects
the basal segment function, ignoring other regions. Moreover, it is angle and load dependant.
However, some studies have shown that it correlates well with RVFAC and Simpson’s method
derived RVEF [35, 54], as well as ventriculography derived RVEF [24] and that it is highly
reliable as a prognostic tool in pulmonary hypertension [52, 55], heart failure [24] and dilated
cardiomyopathy, oblivious of the ischemic or non-ischemic aetiology [52].
Some level of correspondence has been demonstrated between TAPSE (in mm) and RVEF; a
TAPSE of 5 mm corresponds to a 20% RVEF, 10 mm to a 30% RVEF, 15 mm to 40%, 20 mm to
50% [56].
d. Tissue Doppler analysis
Tissue Doppler imaging’s (TDI) may be used to obtain other indices of RV performance such
as the St wave, the isovolumic contraction velocity and the derived myocardial acceleration
(Figure 8) during isovolumic contraction. All these parameters are quite independent of
anatomical properties and do not rely on any geometrical assumptions, but may be influenced
by load conditions. As they are angle dependent, Doppler beam alignment should be optimal.
The isovolumic contraction velocity is measured using either pulsed or colour-coded TDI with
sample volume placement on the RV free wall at the level of the tricuspid annulus. The
isovolumic contraction phase starts immediately after the A’ wave corresponding to ventric‐
ular filling during atrial systole and precedes the St wave which describes ventricle wall
movement during the ejection phase. In one study, the isovolumic contraction velocity was
shown to correlate very well with mean RA pressure and proved to have 100% sensitivity and
78% specificity for a cut-off value <6 cm/s [57-58].
Figure 6. Measurement of the right ventricular ejection fraction (RVEF), views for right ventricle chamber.
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Figure 8. Pulsed wave tissue Doppler with the sample placed at the level of the tricuspid annulus of the RV free wall,
demonstrating peak systolic velocity (St), and myocardial acceleration during isovolumic contraction (IVA).
This parameter may further be used to derive the myocardial acceleration during isovolumic
contraction (IVA) which is calculated as the peak isovolumic contraction velocity divided by
the time to peak velocity. Myocardial acceleration during isovolumic contraction may be
measured either by pulsed-wave TDI or colour-coded TDI, but normal values seem to be
different; in one study, values proved to be up to 20% higher when assessed by pulsed-wave
TDI, by comparison with colour-coded TDI evaluation [23] [59]. In addition to that, normal
values vary with age [60] and heart rate. For tissue Doppler assessment, pooled data from 10
studies established a lower reference value of 2.2 m/s [23]. IVA was studied on several animal
models which lead to significant conclusions which may be implemented in every day practice.
Figure 7. Measurement of the tricuspid annular plane systolic excursion (TAPSE) in normal and pulmonary artery hy‐
pertension individual, in the four chamber view a straight line (M mode) is drawn through the lateral tricuspid valve
annulus.
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Vogel et al. conducted a study on pigs, proving that IVA is afterload and preload independent
[61], while Hashimoto et al. conducted their research on sheep, proving that IVA correlates
very well with peak positive dp/dt measured invasively by right heart catheterization [62]. In
humans, studies have shown that IVA was significantly correlated with disease severity in
patients with chronic obstructive pulmonary disease [63], obstructive sleep apnoea [64], RV
remodelling triggered by type 2 diabetes mellitus [65], and that it may be used for early
detection of RV dysfunction in patients with mitral stenosis [66] or systemic sclerosis, even
before the onset of pulmonary hypertension [67]. Moreover, in one study on patients who
underwent corrective surgery for transposition of the great arteries, IVA was proved to be
superior to the peak systolic myocardial velocity in assessing the reduction of functional
reserve, in both the RV and LV [68].
TDI may also be used for measuring the highest St wave. This parameter is obtained from the
apical four chamber view by positioning the sample volume either at the level of the tricuspid
annulus, on the lateral wall, or in the middle or apical segments segment. The latter locations
are, however, avoided by most physicians as adequate signals are rarely obtained and
measurements are less reproducible, with greater interobserver variability [58]. St may be
measured using pulsed tissue or colour coded TDI, and is, as other TDI parameters, angle
dependent, but less influenced by loading conditions or RV anatomy when compared to other
systolic function parameters. Mean annular velocities have been established at 8.5 – 10 cm/s,
while basal free wall velocities are slightly higher at 9.3 – 11 cm/s [23], with lower velocities in
elderly subjects due to the increased stiffness of the myocardium [60, 69, 70]. The main
limitation of this parameter is determined by the fact that it only reflects changes in systolic
movement of the basal segment which are extrapolated as descriptive for the systolic function
of the entire RV. This type of measurement may sometimes be inaccurate in the presence of
segmental RV systolic dysfunction which may occur in some clinical conditions such as RV
myocardial infarction, ARVD or pulmonary embolism. A St value under 10 cm/s should rise
suspicion of RV dysfunction, especially in young subjects, although a minimum reference
value was established at 6 cm/s by pooled data from several studies [23]. In one research, a St
value of <12 cm/s showed high sensitivity (81%), specificity (82%) and negative predictive
value (92%) for the diagnosis of RV myocardial infarction [71], while Meluzin et al. demon‐
strated it was significantly correlated with RVEF and that a value <11.5 cm/s predicted RV
systolic dysfunction with 90% sensitivity and 85% specificity in patients with heart failure [72].
Also, St was also shown to be lower, as expected, in patients with systemic sclerosis [67].
e. Right ventricular myocardial performance index
Both the systolic and diastolic functions of the RV may be evaluated using the myocardial
performance index, also known as RVMPI or Tei index. This index can be obtained either by
pulsed Doppler or TDI and is defined by the ratio of isovolumic time/ejection time. The ejection
time is assessed by placing the pulsed Doppler cursor at the level of the RVOT and is measured
from the onset to the cessation of the systolic pulmonary artery flow. When the pulsed Doppler
cursor is placed at the level of the tricuspid annulus, the time from the cessation of the A wave
to the onset of the next E wave is measured and the difference between this interval and the
ejection time signifies the total isovolumic time (isovolumic resting time + isovolumic con‐
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traction time). These measurements are taken from two different acoustic windows and,
implicitly, in different points in time, therefore errors can occur if the RR interval is not regular.
Consequently, measurements may only be made if the rhythm is regular and are not feasible
in case of atrial fibrillation. When using the TDI method, measurements are taken during a
single heart beat, by placing the cursor at the level of the tricuspid annulus (Figure 9). The
isovolumic contraction time (IVCT) is measured from the cessation of the At wave to the
beginning of the St wave, the ejection time (ET) – from the onset to the cessation of the St wave,
and the isovolumic relaxation time (IVRT) – from the end of the S’ wave to the onset of the Et
wave. The correlation between the tissue Doppler and pulsed Doppler methods are modest,
due to differences in isovolumic times, which lead to higher cut-off points when tissue Doppler
is used, as it was shown in studies focused on the LV [73, 74]. Moreover, one recent study
showed that LV Tei index assessment by tissue Doppler was better correlated with the LV
ejection fraction in patients with heart failure [75]. Similar results were obtained in a study on
a paediatric population with congenital heart disease which showed that the TDI derived Tei
index values were different from those obtained by pulsed Doppler and that they had
additional utility, as they might help differentiate systolic from diastolic dysfunction by
providing specific information on the isovolumetric intervals [76]. For the RVMPI, the upper
reference limit has been established at 0.40 by the pulsed Doppler method and at 0.55 by the
tissue Doppler method [23]. Any values above these thresholds are considered to be patho‐
logical, as stated by Brierre et al. who obtained a mean value of the Tei index of 0.90 in their
research on idiopathic pulmonary artery hypertension patients; moreover, they showed that
values ≥0.98 were associated with increased mortality [45].
Up to date, RVMPI was proved to be useful for RV function assessment in several studies.
One study on patients with acute RV myocardial infarction showed that the Tei index was
valuable  for  diagnosis,  RV function quantification and,  interestingly,  for  acute  improve‐
ment assessment [77].
In another research by Blanchard et al. conducted on patients with chronic thromboembolic
pulmonary hypertension, RVMPI was shown to be a valuable tool for monitoring disease
severity and for assessing outcome after pulmonary thrombo-endarterectomy, and positively
correlated with pulmonary vascular resistance, measured by right heart catheterization [78].
Moreover, RVMPI was shown to be a high sensitivity and specificity parameter for diagnostic
purposes in patients with acute pulmonary embolism, as well as a valuable tool for assessing
the response to efficient anticoagulant therapy [79-81]. In addition to that, Haddad et al.
demonstrated that both the RVMPI and the RVFAC may have an incremental prognostic value
in terms of mortality and morbidity after valvular heart surgery [82], while others confirmed
its utility in assessing global RV function in children with congenital heart disease [83-84]. The
Tei index also proved its value in RV function assessment in patients with sleep apnoea, as it
was positively correlated with the anoxia-hypoxia index, while RVFAC showed inverse
correlation with the same parameter [85].
The echocardiographic evaluation of RV by RVMPI has many advantages, as it is non-invasive,
widely available, reproducible and independent of any geometric assumptions. If the pulsed
wave Doppler method is used, errors may occur if the RR interval is variable. This downfall
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may, however, be limited by using the tissue Doppler method which allows measurement
taking during a single heart beat, but results are still unreliable in patients with atrial fibrilla‐
tion. Other disadvantages include load dependency and altered results when RA pressure is
elevated, due to artificial IVRT shortening which leads to lower RVMPI values [86].
Figure 9. Measurement of right ventricular myocardial performance index (RVMPI) by pulsed wave Doppler of tricus‐
pid regurgitation and tissue Doppler with the sample placed at the level of the tricuspid annulus of the RV free wall.
f. Analyzing the tricuspid regurgitation flow
RV systolic function assessment can also be performed by analyzing the tricuspid regurgitation
flow, which is commonly visualized from the apical 4-chamber view. Using continuous-wave
Doppler, several parameters can be derived, such as: RV-RA pressure gradient, systolic,
diastolic and mean pulmonary artery pressure (sPAP; dPAP; mPAP), the rate of pressure rise
in the RV (dp/dt), and the previously described right index of myocardial performance
(RVMPI). To this purpose, an optimal parallel alignment of the continuous Doppler cursor to
the tricuspid regurgitation (TR) flow should be obtained. The rate of pressure rise in the RV
(dp/dt) was first described in 1962 and measured invasively by right heart catheterization. An
echocardiographic method based on the Bernoulli equation was developed to serve the same
purpose, although it was shown that continuous-wave Doppler analysis of the TR flow
significantly underestimated peak RV pressures when compared to invasive measurements
[87]. The rate of pressure rise is calculated by measuring the time interval in which the tricuspid
flow velocity rises from 1 m/s to 2 m/s (Figure 10). Based on the Bernoulli equation, this rise
in velocity corresponds to a pressure elevation of 12 mmHg. Other researchers suggest that
dp/dt assessment correlates better with invasive measurements if the studied time interval is
focused on a rise in velocity from 0.5 to 2 m/s, which corresponds to a 15 mmHg rise in pressure
[88]. The value of dp/dt is expressed in mmHg/sec, but normal reference values have not been
established so far; this parameter, although easy to obtain, has limited clinical value, also due
to the fact that it is load and angle dependent. However, values <400 mmHg/s are likely to be
abnormal [23]. One small study showed that the dp/dt over maximum RV pressure ratio had
a significant correlation to the NYHA functional class, while dp/dt by itself had none at all [89].
Nowadays, this parameter is of little interest.
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Figure 10. Measurement of the rate of pressure rise in the ventricles (dp/dt) of tricuspid regurgitation in the four
chamber view in pulmonary artery hypertension individual.
The RV-RA pressure gradient may also be estimated using the peak velocity of the TR flow
based on the simplified Bernoulli equation: peak pressure gradient of TR= 4 x (TR maximum
velocity)2. As it is angle dependant, the best possible alignment of the continuous-wave
Doppler cursor with the regurgitation jet should be obtained and several measurements, from
several acoustic windows (most often, apical 4 chamber view and parasternal RV inflow view),
should be taken (Figure 11). The signal with the highest velocity and density should be used;
the Doppler signal may be enhanced by injecting agitated saline into the venous flow.
Moreover, special attention is necessary to exclude RVOT obstruction, which often occurs in
congenital heart disease. sPAP is then calculated by adding the estimated RA pressure
(assessed by IVC diameter and its inbreathe variations, as described above) to the RV-RA
gradient.
Figure 11. Doppler echocardiographic determination of systolic pulmonary artery pressure (sPAP).
A tricuspid regurgitation jet maximum velocity of ≤ 2.8 m/s renders pulmonary hypertension
unlikely, a velocity of >3.4 m/s – likely, while values between 2.8 m/s and 3.4 m/s indicate that
pulmonary hypertension is possible [90-91]. Normal resting values have been established at
≤36 mmHg for peak systolic pressure, assuming a RA pressure of 3-5 mmHg [23, 92].
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The severity of pulmonary hypertension may be underestimated in the presence of severe
tricuspid regurgitation that leads to elevated RA pressure and, consequently, to a lesser RV-
RA pressure gradient and lower sPAP (Table 6).
TR maximum velocity PAPs
Other echo parameters
suggesting HTP*
PH unlikely ≤ 2.8 m/s ≤ 36 mmHg
PH possible ≤ 2.8 m/s ≤ 36 mmHg +
2.9 – 3.4 m/s 37 – 50 mmHg +/-
PH likely >3.4 m/s >50 mmHg
* dilated right chambers; increased thickness of the RV free wall; abnormal shape and function of the interventricular
septum; dilated pulmonary artery; increased velocity of the pulmonary regurgitation jet; short acceleration time of RV
ejection in the pulmonary artery; PH - pulmonary hypertension
Table 6. Arbitrary criteria for the presence of pulmonary hypertension based on continuous Doppler derived systolic
pulmonary artery pressure (sPAP) and tricuspid regurgitation (TR) jet maximum velocity [90].
Like the sPAP, the dPAP can be derived by applying the Bernoulli equation to the pulmonary
regurgitation flow: dPAP=4 x (end-diastolic regurgitant velocity)2 + RA pressure. The pulmona‐
ry regurgitation flow may also be used to calculate the mPAP pressure after the same princi‐
ple, by the formula mPAP= (4 x early PR velocity) + RA pressure, or by adding RA pressure to
the velocity time integral (VTI) of the tricuspid regurgitation, the latter method being the most
accurate, as it correlates better to invasive measurements by right heart catheterization [93, 94].
Previous methods relied on more vague estimations, based on the sPAP and dPAP: mPAP= 1/3
sPAP + 2/3 dPAP, or obtained by analysing the pulmonary artery continuous wave Doppler
flow, using the formula mPAP= 79 – (0.45 x AT) (AT= acceleration time) [95].
The AT is measured from the onset of the pulmonary flow, which corresponds to the onset of
the QRS complex on the ECG, to the onset of the maximum pulmonary velocity; consequently,
the shorter the AT, the higher the mPAP. This formula applies when the heart rate is between
60 and 100 bpm, and the AT is below 120 msec. A study showed, however, that, in case of
aggravated pulmonary hypertension, when AT shortens below this threshold, the formula
mPAP= 90 – (0.62 x AT) led to more accurate results [95]. Despite the technical progress and
reasonable mathematical and physical assumptions, right chamber and pulmonary pressure
assessment by echocardiography is not sufficient for diagnosing pulmonary hypertension. In
pulmonary artery hypertensive patients, right heart catheterisation remains the golden
standard [94], as it is needed to confirm the diagnosis, to assess severity and to test for vessel
reactivity if specific therapy is considered [90]. Several studies have shown that sPAP is
considerably underestimated by echocardiography when compared to right heart catheteri‐
zation, oblivious of the used method [96-98]. However, despite all the limitations, the assess‐
ment of pulmonary artery pressures by echocardiography can be used as a screening method
for pulmonary hypertension [90, 94].
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Figure 10. Measurement of the rate of pressure rise in the ventricles (dp/dt) of tricuspid regurgitation in the four
chamber view in pulmonary artery hypertension individual.
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Figure 11. Doppler echocardiographic determination of systolic pulmonary artery pressure (sPAP).
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unlikely, a velocity of >3.4 m/s – likely, while values between 2.8 m/s and 3.4 m/s indicate that
pulmonary hypertension is possible [90-91]. Normal resting values have been established at
≤36 mmHg for peak systolic pressure, assuming a RA pressure of 3-5 mmHg [23, 92].
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Strain and strain rate (SR) imaging can provide valuable data on the relative deformation of
myocardial segments under stress. The resting length of the myocardium (L0) changes when
submitted to a certain force (L1). Myocardial strain is best described by the L1-L0/L0 ratio,
expressed in a certain percentage, which is negative when shortening occurs and positive when
the myocardium lengthens. The SR can be derived using strain and the velocity of myocardial
deformation, expressed in 1/s. The particular anatomy of the RV, which is mainly composed of
longitudinal and oblique fibres, renders it highly susceptible to strain variations at lower stress
when compared to the LV [99]. Right myocardial velocities are, thusly, higher than in the LV and
more elevated at the apex, when compared to the base, even in normal individuals [99].
TDI-derived and speckle-tracking echocardiography-derived strain and SR can be used to
assess RV dynamics and were found to be both feasible and roughly comparable. Strain and
SR correlate well with radionuclide RVEF [24].
Normal strain is 19 ± 6 % in the basal RV free wall, 27 ± 6 %, in the median and 32 ± 6 % at the
apex for the prediction of RVEF >50% [100]. This renders strain assessment of the RV quite
strenuous, with important limitations due to the need of perfect alignment of the TDI cursor
to the rather thin free wall of the RV. In addition to that, strain analysis is highly dependent
on hemodynamic variations [101]. In patients with RV disease or dysfunction, peak systolic
strain and SR are significantly reduced and delayed compared with individuals with normal
RV function [24].
RV speckle-tracking is less challenging in terms of angle issues, provided that optimal
endocardial border tracking is performed [102]. In 2D speckle-tracking analysis, a certain
selected zone is studied in motion, allowing a good assessment of the longitudinal, radial and
torsion movements of the RV (Figure 12); however, this method is limited by a low temporal
resolution [102].
h. 3D echocardiography
3D echocardiography may also be used to assess right ventricle systolic and diastolic functions.
It has been previously demonstrated that 3D echocardiography-derived RVEF correlated
Figure 12. Measurement of global right ventricular deformation by speckle-tracking with the sample placed at the
level of the RV free wall in normal and pulmonary artery hypertension individual.
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negatively with 2D-derived pulmonary arterial systolic pressure and positively with TAPSE,
the peak systolic velocity, and the fractional shortening area [32]. In one study, patients with
mitral valve prolapse who underwent surgical treatment had significantly lower TAPSE and
peak systolic velocities of the tricuspid annulus after surgery, while 3D-derived RVEF
remained the same (58.4 ± 4%) [32]. Moreover, 3D echocardiography analysis was used to
describe RV systolic function in patients with various cardiovascular disorders, showing that
patients with pulmonary hypertension had the largest RV volumes and RVEF, while those
with idiopathic dilated cardiomyopathy had considerably lower RVEF when compared to
patients with valvular heart disease [32].
In another study, normal RVEF reference values were established at 38.0% to 65.3% for women
and 29.9% to 58.4% for men [34].
3.2. Cardiac magnetic resonance imaging
Nowadays, cardiac MRI is considered to be the gold standard for determining RV volume and
function [11]. This method should be taken into account when 3D echocardiography is not
sufficient for evaluation.
a. Acquisition and measurements:
Cardiac MRI requires a minimum 1.5 Tesla scanner, with a phased-array cardiac coil. Cine
imaging acquired 2-chamber and 4-chamber views allow the positing of a retrospectively ECG-
gated steady-state free procession pulse sequence using following parameters: repetition time
3.5–4.2 ms, echo time 1.5–1.8 ms, flip-angle 45°, matrix 256 × 256, field of view 250–350 mm,
slice thickness 5–8 mm with a gap of 0–2 mm depending on body size; 12 slices should be
acquired [10]. Cardiac MRI allows an accurate delineation of the endocardial and epicardial
borders in all planes and all cardiac phases; in addition to that, the systolic descent and twist
of the tricuspid valve is quantified by tracking of the valve motion on the long-axis cines in
order to correct for loss of systolic RV volume due to AV ring descent; thirdly, papillary
muscles are delineated, with blood pool thresholding. This technique allows the calculus of
RV end-systolic and end-diastolic volumes, RV ejection fraction and right ventricular mass
with a great degree of precision [103-104]. Cardiac MRI allows a complete assessment of the
RV inflow and outflow, regardless of ventricular size or shape. The extent of myocardial
damage or fibrosis is evaluated using late gadolinium enhancement.
b. Qualitative values:
Several reference values for RV volumes have been mentioned, with significant gender
differences; consequently, larger RV volumes were documented in males when compared to
females: RV end-diastolic volume 190 ± 33 mL vs. 148 ± 35 mL, RV end-systolic volume 78 ±
20 mL vs. 56 ± 18 mL [105]. Other values were obtained in another study, which compared
MRI-derived volumes against 3D echocardiography volumes, proving the former were larger.
The following mean normal values were established for RV end-diastolic, end-systolic, and
stroke volumes: 134.2 ± 39.2 mL vs. 124.0 ± 34.4 mL; 69.7 ± 25.5 mL vs. 65.2 ± 23.5 mL; and 64.5
± 24.1 mL vs. 58.8 ± 18.4 mL [106].
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negatively with 2D-derived pulmonary arterial systolic pressure and positively with TAPSE,
the peak systolic velocity, and the fractional shortening area [32]. In one study, patients with
mitral valve prolapse who underwent surgical treatment had significantly lower TAPSE and
peak systolic velocities of the tricuspid annulus after surgery, while 3D-derived RVEF
remained the same (58.4 ± 4%) [32]. Moreover, 3D echocardiography analysis was used to
describe RV systolic function in patients with various cardiovascular disorders, showing that
patients with pulmonary hypertension had the largest RV volumes and RVEF, while those
with idiopathic dilated cardiomyopathy had considerably lower RVEF when compared to
patients with valvular heart disease [32].
In another study, normal RVEF reference values were established at 38.0% to 65.3% for women
and 29.9% to 58.4% for men [34].
3.2. Cardiac magnetic resonance imaging
Nowadays, cardiac MRI is considered to be the gold standard for determining RV volume and
function [11]. This method should be taken into account when 3D echocardiography is not
sufficient for evaluation.
a. Acquisition and measurements:
Cardiac MRI requires a minimum 1.5 Tesla scanner, with a phased-array cardiac coil. Cine
imaging acquired 2-chamber and 4-chamber views allow the positing of a retrospectively ECG-
gated steady-state free procession pulse sequence using following parameters: repetition time
3.5–4.2 ms, echo time 1.5–1.8 ms, flip-angle 45°, matrix 256 × 256, field of view 250–350 mm,
slice thickness 5–8 mm with a gap of 0–2 mm depending on body size; 12 slices should be
acquired [10]. Cardiac MRI allows an accurate delineation of the endocardial and epicardial
borders in all planes and all cardiac phases; in addition to that, the systolic descent and twist
of the tricuspid valve is quantified by tracking of the valve motion on the long-axis cines in
order to correct for loss of systolic RV volume due to AV ring descent; thirdly, papillary
muscles are delineated, with blood pool thresholding. This technique allows the calculus of
RV end-systolic and end-diastolic volumes, RV ejection fraction and right ventricular mass
with a great degree of precision [103-104]. Cardiac MRI allows a complete assessment of the
RV inflow and outflow, regardless of ventricular size or shape. The extent of myocardial
damage or fibrosis is evaluated using late gadolinium enhancement.
b. Qualitative values:
Several reference values for RV volumes have been mentioned, with significant gender
differences; consequently, larger RV volumes were documented in males when compared to
females: RV end-diastolic volume 190 ± 33 mL vs. 148 ± 35 mL, RV end-systolic volume 78 ±
20 mL vs. 56 ± 18 mL [105]. Other values were obtained in another study, which compared
MRI-derived volumes against 3D echocardiography volumes, proving the former were larger.
The following mean normal values were established for RV end-diastolic, end-systolic, and
stroke volumes: 134.2 ± 39.2 mL vs. 124.0 ± 34.4 mL; 69.7 ± 25.5 mL vs. 65.2 ± 23.5 mL; and 64.5
± 24.1 mL vs. 58.8 ± 18.4 mL [106].





The efficiency of 3D echocardiography vs. cardiac MRI in RV assessment was compared in
many studies. One research group conducted a study on 60 pulmonary artery hypertensive
patients [4], proving that 3D echocardiography had some advantages over cardiac MRI, as it
could be routinely used for serial imaging and at the bedside. Moreover, it was previously
shown that both 3D echocardiography and cardiac MRI may be used to assess RV remodeling
in pulmonary artery hypertension patients [11, 34, 107]. However, cardiac MRI results proved
to be more reproducible in terms of assessing RV ejection fraction and RV mass [26]. Although
less available, cardiovascular MRI is frequently used nowadays to describe RV systolic
function; recent imaging techniques allow a good assessment of parameters such as ventricular
volumes, ejection fraction, and myocardial mass, with increased accuracy when compared to
echocardiography. Stroke volumes, cardiac output, and volumes routed through cardiac
shunts can be derived using flow velocities and cross sectional areas. These methods are similar
to those used in Doppler echocardiography, but provide a better accuracy, as MRI velocity
analysis can be conducted in any orientation or plane. Tissue parameters are best visualized
by contrast enhancement techniques (contrast-enhanced MRI), which typically use gadolini‐
um-based magnetic contrast agents [103]. Similar to strain echocardiography, tagged MRI is
used to study the 3-dimensional motion and deformation in the heart. Tags are regions of the
myocardium, whose longitudinal magnetization has been altered before imaging which
render them dark in MRI. These dark areas are landmarks within the heart which allow the
detection of motion. In one study on patients with idiopathic pulmonary arterial hypertension,
tagged MRI was used to identify significant interventricular asynchrony caused by a pro‐
longed RV systolic contraction time, probably due to impaired electrical conductivity in the
right ventricle. It was then showed that ventricular asynchrony led to impaired LV diastolic
filling and, consequently, to decreased LV end-diastolic volumes [108]. Although further
research would be needed to validate reproducible parameters for RV evaluation, echocar‐
9
 
Figure 13. Cardiac MRI steady-state free procession sequence for the assessment of right ventricular function en-dia‐
stolic and en-systolic. RV=right ventricle; LV=left ventricle.
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diography and cardiac MRI based techniques are, for the time being, of immense value. As
mentioned before, cardiovascular MRI is nowadays considered to be the gold standard for RV
assessment; in one research, some 3D echocardiography-derived measurements, such as the
RVEF, compared well against cardiac MRI results, with little difference (47.8 ± 8.5% vs 48.2 ±
10.8%) [106]. However, in another study, a tendency to overestimate RVEF by 3D echocar‐
diography, with a bias of approximately 13% (95% CI -52% to +27%), has been reported;
moreover, in the same research, RV diastolic and RV systolic volumes were shown to be
systematically and significantly underestimated by 3D echocardiography [109]. Solid correla‐
tions were established between 2D echocardiography tissue Doppler St wave velocity and
MRI-derived RVEF [110]. In addition to that, it was shown that a systolic long-axis peak
velocity of <11 cm/s at the lateral tricuspid annulus was associated with moderately impaired
MRI-derived RVEF, while severely reduced RVEF ≤30% was best detected by RVMPI at a value
of >0.50 [111].
4. Assessment of right ventricular diastolic dysfunction
4.1. Echocardiography
4.1.1. Tissue Doppler analysis
a. Acquisition and measurements:
The assessment of RV diastolic dysfunction strongly resembles LV evaluation. Validated
parameters include the tricuspid flow E and A velocities, as well as the E/A ratio, the E wave
deceleration time and the IVRT, which are assessed in a similar manner to mitral flow
evaluation; the previously mentioned parameters are measured using the apical 4-chamber
view by placing sample volume at the tips of the tricuspid leaflets.
Several limitations undermine the accuracy of tricuspid flow parameters, particularly the
preload and afterload dependency. Preload variations are significant during the respiratory
cycle due to fluctuant intrathoracic pressure, which is diminished during inbreathing and rises
during expiration. Low intrathoracic pressure favours venous return to the RA, leading to
better atrial filling and increased pressure; as a consequence, early diastolic ventricular filling
is improved, with an increase in E wave velocity, while A wave velocities remain almost the
same; subsequently, the E/A ratio may change. Conversely, lower E wave velocities are
obtained when preload decreases during expiration. This is why some authors suggest that at
least 5 beats should be analysed in each patient in order to obtain an average value that should
have clinical significance [112]. Other physiological factors that influence tricuspid flow
patterns are age, gender and tachycardia [112]. Measurements may also be altered by the
presence of severe tricuspid regurgitation or atrial fibrillation [23]. Moreover, the thin-walled
RV is also highly sensitive to afterload variations, particularly in patients with myocardial
infarction or chronic ischemia [113]. TDI is another valuable tool for assessing RV diastolic
function. TDI is used to measure velocities at the level of the tricuspid annulus (Et, At, Et/At)
and to derive the E/Et ratio which is gaining interest as a marker of diastolic dysfunction. In
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diography and cardiac MRI based techniques are, for the time being, of immense value. As
mentioned before, cardiovascular MRI is nowadays considered to be the gold standard for RV
assessment; in one research, some 3D echocardiography-derived measurements, such as the
RVEF, compared well against cardiac MRI results, with little difference (47.8 ± 8.5% vs 48.2 ±
10.8%) [106]. However, in another study, a tendency to overestimate RVEF by 3D echocar‐
diography, with a bias of approximately 13% (95% CI -52% to +27%), has been reported;
moreover, in the same research, RV diastolic and RV systolic volumes were shown to be
systematically and significantly underestimated by 3D echocardiography [109]. Solid correla‐
tions were established between 2D echocardiography tissue Doppler St wave velocity and
MRI-derived RVEF [110]. In addition to that, it was shown that a systolic long-axis peak
velocity of <11 cm/s at the lateral tricuspid annulus was associated with moderately impaired
MRI-derived RVEF, while severely reduced RVEF ≤30% was best detected by RVMPI at a value
of >0.50 [111].
4. Assessment of right ventricular diastolic dysfunction
4.1. Echocardiography
4.1.1. Tissue Doppler analysis
a. Acquisition and measurements:
The assessment of RV diastolic dysfunction strongly resembles LV evaluation. Validated
parameters include the tricuspid flow E and A velocities, as well as the E/A ratio, the E wave
deceleration time and the IVRT, which are assessed in a similar manner to mitral flow
evaluation; the previously mentioned parameters are measured using the apical 4-chamber
view by placing sample volume at the tips of the tricuspid leaflets.
Several limitations undermine the accuracy of tricuspid flow parameters, particularly the
preload and afterload dependency. Preload variations are significant during the respiratory
cycle due to fluctuant intrathoracic pressure, which is diminished during inbreathing and rises
during expiration. Low intrathoracic pressure favours venous return to the RA, leading to
better atrial filling and increased pressure; as a consequence, early diastolic ventricular filling
is improved, with an increase in E wave velocity, while A wave velocities remain almost the
same; subsequently, the E/A ratio may change. Conversely, lower E wave velocities are
obtained when preload decreases during expiration. This is why some authors suggest that at
least 5 beats should be analysed in each patient in order to obtain an average value that should
have clinical significance [112]. Other physiological factors that influence tricuspid flow
patterns are age, gender and tachycardia [112]. Measurements may also be altered by the
presence of severe tricuspid regurgitation or atrial fibrillation [23]. Moreover, the thin-walled
RV is also highly sensitive to afterload variations, particularly in patients with myocardial
infarction or chronic ischemia [113]. TDI is another valuable tool for assessing RV diastolic
function. TDI is used to measure velocities at the level of the tricuspid annulus (Et, At, Et/At)
and to derive the E/Et ratio which is gaining interest as a marker of diastolic dysfunction. In




clinical practice, both pulsed and colour TDI may be used; the former technique is simpler and
provides a high temporal resolution, but is hindered by low spatial resolution [114]; the latter
has high spatial resolution, but lower temporal resolution and provides mean velocities [115],
as opposed to pulsed TDI, by which maximum velocities are measured. Although considered
superior to pulsed wave Doppler techniques, TDI measurements have their limitations. Firstly,
like pulsed Doppler parameters, they are influenced by age and gender [116].
Figure 14. Pulsed wave tissue Doppler with the sample placed at the level of the tricuspid annulus of the RV free wall,
demonstrating diastolic parameters (Et and At).
b. Qualitative values:
Moreover, although previous studies focused on the LV supported TDI load independency
[117], Pelà et al. demonstrated in their research on healthy subjects that RV Et and At wave
velocities were dependent on loading conditions; however, they also showed that Et and At
velocity variations were proportional, and consequently, despite alterations in preload, the Et/
At ratio remained constant. [118]. According to Horton et al., measuring parameters from ≥ 3
different beats during apnoea may reduce errors derived from load variations and the
translational motion of the myocardium [119]. Despite the limitations, several researches have
confirmed that pulsed and tissue Doppler allow a clinically significant evaluation of RV
diastolic function. Puwanat et al. demonstrated that a tricuspid E/Et ratio >6 was associated
with a mean right atrium pressure >10 mmHg in patients with heart failure and preserved
ejection fraction [120]; this finding was consistent with data from a previous research by
Utsunomyia et al. who demonstrated that intraatrial pressure assessment by use of the E/Et
ratio was comparable with invasive hemodynamic measurements obtained by right heart
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catheterization and valuable as a prognostic tool for cardiovascular events in patients with
chronic pulmonary artery hypertension [121] (Table 7).
Degree of diastolic dysfunction Tricuspid E/A ratio Additional parameters
Impaired relaxation < 0.8 E/Et >6
Pseudonormal filling 0.8 – 2.1
diastolic flow predominance in the hepatic
veins TDE < 120 msec
Restrictive filling > 2.1
late systolic anterograde flow in the
pulmonary artery
Table 7. Right ventricle diastolic dysfunction assessment
c. Clinical Application
As in the case of the left ventricle, RV diastolic function is the first to be impaired, preceding
systolic dysfunction. Therefore, when RV impairment is suspected, diastolic function assess‐
ment is advised, as RV diastolic dysfunction has been confirmed as a marker of poor prognosis
[23]. Most studies support the use of the following parameters: trans-tricuspid E/A ratio,
E/Et ratio, and RA size [23].
4.1.2. Color M-mode flow propagation velocity
a. Acquisition and measurements:
Color M-Mode flow propagation velocity (Vp) is most commonly measured by the slope
method from the apical 4-chamber view, using color flow imaging with a narrow color sector;
gain is adjusted to avoid noise. The M-mode cursor is placed at the center of the RV inflow
blood column from the tricuspid valve to the apex. The color flow baseline is shifted to lower
the Nyquist limit so that the central highest velocity jet is blue. Flow propagation velocity (Vp)
is measured as the slope of the first aliasing velocity during early filling, measured from the
tricuspid valve plane to 4 cm distally into the RV cavity. Alternatively, the slope of the
transition from no color to color may be measured.
b. Qualitative values:
Vp values >50 cm/s are considered normal for the RV. The Et/Vp ratio varies proportionally with
RA pressure, and may therefore be used either by itself, or in combination with IVRT to assess
filling pressures.  However, this rather challenging method is redundant in patients with
decreased RV ejection fraction in which other parameters precisely identify diastolic dysfunction.
c. Clinical Application
The slowing of tricuspid-to-apical flow propagation measured by color M-mode Doppler is
valuable in identifying diastolic dysfunction. In addition, it may help in assessing filling
pressures when used in conjunction with tricuspid E. Essays were made to measure non-
invasively the tricuspid-to-apical pressure gradient by color M-mode Doppler, but the method
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demonstrating diastolic parameters (Et and At).
b. Qualitative values:
Moreover, although previous studies focused on the LV supported TDI load independency
[117], Pelà et al. demonstrated in their research on healthy subjects that RV Et and At wave
velocities were dependent on loading conditions; however, they also showed that Et and At
velocity variations were proportional, and consequently, despite alterations in preload, the Et/
At ratio remained constant. [118]. According to Horton et al., measuring parameters from ≥ 3
different beats during apnoea may reduce errors derived from load variations and the
translational motion of the myocardium [119]. Despite the limitations, several researches have
confirmed that pulsed and tissue Doppler allow a clinically significant evaluation of RV
diastolic function. Puwanat et al. demonstrated that a tricuspid E/Et ratio >6 was associated
with a mean right atrium pressure >10 mmHg in patients with heart failure and preserved
ejection fraction [120]; this finding was consistent with data from a previous research by
Utsunomyia et al. who demonstrated that intraatrial pressure assessment by use of the E/Et
ratio was comparable with invasive hemodynamic measurements obtained by right heart
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catheterization and valuable as a prognostic tool for cardiovascular events in patients with
chronic pulmonary artery hypertension [121] (Table 7).
Degree of diastolic dysfunction Tricuspid E/A ratio Additional parameters
Impaired relaxation < 0.8 E/Et >6
Pseudonormal filling 0.8 – 2.1
diastolic flow predominance in the hepatic
veins TDE < 120 msec
Restrictive filling > 2.1
late systolic anterograde flow in the
pulmonary artery
Table 7. Right ventricle diastolic dysfunction assessment
c. Clinical Application
As in the case of the left ventricle, RV diastolic function is the first to be impaired, preceding
systolic dysfunction. Therefore, when RV impairment is suspected, diastolic function assess‐
ment is advised, as RV diastolic dysfunction has been confirmed as a marker of poor prognosis
[23]. Most studies support the use of the following parameters: trans-tricuspid E/A ratio,
E/Et ratio, and RA size [23].
4.1.2. Color M-mode flow propagation velocity
a. Acquisition and measurements:
Color M-Mode flow propagation velocity (Vp) is most commonly measured by the slope
method from the apical 4-chamber view, using color flow imaging with a narrow color sector;
gain is adjusted to avoid noise. The M-mode cursor is placed at the center of the RV inflow
blood column from the tricuspid valve to the apex. The color flow baseline is shifted to lower
the Nyquist limit so that the central highest velocity jet is blue. Flow propagation velocity (Vp)
is measured as the slope of the first aliasing velocity during early filling, measured from the
tricuspid valve plane to 4 cm distally into the RV cavity. Alternatively, the slope of the
transition from no color to color may be measured.
b. Qualitative values:
Vp values >50 cm/s are considered normal for the RV. The Et/Vp ratio varies proportionally with
RA pressure, and may therefore be used either by itself, or in combination with IVRT to assess
filling pressures.  However, this rather challenging method is redundant in patients with
decreased RV ejection fraction in which other parameters precisely identify diastolic dysfunction.
c. Clinical Application
The slowing of tricuspid-to-apical flow propagation measured by color M-mode Doppler is
valuable in identifying diastolic dysfunction. In addition, it may help in assessing filling
pressures when used in conjunction with tricuspid E. Essays were made to measure non-
invasively the tricuspid-to-apical pressure gradient by color M-mode Doppler, but the method




is not currently intended for routine clinical application, due to its difficulty. The non-invasive
imaging assessment of the RV has gained raising interest and recent research has provided
data which may improve standard clinical protocols. However, highly accurate reference
values are yet to be established, and there are currently few available and reproducible
parameters.
Figure 15. Pulsed color M-mode Vp imaging with the sample placed at the level of the tricuspid annulus of the RV
free wall in pulmonary artery hypertension individual.
4.2. Cardiac magnetic resonance imaging
a. Acquisition and measurements:
The assessment of RV diastolic dysfunction by cardiac MRI is similar, as a principle, to the
echocardiographic evaluation. 1.5 Tesla systems can be used to characterize the transtricuspid
flow. To this purpose, 4-chamber views should be acquired. ECG-gated phase-contrast pulse
sequences are positioned retrospectively, in a plane perpendicular to the transtricuspid inflow,
at the level of the opened tricuspid tips, just bellow the tricuspid valve annulus. Two dynamic
phase-contrast series, corresponding to an entire cardiac cycle, are acquired during breathhold:
1) the transtricuspid flow velocity sequence, and 2) a myocardial longitudinal velocity
sequence. Due to technical progress, cardiac MRI is increasingly being used for blood and
myocardial velocities assessment. In addition to that, several studies have demonstrated the
usefulness of phase-contrast MRI for measuring diastolic function parameters [122]. However,
these analyses are mostly based on manual positioning of regions of interest (ROIs) within the
transtricuspid flow area or the myocardium on multiple phases [122, 123]. The derivative of
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the time/volume curve, expressed as peak filling rate is used to quantify diastolic function. The
early and active peak tricuspid filling rates (PFRE and PFRA) and their ratio may be calculated
[104].
b. Qualitative values:
Maceira et al [104] published the first normal ranges for MRI-derived RV diastolic function:
PFRE=371 mL/s, or 202 mL/m2, PFRA=429 mL/s, or 233 mL/m2, PFRE/PFRE = 0.9 were signifi‐
cantly higher in males [104].
5. Hemodynamic assessment
As previously mentioned, Doppler echocardiography may be used for the non-invasive,
indirect assessment of pulmonary artery pressures. To this purpose, the RV-RA pressure
gradient is calculated by analyzing the tricuspid regurgitation flow and the obtained value is
added to the estimated RA pressure; the latter is estimated by measuring the IVC and its
collapsibility after a “sniff”. The value of sPAP thusly derived is somewhat empirical. Several
studies have shown that Doppler echocardiography systematically under- or overestimates
pulmonary pressures, by comparison with direct, invasive measurements by right heart
catheterization [96, 124].
Currently, right heart catheterization remains the gold standard for pulmonary artery pressure
assessment, as it is necessary to confirm the diagnosis, assess hypertension severity and the
reactivity to vasodilator agents [90]. Invasive measurements are particularly useful in patients
with NYHA II and III heart failure who have mild pulmonary hypertension as assessed by
echocardiography. In addition to that, right heart catheterization provides the advantage of
vasoreactivity testing, which is compulsory before initiating vasodilator therapy and may help
predict the response to treatment; nitric oxide, adenosine and epoprostenol are most com‐
monly used for this purpose [90]. Patients who have an acute response to vasoreactivity testing
are more likely to respond to long-tem therapy [125].
In conclusion, echocardiography may be used as a screening method, as it indicates the
likelihood of pulmonary artery hypertension, rather than providing an actual diagnosis.
Results should always be validated by right heart catheterization, particularly if specific
vasodilator treatment is intended. All in all, 2D echocardiography has some limitations, some
related to the empirical assessment of sPAP, others to the imprecision in chamber measure‐
ments due to geometrical assumptions or difficult endocardial border tracing. Presently,
cardiac MRI is the golden standard in RV structure and function evaluation, due to its
unlimited imaging planes, higher image resolution, and the ability to calculate volumes using
three-dimensional measurements; however, cardiac MRI is seldom available in many centres,
and hindered by prolonged acquisition and processing times. Moreover, its use is still limited
in patients with implanted metallic devices, such as pace-makers, defibrillators, metallic
prostheses or insulin pumps. Right heart catheterization allows a good evaluation of sPAP,
but it is an invasive procedure and is not usually performed in the absence of other evidence
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The assessment of RV diastolic dysfunction by cardiac MRI is similar, as a principle, to the
echocardiographic evaluation. 1.5 Tesla systems can be used to characterize the transtricuspid
flow. To this purpose, 4-chamber views should be acquired. ECG-gated phase-contrast pulse
sequences are positioned retrospectively, in a plane perpendicular to the transtricuspid inflow,
at the level of the opened tricuspid tips, just bellow the tricuspid valve annulus. Two dynamic
phase-contrast series, corresponding to an entire cardiac cycle, are acquired during breathhold:
1) the transtricuspid flow velocity sequence, and 2) a myocardial longitudinal velocity
sequence. Due to technical progress, cardiac MRI is increasingly being used for blood and
myocardial velocities assessment. In addition to that, several studies have demonstrated the
usefulness of phase-contrast MRI for measuring diastolic function parameters [122]. However,
these analyses are mostly based on manual positioning of regions of interest (ROIs) within the
transtricuspid flow area or the myocardium on multiple phases [122, 123]. The derivative of
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the time/volume curve, expressed as peak filling rate is used to quantify diastolic function. The
early and active peak tricuspid filling rates (PFRE and PFRA) and their ratio may be calculated
[104].
b. Qualitative values:
Maceira et al [104] published the first normal ranges for MRI-derived RV diastolic function:
PFRE=371 mL/s, or 202 mL/m2, PFRA=429 mL/s, or 233 mL/m2, PFRE/PFRE = 0.9 were signifi‐
cantly higher in males [104].
5. Hemodynamic assessment
As previously mentioned, Doppler echocardiography may be used for the non-invasive,
indirect assessment of pulmonary artery pressures. To this purpose, the RV-RA pressure
gradient is calculated by analyzing the tricuspid regurgitation flow and the obtained value is
added to the estimated RA pressure; the latter is estimated by measuring the IVC and its
collapsibility after a “sniff”. The value of sPAP thusly derived is somewhat empirical. Several
studies have shown that Doppler echocardiography systematically under- or overestimates
pulmonary pressures, by comparison with direct, invasive measurements by right heart
catheterization [96, 124].
Currently, right heart catheterization remains the gold standard for pulmonary artery pressure
assessment, as it is necessary to confirm the diagnosis, assess hypertension severity and the
reactivity to vasodilator agents [90]. Invasive measurements are particularly useful in patients
with NYHA II and III heart failure who have mild pulmonary hypertension as assessed by
echocardiography. In addition to that, right heart catheterization provides the advantage of
vasoreactivity testing, which is compulsory before initiating vasodilator therapy and may help
predict the response to treatment; nitric oxide, adenosine and epoprostenol are most com‐
monly used for this purpose [90]. Patients who have an acute response to vasoreactivity testing
are more likely to respond to long-tem therapy [125].
In conclusion, echocardiography may be used as a screening method, as it indicates the
likelihood of pulmonary artery hypertension, rather than providing an actual diagnosis.
Results should always be validated by right heart catheterization, particularly if specific
vasodilator treatment is intended. All in all, 2D echocardiography has some limitations, some
related to the empirical assessment of sPAP, others to the imprecision in chamber measure‐
ments due to geometrical assumptions or difficult endocardial border tracing. Presently,
cardiac MRI is the golden standard in RV structure and function evaluation, due to its
unlimited imaging planes, higher image resolution, and the ability to calculate volumes using
three-dimensional measurements; however, cardiac MRI is seldom available in many centres,
and hindered by prolonged acquisition and processing times. Moreover, its use is still limited
in patients with implanted metallic devices, such as pace-makers, defibrillators, metallic
prostheses or insulin pumps. Right heart catheterization allows a good evaluation of sPAP,
but it is an invasive procedure and is not usually performed in the absence of other evidence




of pulmonary artery hypertension. Standard 2D echocardiography is widely available,
relatively cheap, does not present any risk for the patient, and may be performed even in the
presence of metallic devices which would normally hinder an MRI examination. Although it
only indicates the likelihood of pulmonary artery hypertension, it may be used to select
candidates for right catheterization. In terms of assessing RV structure and function, further
research would be needed in order to provide solid, reproducible parameters, with normal
reference values.
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1. Introduction
While often overlooked by traditional echocardiography, the lungs and evaluation of extrava‐
scular lung water (EVLW) can be assessed by direct visualization with relatively simple
ultrasonographic techniques. The results can help guide clinicians towards the cause of a
patient’s dyspnea and in the case of pulmonary edema even semi-quantitatively asses EVLW.
Additionally the exam can be repeated as often as necessary to monitor response to treatment
without fear of subjecting the patient to ionizing radiation associated with conventional chest
radiography.
Advancing technology has allowed for increasingly miniaturized and portable ultrasound
systems to the point where exams can be performed quickly at the bedside, often by the
rounding physician. The more common standard of care for quantifying pulmonary edema
has been a chest radiograph which, depending on the institution, may require more time to
perform and a more formal interpretation than a portable ultrasound [1]. Even when it is
obtained, chest radiograph can have a low sensitivity for common causes of dyspnea such as
pulmonary edema [2, 3]. This may be due in part to poor radiographic windows of the patient
or the intraobserver variability and skills of those interpreting the x-ray [4, 5]. In the case of
acute pulmonary edema, the practitioner using techniques of lung ultrasound, can actually
visualize the edema, classify it semi-quantitatively, and prescribe interventions before other
traditional diagnostic techniques such as chest radiograph can even occur.
The lung ultrasound finding of “Comet Tails” has been well studied in how it relates to
alveolar-interstitial syndromes. These syndromes include conditions with diffuse involvement
of the pulmonary interstitium which lead to respiratory distress through impairment of
alveolar-capillary exchange. Chronic conditions include pulmonary fibrosis, whereas acute
entities are acute respiratory distress syndrome (ARDS), interstitial pneumonia, and acute
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pulmonary edema [5]. With careful attention paid by the examiner at the bedside to the
patient’s history and monitoring the response to treatment, the ultrasonographic finding of
comet tails can be extremely useful in narrowing the differential diagnosis.
2. Definitions
“A-lines and B-lines” are two separate and distinct ultrasonographic images which may be
seen during examination of the lungs by ultrasound (See Figures 1 &2). Their presence is not
mutually exclusive, but the formation of each arises from a different underlying structure.
Figure 1. Image of comet tail “B-lines”
Comet-tails or “B-lines” are defined as hyperechoic reflections which originate only from and
travel roughly perpendicular to the pleural line of the lung. They have a narrow base and form
a ray spreading away from the transducer towards the bottom of the screen and synchronously
move with lung respiration. All ultrasound images are formed when a reflection occurs at the
interface of two regions with differing acoustic impedance [6]. In the case of comet tails this
impedance occurs between fluid filled interlobular septa, with the acoustic impedance of water
being 1.48x105gp/cm2 and that of an air filled lung with the acoustic impedance of air being of
0.0004x105gp/cm2. Interlobular septa are structures within the lung containing lymphatic
vessels. These septa are below the resolution of the ultrasound beam, which can only detect
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objects larger than 1 mm. Instead of showing up as a distinct structure, in the right circum‐
stances the areas of highly different acoustic impedance show up as a comet tail [7,8].
Under normal (non-edematous or fibrotic) conditions comet tails are absent because no
acoustic mismatch occurs as the beam passes through the subpleural space. However, in
conditions known as alveolar-interstitial syndromes an area of high acoustic mismatch occurs
at the subpleural space were interlobular septa are in contact with the pleural lining. In the
case of pulmonary edema this mismatch occurs between the differing impedances of air and
water, however it can also occur anytime there is an area of differing impedances at the surface
of the lungs such as pleuritis, fibrosis, or even chronic obstructive pulmonary disease [9].
Even though these structures are smaller than the resolution of the ultrasound beam, the
reflections cans still be generated and sent back to the ultrasound probe. Continued reflections
set up the phenomenon of reverberation which acts as a continued source of reflections back
to the piezoelectric crystal. Since the ultrasound interprets time as distance, and each successive
echo or return to the transducer occurs over a more distant time than the original signal, the
ultrasound interprets these signals as reflections from a structure more distal from the
ultrasound probe [6]. In this way a “beam” or comet tail image is created on the echo screen.
(See Figure 3) Histologically the interlobular septa are 7 mm apart when they reach the sub
pleural space and this is roughly the distance between the origins of individual comet tails at
the pleural line [7].
Figure 2. Image of pleural “A-lines.”
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Figure 3. The hypothesized physical and anatomic basis of echocardiographic lung comet tails. Reflections of the ul‐
trasound beam between thickened interlobular septa and the pleura generate a resonance signal over a prolonged
time. The increased return over time is interpreted by the ultrasound machine as a hyperechoic structure originating
deeper in the tissue and is displayed as a comet-tail on the ultrasound screen. (Illustrations and images from Jambrik
et al. Usefulness of ultrasound lung comets as a nonradiologic sign of extravascular lung water. Am J Cardiol
2004;93:1265-1270, with permission from Excerpta Medica, Inc.)
For the comet tail image to form, these thickened intralobular septa must be in contact with
the sub pleural space as any air between them and the transducer has such a low acoustic
impedance that the echo return takes too long and is simply “cancelled out” by the machine.
(This is the reason lung comets are not seen in pneumothorax and can aid in the diagnosis of
that condition.) [6] In a traditional chest radiograph these septa thickened by pulmonary
edema are termed “Kerley B-lines” [10, 11].
A-Lines are another distinct ultrasonographic entity separate from the “B-line” comet tails. A-
lines are hyperechoic lines which run roughly horizontal across the ultrasound screen and are
parallel to the pleural line. These lines are equidistant to each other and are the same distance
from each other as the pleural line is from the skin because they are reverberations of the pleural
line. Again the ultrasound machine interprets the signals it receives temporally from the
reverberations as depth. Hence the reflections are seen as lines deeper on the screen. The
presence of A-lines, and absence of B-lines indicates the presence of “dry” intralobular septa
and is a strong predictor of a normal capillary wedge pressure [12].
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3. History and origins
The “comet-tail” ultrasonographic sign was first described by Ziskin and colleagues in 1982
when an intrahepatic shotgun pellet was observed to create an artifact similar to what is seen
in lung comets [8]. Other conditions affecting the pleura of the lung were later noted to create
a similar pattern [9]. However it was not until 1997 when Daniel Lichtenstein, a French critical
care physician, described lung comet tails as an ultrasonographic sign of alveolar-interstitial
syndrome. In his paper he examined 250 patients, 121 with evidence of either wide-spread
(N=92) or localized (N=29) evidence of alveolar-interstitial syndrome on chest x-ray and 129
patients with a normal chest radiograph. He found the sensitivity of ultrasound in detecting
this pattern was 93.4% with a specificity of 93.0% in patients who did not have evidence for
this on chest x-ray [7].
When Lichtenstein compared chest computerized tomography (CT) to the ultrasound findings
on 29 of his 250 patients, he found comet tails were generated diffusely across the lungs from
two distinct sources. Both of these sources were lesions associated with acute pulmonary
edema, thickened sub-pleural interlobular septa and ground-glass regions. Occasionally even
*CTS: Comet Tail Score.
Figure 4. Proposed algorithm for use of lung comet tails in the evaluation of patients with acute dyspnea. In the case
of pulmonary edema, serial ultrasonographic exams performed after therapeutic intervention(s) will reveal a diminish‐
ing number of comet tails. This algorithm is suggested as a possible supplement for typical clinical assessment in the
decision making process.
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“normal” subjects registered the rare comet tail in the diaphragmatic regions of the lung, and
this was detected in both x-ray and CT scan [7].
Clinical applications of comet tails began after Jambrik and colleagues evaluated 121 hospi‐
talized patients with lung ultrasound (see technique below) and compared the findings to chest
x-ray. They found a significant linear correlation between a comet tail score (CTS) and x-ray
(r=0.78, p<.01). When patients were examined multiple times, an even higher intrapatient
correlation was seen (r=0.89; p<0.01). [13]
Lichtenstein and Jambrik’s observations were expanded to the medical in-patient setting by
Tsereva who validated the technique in patients with diastolic heart failure [14] and by
Volpicelli, who validated the use of ultrasound in diagnosis alveolar interstitial syndrome with
a 85.7% sensitivity and 97.7% specificity. The lower sensitivity in the later study can be
explained by the timing of the x-ray and the ultrasounds. The chest radiographs which the
ultrasounds were compared to were taken at admission and guided the treatment given,
whereas the lung ultrasounds were done after the initiation of therapy. Thus for some patients
the lack of comet tails was merely the resolution of pulmonary edema, but in the analysis
resulted in a lower sensitivity of the ultrasound technique [5]. Other researchers further
validated lung ultrasound and have suggested that it is superior to chest x-ray with sensitivities
similar to Nt-proBNP levels [15]. Nt-proBNP (N-terminal probrain type natriuretic peptide)
has become a common biomarker for fluid overload and tracking health status in heart failure
patients. However, fluid overload may not always correlate with interstitial pulmonary edema
and thus may be a marker primarily of vascular fluid overload.
In an effort to help quantify the number of comet tails seen on exam, Agricola et al. evaluated
post-cardiac surgery patients. They devised a relatively simple definition for a positive or
negative comet tail exam. A positive comet tail test was simply multiple bilateral comet tails
seen over the whole lung surface. A negative test was with the rare occasional comet tail, the
absence of comet tails, or comet tails confined to the last intercostals space. They then compared
the patient’s comet tail test to the amount of extravascular lung water (EVLW) determined by
Pulse Contour Cardiac Output (PiCCO - is an invasive technique requiring catheters and uses
principals of transpulmonary thermodilution and arterial pulse contour analysis in order to
estimate extravascular lung water), to the patient’s wedge pressure, and to their radiologic
score as determined by chest x-ray. Again good correlation was seen between the radiologic
assessment of EVLW and comet tails (r=0.60, p<0.0001) and also when compared to wedge
pressure (r=0.48, p<0.0001). Most useful was the comparison to EVLW. Normal EVLW is <500
mL with alveolar flooding occurring when EVLW reaches more than 75% above its normal
limit [16, 17]. With this in mind, the negative test had a 90% sensitivity and 89% specificity of
accurately detecting an EVLW volume <500 mL. Likewise a positive test had a 90% and 86%
sensitivity and specificity of detecting EVLW >500 mL. When comparing the comet tail test to
chest radiographs and PiCCO, they found they were even able to detect excess EVLW below
the threshold which would cause alveolar edema (sub clinical or early stages of pulmonary
edema) with 87% and 89% sensitivity and specificity [11].
Monitoring EVLW through the formation of lung comet tails was shown to be even more
important than knowing a patients overall volume status. Using bioelectric impedance
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Mallamaci demonstrated that in dialysis patients, overall volume status was not linked to
pulmonary congestion and the formation of comet tails. Rather Comet tails, and pulmonary
congestion, had more to do with a patient’s left ventricular function. They also demonstrated
the ability of comet tails to detect patient who were asymptomatic as 57% of patients had
moderate to severe pulmonary congestion but did not have symptoms suggesting such [18].
This is in keeping with Lichtenstein’s original paper which discussed a patient with a fat
embolism who had the sonographic sign of comet tails three days before symptoms occurred
[7] and in older literature which argued that alveolar edema, which would lead to symptoms,
is preceded by interstitial edema (which may or may not cause symptoms but can now be
detected by ultrasound) [19].
4. Technique
The standard technique for quantification of comet tails has been reported in a number of
studies and was pioneered by Picano and colleagues [9,13, 11]. This technique has shown its
utility clinically as used by the Himalayan Rescue Association to help diagnose and monitor
the degree of pulmonary edema in high-altitude pulmonary edema (HAPE). [20]
The exam is performed using any commercially available portable ultrasound device which
has a 1-7 MHz phased array probe. We recommend the use of the 1-5 MHz cardiac probe as it
is ideal for viewing between rib spaces and still allows deep enough penetration of the
ultrasound beam to view distal structures. Other groups have also found adequate views with
the high frequency linear probes as well as the abdominal probes as well [21].
The patient is placed in a supine or near supine position with the anterior chest wall exposed.
Each intercostals space from the second to the fifth on the right and the second to the fourth
on the left is scanned in four different positions. These are para-sternal, midclavicular, anterior
axillary, and mid-axillary. This gives the examiner a total of 28 different windows to examine,
16 on the right and 12 on the left (See graphic representation Table 1).




















Table 1. Diagram of the ultrasound windows used to obtain the Comet Tail Score (CTS). This technique was proposed
by Jambrik at al. and used by Jambrik, Fagenholtz, Pratali, Agricola, Picano, Mallamaci. Each window is evaluated for
comet tails, and the number present is added to form a cumulative score.
Within each window, comet tails as defined above are counted. The sum of the comet tails seen
can then be compiled for a comet tail score (CTS). The intra- and interobserver variability using
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“normal” subjects registered the rare comet tail in the diaphragmatic regions of the lung, and
this was detected in both x-ray and CT scan [7].
Clinical applications of comet tails began after Jambrik and colleagues evaluated 121 hospi‐
talized patients with lung ultrasound (see technique below) and compared the findings to chest
x-ray. They found a significant linear correlation between a comet tail score (CTS) and x-ray
(r=0.78, p<.01). When patients were examined multiple times, an even higher intrapatient
correlation was seen (r=0.89; p<0.01). [13]
Lichtenstein and Jambrik’s observations were expanded to the medical in-patient setting by
Tsereva who validated the technique in patients with diastolic heart failure [14] and by
Volpicelli, who validated the use of ultrasound in diagnosis alveolar interstitial syndrome with
a 85.7% sensitivity and 97.7% specificity. The lower sensitivity in the later study can be
explained by the timing of the x-ray and the ultrasounds. The chest radiographs which the
ultrasounds were compared to were taken at admission and guided the treatment given,
whereas the lung ultrasounds were done after the initiation of therapy. Thus for some patients
the lack of comet tails was merely the resolution of pulmonary edema, but in the analysis
resulted in a lower sensitivity of the ultrasound technique [5]. Other researchers further
validated lung ultrasound and have suggested that it is superior to chest x-ray with sensitivities
similar to Nt-proBNP levels [15]. Nt-proBNP (N-terminal probrain type natriuretic peptide)
has become a common biomarker for fluid overload and tracking health status in heart failure
patients. However, fluid overload may not always correlate with interstitial pulmonary edema
and thus may be a marker primarily of vascular fluid overload.
In an effort to help quantify the number of comet tails seen on exam, Agricola et al. evaluated
post-cardiac surgery patients. They devised a relatively simple definition for a positive or
negative comet tail exam. A positive comet tail test was simply multiple bilateral comet tails
seen over the whole lung surface. A negative test was with the rare occasional comet tail, the
absence of comet tails, or comet tails confined to the last intercostals space. They then compared
the patient’s comet tail test to the amount of extravascular lung water (EVLW) determined by
Pulse Contour Cardiac Output (PiCCO - is an invasive technique requiring catheters and uses
principals of transpulmonary thermodilution and arterial pulse contour analysis in order to
estimate extravascular lung water), to the patient’s wedge pressure, and to their radiologic
score as determined by chest x-ray. Again good correlation was seen between the radiologic
assessment of EVLW and comet tails (r=0.60, p<0.0001) and also when compared to wedge
pressure (r=0.48, p<0.0001). Most useful was the comparison to EVLW. Normal EVLW is <500
mL with alveolar flooding occurring when EVLW reaches more than 75% above its normal
limit [16, 17]. With this in mind, the negative test had a 90% sensitivity and 89% specificity of
accurately detecting an EVLW volume <500 mL. Likewise a positive test had a 90% and 86%
sensitivity and specificity of detecting EVLW >500 mL. When comparing the comet tail test to
chest radiographs and PiCCO, they found they were even able to detect excess EVLW below
the threshold which would cause alveolar edema (sub clinical or early stages of pulmonary
edema) with 87% and 89% sensitivity and specificity [11].
Monitoring EVLW through the formation of lung comet tails was shown to be even more
important than knowing a patients overall volume status. Using bioelectric impedance
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Mallamaci demonstrated that in dialysis patients, overall volume status was not linked to
pulmonary congestion and the formation of comet tails. Rather Comet tails, and pulmonary
congestion, had more to do with a patient’s left ventricular function. They also demonstrated
the ability of comet tails to detect patient who were asymptomatic as 57% of patients had
moderate to severe pulmonary congestion but did not have symptoms suggesting such [18].
This is in keeping with Lichtenstein’s original paper which discussed a patient with a fat
embolism who had the sonographic sign of comet tails three days before symptoms occurred
[7] and in older literature which argued that alveolar edema, which would lead to symptoms,
is preceded by interstitial edema (which may or may not cause symptoms but can now be
detected by ultrasound) [19].
4. Technique
The standard technique for quantification of comet tails has been reported in a number of
studies and was pioneered by Picano and colleagues [9,13, 11]. This technique has shown its
utility clinically as used by the Himalayan Rescue Association to help diagnose and monitor
the degree of pulmonary edema in high-altitude pulmonary edema (HAPE). [20]
The exam is performed using any commercially available portable ultrasound device which
has a 1-7 MHz phased array probe. We recommend the use of the 1-5 MHz cardiac probe as it
is ideal for viewing between rib spaces and still allows deep enough penetration of the
ultrasound beam to view distal structures. Other groups have also found adequate views with
the high frequency linear probes as well as the abdominal probes as well [21].
The patient is placed in a supine or near supine position with the anterior chest wall exposed.
Each intercostals space from the second to the fifth on the right and the second to the fourth
on the left is scanned in four different positions. These are para-sternal, midclavicular, anterior
axillary, and mid-axillary. This gives the examiner a total of 28 different windows to examine,
16 on the right and 12 on the left (See graphic representation Table 1).
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by Jambrik at al. and used by Jambrik, Fagenholtz, Pratali, Agricola, Picano, Mallamaci. Each window is evaluated for
comet tails, and the number present is added to form a cumulative score.
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this method has been reported as 5.1% and 7.4% respectively [13]. For clinical purposes Picano
and colleges report the comet tail score in a semiquantitative manner for patients in pulmonary
edema (Table 2).
Score Number of Comet Tails EVLW




Table 2. Semiquantitive classification of the Comet Tail Score (CTS)as proposed by Picano and colleagues.
4.1. Other techniques
Simpler less quantitative techniques have also been described with good prediction of
pulmonary edema. Volpicelli and colleagues described a technique where each hemithorax is
divided into four quadrants (8 total), upper and lower anterior and upper and lower lateral
divided longitudinally by the anterior axillary line and transversely by the 2nd intercostal space.
An exam was considered abnormal (positive for edema) if it had all of the following features:
1. At least three comet tails per scan.
2. Diffusely positive with more than one scan per side containing comet tails.
3. Bilateral presence of comet tails.
By using these criteria this group found a 85.7% sensitivity and 97.7% specificity when
compared to chest x-ray for detecting the presence of pulmonary edema [5].
5. Application and differential diagnosis
The presence of occasional sporadic comet tails can be a normal finding. Typically these are
limited to the last lateral intercostals space above the diaphragm with a hot spot often seen on
the right most caudal anterior axillary window [22, 9]. Care must be taken, however, in
attributing a hot spot in the lower lateral windows to a benign finding, as local lung consoli‐
dation from diseases such as ARDS, atelectasis, or pneumonia can exhibit this pattern. [22,
11]. In those cases, the clinical presentation of dyspnea with other physical signs and symptoms
such as low oxygen saturations and fever should be used to help differentiate “normal” from
Hot Topics in Echocardiography58
diseased state. With the case of patients presenting with dyspnea, the pathologic state should
be considered present until “ruled out” with other diagnostic modalities. However in the
research arena where “healthy” subjects may be tested, the pre-test probability that comet tails
localized to the last lateral intercostals spaces are normal, is high.
A diffuse bilateral comet tail pattern is not considered normal and is indicative of alveolar-
interstitial syndromes (AIS). These can be brought about by a number of disease entities
including chronic conditions such as pulmonary fibrosis, and acute entities such as acute
respiratory distress syndrome (ARDS), interstitial pneumonia, and acute pulmonary edema
[5]. Different clinical presentations can help elucidate the etiology of these different diseases
which have the same comet tail pattern. The time course of the illness can differentiate chronic
causes such as pulmonary fibrosis and acute causes such as pulmonary edema. Additionally
slight variations in the pattern of comet tails are noted. In the case of a fibrotic lung, the comet
tails are equal in both hemi thoraces, whereas in cardiac pulmonary edema they are bilateral
but with a predilection for the right hemi-thorax. Also in the fibrotic lung comet tails are more
patchy than in pulmonary edema, and are stable with diuretic therapy [9].
Highly dense entities such as ARDS typically give rise to comet tails only in regions where the
diseased lung is in contact with the sub-pleural space. These highly dense areas give rise to
multiple comet tails less than 3 mm apart, whereas comet tails arising from thickened inter‐
lobular septa are 7 mm apart [23]. Additionally an ARDS pattern also gives rise to comet tails
in focal areas which coalesce together and form comet tails of differing lengths and multiple
irregular comet tails [7, 23, 1].
Importantly comet tails which arise from pulmonary edema should respond to treatment and
disappear as interventions are made [18]. If they do not, then an alternate diagnosis should be
sought. This reenforces the need for serial exams many authors encourage repeat exams to
monitor response to therapy.
Since the presence of the occasional comet tail is considered normal, the lack of comet tails can
be diagnostic as well. Comet tail formation requires an area of differing acoustic impedances,
when this is not present no comet tails are created. Such is the case of a pneumothorax. In
examining for this potential emergent condition, an additional ultrasonographic sign must be
viewed, that of the “sliding lung sign.” This is the hyperechoic line which is the interface
between the visceral and parietal pleura. This line will slide back and forth with respiration.
When there is no sliding of this line, and an absence of comet tails, a pneumothorax should be
suspected [24]. The is particularly helpful when some studies show that standard chest x-ray,
in addition to taking longer, misses 30% of cases [25-27]. This is contrasted to the lung
ultrasound which in a large meta-analysis and systematic review looked at 8 studies repre‐
senting 1,048 patients. When using both the absence of lung comet tails and sliding lung sign
ultrasound was 90.9% sensitive and 98.2% specific in making the diagnosis of pneumothorax.
In the same analysis chest radiograph was only 50.2% sensitive, but with a similar specificity
of 99.4% [28].
In patients with minimal comet tails confined to the intercostal space above the diaphragm, or
no comet tails present on lung ultrasound, but who otherwise present with dyspnea, other
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this method has been reported as 5.1% and 7.4% respectively [13]. For clinical purposes Picano
and colleges report the comet tail score in a semiquantitative manner for patients in pulmonary
edema (Table 2).
Score Number of Comet Tails EVLW
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[5]. Different clinical presentations can help elucidate the etiology of these different diseases
which have the same comet tail pattern. The time course of the illness can differentiate chronic
causes such as pulmonary fibrosis and acute causes such as pulmonary edema. Additionally
slight variations in the pattern of comet tails are noted. In the case of a fibrotic lung, the comet
tails are equal in both hemi thoraces, whereas in cardiac pulmonary edema they are bilateral
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Highly dense entities such as ARDS typically give rise to comet tails only in regions where the
diseased lung is in contact with the sub-pleural space. These highly dense areas give rise to
multiple comet tails less than 3 mm apart, whereas comet tails arising from thickened inter‐
lobular septa are 7 mm apart [23]. Additionally an ARDS pattern also gives rise to comet tails
in focal areas which coalesce together and form comet tails of differing lengths and multiple
irregular comet tails [7, 23, 1].
Importantly comet tails which arise from pulmonary edema should respond to treatment and
disappear as interventions are made [18]. If they do not, then an alternate diagnosis should be
sought. This reenforces the need for serial exams many authors encourage repeat exams to
monitor response to therapy.
Since the presence of the occasional comet tail is considered normal, the lack of comet tails can
be diagnostic as well. Comet tail formation requires an area of differing acoustic impedances,
when this is not present no comet tails are created. Such is the case of a pneumothorax. In
examining for this potential emergent condition, an additional ultrasonographic sign must be
viewed, that of the “sliding lung sign.” This is the hyperechoic line which is the interface
between the visceral and parietal pleura. This line will slide back and forth with respiration.
When there is no sliding of this line, and an absence of comet tails, a pneumothorax should be
suspected [24]. The is particularly helpful when some studies show that standard chest x-ray,
in addition to taking longer, misses 30% of cases [25-27]. This is contrasted to the lung
ultrasound which in a large meta-analysis and systematic review looked at 8 studies repre‐
senting 1,048 patients. When using both the absence of lung comet tails and sliding lung sign
ultrasound was 90.9% sensitive and 98.2% specific in making the diagnosis of pneumothorax.
In the same analysis chest radiograph was only 50.2% sensitive, but with a similar specificity
of 99.4% [28].
In patients with minimal comet tails confined to the intercostal space above the diaphragm, or
no comet tails present on lung ultrasound, but who otherwise present with dyspnea, other
Lung Ultrasound Comet Tails — Technique and Clinical Significance
http://dx.doi.org/10.5772/56198
59
common diagnoses should be considered. These include COPD, acute bronchitis, and pulmona‐
ry embolism [1]. The issue of COPD is a special consideration which has been studied by at least
three groups. In the initial comet tail paper, Lichtenstein observed that COPD could give rise to
a fibrotic pattern, bilateral comet tails [7]. However later work performed by the same author
comparing ultrasound to x-ray diagnosis suggested that the presence of diffuse bilateral comet
tails was absent in 92% of patient with COPD (N=26) and absent or confined only to the laster
intercostal space in 98.75% of patients without respiratory disorder (N=80). The two patients in
the COPD group who had a positive test (the false positives) had pneumonia in the regions
viewed as positive on ultrasound. In the patients without respiratory symptoms, one patient
demonstrated a positive test. Interestingly even though he did not have any symptoms, that one
patient was admitted for acute renal failure requiring urgent dialysis, again supporting the idea
that ultrasound findings occur before symptoms [22]. Additional studies also support the lack
of findings of comet tails in COPD exacerbations. In fact in one study looking at the presence of
comet tails in patients with acute shortness of breath, the most common discharge diagnosis of
patients who did not exhibit bilateral diffuse comet tails was COPD [1, 18, 21].
Overall this technique allows for the rapid assessment of patients in respiratory distress and
can take less than three minutes [9, 15]. When used for detecting pulmonary edema, it has
nearly a 95% concordance with chest radiographs [1] and, as discussed above, may be more
sensitive than chest radiograph for this diagnosis [15]. A gross recognition of the comet tail
pattern present, as well as the patient’s history and response to treatment can guide the
clinician to the correct diagnosis. In terms of application, bedside ultrasound in many emer‐
gency departments and intensive care units is readily available.
6. Special situations
Due to its ease of use, portability and relative low cost, this technology is ideally suited for
remote research and clinical applications. In fact a bedside ultrasound is the only diagnostic
imaging currently used on the International Space Station.
Research applications have used the ultrasonographic finding of comet tails to monitor
pulmonary edema in healthy volunteers subjected to extreme environments. These include
ironman athletes, breath-hold deep divers, and mountain climbers [29]. Due to the remote
nature of the conditions, ultrasound is especially useful in mountaineering where up to 10%
of climbers above 4,000 M develop the life-threatening condition known as High Altitude
Pulmonary Edema [30]. (See Figure 5) At an altitude of 4,240 M Fagenholz, using the CTS
technique described in this chapter, showed that a CTS score of 35 +/- 11 corresponded to
patients suffering from HAPE which differed from those who were short of breath from other
causes who had a CTS of 12 +/-6.8 [20]. Others have shown that in the presence of normal left
ventricular function and normal pulmonary artery pressures, sojourners above 4790 m can
develop pulmonary edema with a corresponding decrease in oxygen saturation. The comet
tails describe in these studies had right lung predominance [31]. When used in the high altitude
environment, care should be taken to ensure that the device employed uses solid state storage.
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This is found on most modern portable ultrasounds. Non-solid state devices cool using fans
which will over heat at extreme altitudes.
Figure 5. Author (DS) demonstrating the ease of use and portability of modern ultrasound systems by performing an
assessment of EVLW at the base camp of Mt Everest, ele 5,364 M, on an elite climber.
7. Conclusion
Although dyspnea is a leading cause of hospital admission, determining its etiology and
subsequent treatment remains one of the greatest diagnostic challenges a clinicians faces.
While many have lamented the perceived loss of physical exam skills amongst practitioners,
the traditional lung exam and classic findings heard on auscultation are often difficult to hear
in a noisy intensive care unit or emergency department [32, 33]. Even in ideal circumstances,
there is abundant literature to suggest that the physical exam may be inaccurate [14, 15]. This
leads the clinician to rely on adjuncts to aid in diagnosis.
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In the case of dyspnea, chest radiograph are typically employed to help narrow the differential
diagnosis. However even these can be fraught with difficulties including time to obtain, and
read the x-ray. Fortunately the field of ultrasound and echocardiography has greatly expanded
in the past 20 years. The lung ultrasound finding of comet tails can help guide therapeutic
interventions, and unlike chest radiograph, the exam can be repeated without fear of increased
radiation exposure.
With the advent of small bedside machines, lung ultrasound techniques can become an
extension of the physical exam. These exams can be repeated as often as necessary in response
to changing clinical conditions. In this way ultrasonographers can guide real-time decision
making for patient care.
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In the case of dyspnea, chest radiograph are typically employed to help narrow the differential
diagnosis. However even these can be fraught with difficulties including time to obtain, and
read the x-ray. Fortunately the field of ultrasound and echocardiography has greatly expanded
in the past 20 years. The lung ultrasound finding of comet tails can help guide therapeutic
interventions, and unlike chest radiograph, the exam can be repeated without fear of increased
radiation exposure.
With the advent of small bedside machines, lung ultrasound techniques can become an
extension of the physical exam. These exams can be repeated as often as necessary in response
to changing clinical conditions. In this way ultrasonographers can guide real-time decision
making for patient care.
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1. Introduction
Ischemic mitral regurgitation remains an underestimated and important clinical problem. It
is a complex multifactorial disease that involves global and regional left ventricular remodel‐
ing as well as dysfunction and distortion of the components of the mitral valve including the
chordae, annulus and leaflets. The prevalence rate of development of mild or more severe
degree of mitral insufficiency after myocardial infarction has been estimated to be up to 50%
and is associated with worse prognosis (Stevenson 1987, Lamas 1997, Grigioni 2001).
Based on the clinical presentation, the ischemic mitral regurgitation was classified as acute or
chronic (Mitesh, 2009). Although the acute ischemic mitral regurgitation is relatively rare,
whenever present, it has a rapid evolution, with an extremely poor survival rate. On the other
hand, the chronic ischemic mitral regurgitation is much more frequent, but it’s the consequence
of a slower pathological process, with a better survival rate. The echocardiography identifies
all patterns of ischemic mitral regurgitation; nonetheless the classification as acute, sub-acute
or chronic ischemic mitral regurgitation is rather clinical, than an echocardiographic one.
Beside the complete rupture of papillary muscle, other patterns of ischemic mitral regurgita‐
tion cannot be practically located in time by echo. It is possible to have the same echocardio‐
graphic feature of the lesion in acute and in chronic settings; only the clinical presentation of
the patient helps in the diagnosis of acute / sub-acute or chronic ischemic mitral regurgitation.
So the echo exam has to be seen as complementary to clinical data, rather than a singular
method of diagnosis.
In everyday practice the management of ischemic mitral regurgitation represents a combined
problem of physiopathology, quantification and diagnosis that, together, drive the individual
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patient prognosis but, in case of patients candidate to open heart surgery this becomes a very
complex issue. With intraoperative TEE echocardiography, the exact identification of the
mechanism of ischemic mitral regurgitation represents a cornerstone element for surgical
planning and patient management. In case of significant residual mitral regurgitation a second
run of the extracorporeal circulation may be necessary requiring a well-founded experience
from the echocardiographer as the TEE intraoperative findings may be sometimes misleading.
The relation between the ischemic mitral regurgitation, surgery and echocardiography, as tool
for surgical planning and postoperative control, will be addressed in this chapter. The
suboptimal results obtained by the most commonly used surgical strategy, that is, restrictive
annuloplasty combined with coronary artery bypass graft, emphasizes the need to develop
alternative or concomitant surgical techniques that directly target the causal mechanisms of
the disease. Recent data show that this procedure is associated with a 10% to 20% rate of
persistent mitral regurgitation soon after operation and a 50% to 70% rate of recurrent mitral
insufficiency at five years (Hashim 2012, Magne 2009). Hereafter, the topics will be focused
mainly on the echo assessment of the patients candidate for open-heart surgery. A particular
attention will be paid to the papillary muscle and to the mitral valve geometry and their role
in the pathophysiology of ischemic mitral insufficiency. Understanding the mechanisms of the
different types of ischemic mitral regurgitation is mandatory for echocardiographer and
surgeon to tailor the right strategy for the valve repair, and it is indeed a challenging task for
both.
2. Physiopathology: Concepts regarding post-myocardial left ventricular
remodeling, acute and chronic ischemic mitral valve and the valve
geometry
It is generally assumed that the ischemic mitral regurgitation is not a valve disease, the ‘engine’
of valve insufficiency being the remodeling process of the left ventricle, depending on the
localization and extension of the myocardial infarction. In ischemic heart disease, the mitral
leaflets (and also the chordae) are typically structurally normal, but the leaflets are tethered
and their motion is relatively restricted, owing to regional and global ventricular remodeling,
with apical displacement of the posteromedial papillary muscle.
Sometimes the remodeling process starts immediately after the onset of myocardial infarction
causing structural ischemic mitral regurgitation, which is associated with a poor prognosis,
due to the concomitant acute infarction, acute papillary muscle remodeling and acute ischemic
mitral regurgitation. For a successful management of this acute mechanical complication the
key point is the early diagnosis, which has to be done before the complete rupture of the
papillary muscle occurs. This life-threatening complication has otherwise to be considered a
failure due to late echocardiographic and clinic diagnosis.
Overall, there is only scanty literature concerning the echocardiographic assessment of the
papillary muscle and it is no surprising then to see that its use in the everyday practice is, so
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far, very limited. There are only few general recommendations and the guidelines do not
include them in the systematic evaluation of the ischemic mitral regurgitation. Most of the
current information focuses on regional and global ventricular remodeling, with leaflets
tethering and tenting, motion restriction and annular dilatation. Frequently, the ischemic
remodeling of papillary muscle is difficult to document; nevertheless with an accurate analysis,
often performed in non-standard echocardiographic views, the diseased papillary muscle may
be identified.
In coronary patients with mitral insufficiency, beside the ventricular remodeling, annular
dilatation and leaflets (mobility and tethering), the echocardiographer has to focus the
attention on the shape, the length and the thickness of the papillary muscle, mainly in acute
circumstances, when the acute remodeling process is just beginning (fig 1).
Figure 1. Acute inferior MI with severe MR due to acute post-ischemic elongation of PP MM. Note the abnormal
length and shape of the very slim PP MM. The tip reaches the level of the MV annular plane. Often (as in this case), the
elongation PP MM is visible in a different plane respect of the MR at color Doppler. MI = myocardial infarction; MR =
Mitral regurgitation; PP MM = papillary muscle; MV = mitral valve.
On the other hand, in the case of chronic ischemic mitral insufficiency, all the remodeling
processes of left ventricle causing the ischemic mitral regurgitation are slower, the evolve over
time and usually the echo diagnosis is not so tricky. Generally, the patterns of chronic ischemic
mitral regurgitation are quite often the same: tethering of the papillary muscle, chordae and
leaflets, various degree and progressive dilation of the left ventricular cavity and mitral
annulus, mitral valve tenting, with reduced / loss of coaptation and restriction of one or both
leaflets (fig 2, 3). The post-infarction loss of the contractile ventricular mass is directly corre‐
lated with the remodeling process, expressed by the heart dilatation and decreasing of cardiac
reserve. All the elements belonging to the mitral apparatus will be involved in this process,
but the leaflets and the chordae are, as a matter of fact, preserved.
Ischemic mitral regurgitation has several pathophysiological determinants. It has been defined
as a ventricular disease that affects the mitral apparatus, because both myocardial infarction
and ischemia generate progressive global and regional left ventricular remodeling, and
consequently, a functional mitral regurgitation. Apical and posterior displacement of the
papillary muscle is a typical echocardiographic finding. This process starts ordinarily with the
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posterior leaflet because the posterior mitral annulus is thinner, weaker, more flexible and
without a zone of resistance. On the contrary, the anterior leaflet has a more thickened and
less malleable annulus. In this way the posterior leaflet became firstly restricted while the
anterior is involved only later on. The echocardiography is able to assess the relationship
between the LV cavity (shape, dimensions, volume), the mitral leaflets (as mobility, leaflet
apposition, length and height of coaptation, annulus dimension, etc) and the valve geometry.
In the case of chronic ischemic mitral regurgitation and ischemic dilated cardiomyopathy,
(generally patients with anterior and inferior infarction), the right balance between the dimen‐
sion of the mitral valve and the ‘new’ dimension of the double infarcted ventricular cavity is lost,
so that the mitral valve becomes insufficient. Conceptually, it may be assumed that there is a
phenomenon of ‘mismatch’ between the ‘too large’ left ventricle and ‘too small’ mitral valve
apparatus, which is unable to extend the drapery of the leaflets and to adapt to the new dimension
of the infarcted ventricle (fig 3). That’s why, in case of critical coronary artery disease leading to
left heart dilatation and ischemic mitral regurgitation, the ‘standard’ surgical approach of
coronary artery by-pass grafting (CABG) plus undersized ring alone, may not solve complete‐
ly the mitral regurgitation and, over time, the repair may fail (Magne 2009). In these cases the
annuloplasty ring alone is not enough to achieve sufficient ‘fabrics’ for a stable coaptation and
repair. Ideally speaking, to get a good repair more tissue is needed to enlarge the mitral valve.
This concept will be addressed in the chapter of chronic ischemic mitral regurgitation.
The chronic ischemic mitral regurgitation is classified as a III°b type of mitral insufficiency
essentially due to the systolic restriction of the posterior leaflet (Table 1). The practice dem‐
onstrates that in the case of ischemic mitral regurgitation this classification may be incomplete
and misleading because the chronic ischemic mitral regurgitation has always a combined
annular dilation of the valve, which in fact is a type I° mechanism of mitral regurgitation in
Carpenter’s classification (Carpentier 1983 & 2010). That’s why, for a better and more precise
diagnosis of the mechanisms of ischemic mitral regurgitation, the mitral valve geometry has
to be carefully assessed.
Figure 2. Inferior myocardial infarction with ischemic mitral regurgitation due to systolic restriction of posterior mitral
leaflet (2D and 3D systolic frame, from two different patients). Note the systolic tension on the chordae belonging to
the posterior mitral valve with limited excursion of the cusp, the asymmetrical apposition of the anterior leaflet and
the reduced area of coaptation.
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As noted (Cerin 2006, Tesler 2009), from the geometrical point of view, the normal mitral valve
presents a triangle delimited between the coaptation point (typically sited inside of the
ventricular cavity) and two others referral points, placed on the anterior and posterior mitral
annulus (standard pattern of a normal mitral valve – Fig 4). This echocardiographic virtual tool
demonstrates to be useful in judging the mitral valve structural and functional abnormalities
(Cerin 2012). When the echocardiographic presentation of ischemic mitral regurgitation is
consistent with obvious deformation of this virtual triangle, this should raise the suspicion of
a possible papillary muscle abnormality with elongation of sub-valvular apparatus, alongside
to reduce / loss of leaflet coaptation.
In some cases the geometry of the mitral valve may be so distorted that an elongation of the
sub valvular apparatus has to be suspected or is clearly present. In these particular cases, the
echocardiography examination has to be focused on the papillary muscle lesions; this might
require the execution of the exam in several off axis views, beside the standard ones. Patients
with distortion of mitral valve geometry (fig 5A) will not fit within the III°b of Carpentier’s
classification. Some of these patient may present a clear ischemic mitral valve prolapse (type
II° Carpentier), but many of them will show only a distortion of the ‘standard’ mitral valve
triangle, with the coaptation point still present inside of the left ventricular cavity. The
Figure 3. Ischemic dilated cardiomyopathy and the concept of “mitral - ventricular mismatch” (see the text). Patient
with double myocardial infarction (anterior and inferior).Ischemic dilated cardiomyopathy and chronic ischemic mitral
insufficiency. Note the spherical shape and dilatation of the left ventricular cavity, the reduced surface of coaptation
of mitral leaflet (2mm), due to the annular dilatation (41mm) and the laterally migration of the papillary muscle.
Type I° Normal leaflet motion
Type II° Excess leaflet motion (leaflet prolapse)
Type III° Restricted motion
III°a Restricted opening
III°b Restricted closure
Table 1. Carpentier’s classifications of Mitral Regurgitation
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geometrical analysis of these patients will show the disappearance of the mitral valve triangle
and a progressive the transformation of it in a ‘trapeze’. (Fig 5B).
Figure 5. A (up) and B (down). Ischemic mitral regurgitation with distorted mitral valve geometry. Note the absence
of the ‘standard triangle of coaptation’ which as a matter of fact was transformed into a ‘trapeze’ due to the post-
ischemic ‘crash’ of the edge of the mitral valve, generated by papillary muscle elongation (drawing).
The repair strategy by the undersized rings alone may not solve the mitral regurgitation in
patients with distorted mitral valve geometry (due to papillary muscle elongation). This
Figure 4. The coaptation triangle and the mitral valve geometry. The normal pattern of mitral valve anatomy and
function is characterized by the triangle of coaptation which is defined by the coaptation point (C), normally sited in‐
side of the left ventricular cavity and two other points (A, B) placed on the anterior and posterior mitral annulus.
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because the small ring corrects the mitral annulus deformation only, whereas the main
problems of these patients are represented by the displacement of coaptation plane too ‘high’,
nearby the mitral annulus, the distortion of the coaptation surface and plane due to the ‘crash’
of the tip of the mitral valve tenting and the reduced mitral leaflet coaptation (fig 5B, scheme).
The mechanism of regurgitation in these patients is clearly more complex than the classical
‘leaflet restriction’ (III°b type of Carpentier’s classification).
Often the mechanisms involved in the ischemic mitral regurgitation are multiple, complex and
intricate, and the surgical planning of the valve repair must to be tailored, ignoring partially
and sometimes totally the classifications; classifications often focus on the mitral leaflet only
(which are practically normal) and do not include the papillary muscles, the mitral valve
geometry and the grade of general or regional left ventricular remodeling.
Depending of the clinical context, a check list of the echocardiographic elements has to include:
dimension of the left ventricular cavity (as diameter and volume), diameter of the mitral
annulus (transthoracic, PSLAx systole), the sphericity index and the distance between the
papillary muscle (in case of ischemic cardiomyopathy), the length of leaflets coaptation, the
length of the anterior leaflet, the ‘height’ of the posterior leaflet, the mobility of the anterior
and most of all the posterior leaflet, etc.
From this point of view, beside of the others elements involved in valve regurgitation, the use
of the triangle of coaptation as tool of mitral valve geometry (Cerin 2010) shows to be a suitable
instrument ‘to judge’ better the mechanisms of ischemic mitral regurgitation (Fig 4, 5A, 5B).
In some cases, due to obviously papillary muscle elongation, the triangle may completely
disappear (see the Fig 6).
Figure 6. Chronic ischemic mitral regurgitation, due to reduce leaflet coaptation (approx. 2mm), dilatation of the left
ventricle (EDVol 245ml) and of the mitral annulus (Ø45mm). Note the absence of ‘the coaptation triangle’ due to is‐
chemic elongation of papillary muscle: the length of papillary muscle is completely unusual, having the tip situated
very near to the mitral annulus. Note also the triangular shape of this muscle, with a very sharp tip, due to progressive
post-ischemic remodeling with elongation: so called ‘thorn papillary muscle’. Because of the abnormal post-ischemic
elongation of the papillary muscle, the normal geometry of mitral valve was distorted and the triangle of coaptation
disappears. NB – all the images belong to the same patient.
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The echocardiographic assessment of the mechanisms of the ischemic mitral regurgitation,
which is the key for the tailored surgical approach, may be sometimes complex and tricky, due
to a true mosaic of intricate mechanisms, difficult to be embedded and defined by a standard
classification. The echocardiographer has to be aware of the complexity of the left ventricular
remodeling process and to assess the mitral valve apparatus using multiple views and to pay
particular attention to the analysis of the mitral valve geometry.
3. Acute ischemic mitral regurgitation
Background. Acute ischemic mitral valve regurgitation may occur in the setting of acute
myocardial infarction owing to necrosis and rupture of papillary muscle tissue or abnormal
coaptation of the leaflets, due to distortion of ventricular geometry. Hemodynamically
significant mitral regurgitation is possible in both anterior and inferior infarcts, but its
incidence appears higher in the inferior myocardial infarction group such as 40% vs 15% - see
the Fig 7 (Estes 1966, Dagum 2000, Timek 2003). Post-infarction mitral regurgitation may be
associated to multiple cardiovascular risk factors such as diabetes, abnormal body mass index
(>25), advanced age, female gender, coexistence of peripheral arteriopathy and prior infarction
(Green, 1999).
Figure 7. Differences in the vascularization of the papillary muscle. Postero-medial papillary muscle usually receives
the blood only form the right coronary artery (rarely from circumflex artery), respect of the antero-lateral papillary
muscle which has two sources of vascularization: left anterior descending artery and circumflex artery. By courtesy of
MURESIAN Horia, MD, PhD - 2009.
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The acute ischemic mitral regurgitation (Fig 8) is more often due to structural lesions as complete
or partial rupture of the papillary muscle, and less frequent due to an elongation of the mus‐
cle. The echocardiographic diagnosis may not be easy and it is often based on the use of the TEE
in the emergency facility. The key issue in the successful management of these patients is timely
intervention. If the clinical conditions and the logistic allow it, the patient should be urgently
taken to the operating room. Most often, the acute ischemic regurgitation is surgically treated
by mitral valve replacement. Mitral valve repair is rare, but, in specific cases, it may be a valid
alternative. This depends on the quality and on the entity of the structural alteration of the
subvalvular apparatus, and also on the experience of the surgical team.
From the echocardiographic point of view, the acute structural ischemic mitral regurgitation
may present three different patterns: transection of papillary muscle (“too late” diagnosis),
partial rupture of the papillary muscle (“timely” diagnosis) and elongation of the papillary
muscle (the “tricky” echo diagnosis); see the scheme on the Fig 8.
Figure 8. Echocardiographic classification of the structural acute ischemic mitral regurgitation (scheme). The upper
pictures represent a case with transection of papillary muscle, in a patient with cardiogenic shock (“too late” echo di‐
agnosis). In the bottom raw acute papillary muscle elongation (the first pictures on the left) and partial rupture of pap‐
illary muscle (right picture, yellow arrow); both patients were in 3rd NYHA Class.
The gloomy clinical prognosis of acute significant ischemic mitral regurgitation associated to
myocardial infarction (moderate or severe degree) is illustrated by its devastating impact on
short- and long-term survival: almost one out of 4 patients die at one month and more than
one out of 2 after one year (24% early and 54% 1-year mortality rate) (Otto, 2012).
In most cases the acute ischemic mitral regurgitation is a syndrome with conspicuous clinical
implications. Generally, the clinical presentation of these patients is compatible with a hyper
acute heart failure; they are highly symptomatic and may present with overt acute pulmonary
edema, cardiogenic shock or even sudden death. Only minorities of patients are mildly
symptomatic or asymptomatic and may present just a new systolic murmur.
Based on the echocardiography exam the acute ischemic mitral regurgitation may be divided
in structural and functional. The structural ischemic mitral regurgitation is determined by
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implications. Generally, the clinical presentation of these patients is compatible with a hyper
acute heart failure; they are highly symptomatic and may present with overt acute pulmonary
edema, cardiogenic shock or even sudden death. Only minorities of patients are mildly
symptomatic or asymptomatic and may present just a new systolic murmur.
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complete papillary muscle rupture (transection), by partial detachment of one or both tips of
a papillary muscle with subsequent elongation and by acute remodeling of papillary muscle
with elongation (fig 8). In some cases the ischemic event may involve the point of insertion of
the tendineous chord(s) which may result in a ‘flail’ which is an uncommon pattern for this
pathology but may explain this kind of lesion.
In summary a myocardial infarction, in acute settings, may have one of the three structural
damages on the papillary muscle: transection, partially rupture or elongation. The first two
situations have already largely been described in many publications. This is not the case with
the papillary muscle elongation, which is closer to chronic ischemic regurgitation and where
the echocardiographic geometrical analysis, based on the triangle of coaptation, plays an essential
role in diagnosis.
3.1. Papillary muscle necrosis with complete rupture of papillary muscle
Papillary muscle necrosis with complete rupture of papillary muscle is an uncommon but
dramatic type of ischemic mitral insufficiency, with approx. 1.0% incidence in patients with
myocardial infarction (Clements 1985). This is a life-threatening complication of myocardial
infarction that requires a prompt diagnosis and surgical intervention (Fig 9). The posterome‐
dial papillary muscle is more frequently involved because of its single coronary artery blood
supply (Fig 7). Chordae to both leaflets arise from each papillary muscle so that, in cases of
"complete" rupture, both leaflets are affected. The echocardiography exam generally shows
loss of leaflets coaptation due to the floating ruptured papillary muscle (‘flail’ mitral valve).
In these patients the echocardiographic diagnosis is relatively simple and, generally, may be
done using transthoracic exam. These patients belong to the type II° Carpentier’s classification.
Nonetheless the complete rupture is rare; it carries a poor prognosis for the onset of acute
pulmonary oedema and low output syndrome. Without surgery, the mortality is very high,
up to 75% within the first 24 hours (Tcheng, 1992, Kirklin 2012). As a consequence, the
echocardiographic diagnosis must rapidly be performed and the patient must be timely taken
to the operating room. In most cases the intervention is a mitral valve replacement. However
the operative mortality is high, ranging from 23 to 45%, increasing in late referral. It may reach
57% in cases of reoperations (Loisance, 1990).
3.2. Incomplete papillary muscle rupture
Sometimes the papillary muscle is only partially ruptured. To avoid the high operative
mortality in case of complete papillary muscle rupture, the diagnosis of papillary muscle
rupture has to be done on this circumstance. Usually the clinical manifestation of this condition
is an episode of acute heart failure occasionally with a relative stabilization and sometimes
with a new systolic murmur. The echocardiographic diagnosis may be available using the
transthoracic approach, but might also be relatively tricky and then the TEE should be
preferred for the reasons mentioned above (unstable patient, unclear transthoracic view).
The echocardiographic presentation of this type of structural ischemic mitral regurgitation
generally shows a prolapse of one leaflet; also the type II° Carpentier’s classification (which in
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reality is a ‘false’ mitral valve prolapse). An asymmetric apposition of the ‘prolapsed’ leaflet is also
present. Often these patients are misdiagnosed as ‘mitral prolapse’, because the echocardiogra‐
pher focuses the attention only on the mitral valve, neglecting to assess the papillary muscle. So,
it is possible to fall into the trap, because at variance from the mitral valve, the papillary muscle
is generally seen in a different echocardiographic plane, and often off axis view. If the echocar‐
diographer doesn’t have the concept of possible elongation of the papillary muscle due to the
structural post-necrotic lesion, the true etiology of the lesion may be missed (Fig 10).
The take home message is to check explicitly the papillary muscle, searching it from different
off axis views, starting from the clinical settings of the patient, essentially in case of abnormal
geometry of the mitral valve. At any transthoracic suspicion of partial papillary muscle rupture
the TEE exam must be done, chiefly in acute settings. The partial papillary muscle lesion may
be otherwise missed and it may evolve to a complete rupture. At the echo, the ruptured head
shows a hypermobile, redundant excursion which may mimic a degenerative lesion (e.g.
Barlow disease). It is critical to remember that in most cases of papillary muscle involvement,
massive mitral regurgitation is present and the surgery must be rapidly accomplished (Fig
11). In some cases mitral valve repair is possible depending on the intraoperative findings, the
elapsed time from the acute myocardial infarction and the surgeon experience.
3.3. Acute remodeling of the papillary muscle with elongation
Acute remodeling of the papillary muscle with elongation is the third and rare form of acute
ischemic mitral regurgitation which, usually, involves the inferior-posterior papillary muscle.
Figure 9. Acute severe structural ischemic mitral regurgitation due to transection of papillary muscle (2D TEE intrao‐
perative exam). Note the loss of coaptation due to complete rupture of papillary muscle and flail (arrows). Both pa‐
tients, with hemodynamic instability, were transferred to Cardiac Surgery Dpt. the same day of the transthoracic
diagnosis. An emergency mitral valve replacement and CABG was successfully performed after coronary angiography.
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At the echo, the papillary muscle has a triangular shape and appears elongated and often slim
(fig 12). This elongation determines a displacement of the coaptation point towards the mitral
annular plane and to the left atrium, with subsequent mitral regurgitation. In this way the
appearance of mitral valve is likewise similar with the mitral valve prolapse (type II° Car‐
pentier classification), but the etiology is the myocardial necrosis and not the anomaly of the
connective tissue as in Barlow / Marfan disease.
The echocardiographic documentation of the ischemic etiology in these cases might be tricky.
In order to better characterize the structural anatomy of the myocardium at the level of the
infarcted or ischemic papillary muscle, additive methods could prove useful such as SPECT,
cardiac MRI or PET, showing the myocardial scar or necrosis. Anyway, the diagnosis is
extensively based on the geometrical analysis of the mitral valve apparatus performed by
echocardiography.
Figure 10. Ischemic mitral regurgitation due to acute elongation of papillary muscle, appearing as mitral valve pro‐
lapse. The pictures on the middle raw show prolapse of both mitral leaflet. In reality, only the focused examination on
the papillary muscle shows the triangular shape of the muscle, with a sharp tip and a partial tearing beside (arrow,
bottom raw, 3D TTE).
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The echocardiographic presentation of these patients shows a mitral valve with excess leaflets
motion and prolapse, having the coaptation point situated ‘very high’ near the mitral annulus,
due to an elongated papillary muscle. If the papillary muscle is difficult to visualize, the virtual
tool of triangle of coaptation may be useful to suppose the true etiology, considering that the
normal geometry of the mitral valve will be distorted, with disappearance of the standard
triangle.
Figure 12. Acute post-ischemic elongation of papillary muscle (yellow arrows); scheme, intraoperative photo and 2D
and 3 D Echo. Note the tip of the papillary muscle (in the intraoperative picture and Echo slides) which reaches at the
level of the mitral annulus. The papillary muscle is very thin, with a slim triangular shape and a very sharp tip: ‘thorn
papillary muscle’. In all cases the mitral valve presents severe regurgitation. Note the absence of the triangle of coap‐
tation, due to the migration of the coaptation plane nearby the mitral valve annulus.
Figure 11. Partial rupture of papillary muscle (yellow arrows); TEE 3 D and 2 D exam and intraoperative picture.
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The proper diagnosis and thus the management of such a serious clinical condition as the acute
ischemic mitral regurgitation must rely on clear and robust echocardiographic concepts such
as mitral valve geometry and functional anatomy. As already said the normal mitral valve
geometry is the standard that guides both the evaluation of the various valve lesions and the
surgical treatment. The central feature of the normal mitral valve geometry is represented by
the triangle of coaptation (fig 4). The coaptation length (CL) and the coaptation height (CH)
are cornerstone elements used in order to fully describe the valve geometry and to assess the
result of the repair (Cerin 2012). It may be assumed that from a three dimensional geometrical
perspective the triangle of coaptation corresponds roughly to an asymmetrical tent. In the
course of perioperative echocardiographic study, the systematical analysis of the mitral valve
apparatus is done, focusing on whether the triangle of coaptation is present or not. This
geometrical concept of the mitral valve allows the repair to be performed even in some of the
serious cases of acute mitral regurgitation.
Nevertheless, it should be underlined that this condition, even if rare, is a very severe cardio‐
logical emergency, often characterized by low cardiac output and high early mortality; with
medical therapy about 90% of patients with acute ischemic mitral regurgitation will died in
the first two months. This is the reason why surgical correction must not be delayed. The
predictors of better survival are: early operation, short duration of shock and mild degree of
left/right ventricular impairment. For the management of these patients the use of intra-aortic
balloon pumping and / or ventricular assist device (fig 13), out of inotropic pharmacologic
support, is mandatory. Surgery might be delayed up to 2-3 weeks only when patient is stable;
in this setting, as noted, the surgery is performed with lower risk.
Figure 13. Acute heart failure due to ischemic mitral regurgitation. TEE intraoperative picture showing the assessment
of the right position of the ventricular assist device (Impella) into the left ventricular outflow tract.
4. Chronic ischemic mitral regurgitation
4.1. Physiopathological consideration
Largely, the chronic ischemic mitral regurgitation is considered a long-lasting developing
process of LV remodeling after myocardial infarction, causing mitral regurgitation by dys‐
function and distortion of the components of the mitral valve including the chordae, the
annulus and the leaflets. Nevertheless, this is not always true: some patient with acute
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infarction may develop an acute and dynamic process of ventricular remodeling involving the
papillary muscle, which may not be perceived or checked in real time at echo and discovered
later, as ‘chronic’ mitral regurgitation.
From this point of view, the classification of ischemic mitral regurgitation in acute and chronic
may be in some cases misleading; ischemic mitral regurgitation is a ventricular disease,
following the same steps as the myocardial infarction. So, as the myocardial infarction
recognizes an acute period, a recent (sub-acute) and then a stable (chronic) phase, it seems
logical to use the same classification for ischemic mitral regurgitation. In the era of shorter
hospitalization of infarcted patients the acute ischemic mitral regurgitation, being a dynamic
phenomenon, may be missed at the first echo examinations and ‘discovered’ over time, as ‘late’
complication (Popa BA 2007) (fig 14); Thus, the echocardiographer has to be aware that the
classification in acute or chronic may reflect mainly the moment of diagnosis and less the true
period of time when the lesion occurred. This aspect is important as regard the prognosis of
ischemic mitral regurgitation, because, as noted, the acute and sub-acute ischemic mitral
regurgitation have a worse prognosis over a short period of time, respect of chronic ischemic
mitral regurgitation.
14 A 14B 14C 
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Figure 14. Severe ischemic mitral regurgitation (14D) diagnosed by TTE 10 years after an acute ‘uncomplicated’ myo‐
cardial infarction. The clinical presentation of the patient was exertion dyspnea. Ten years before, at discharge from
the hospital the Echo exam has been normal. Note the elongation of the papillary muscle (14 A,C,E), causing loss of
leaflet coaptation (14 A,C), with marginal prolapse of A2 scallop (14B,C). Apparently the patient presents an A2 local‐
ized prolapse (14BC), which, in reality is caused by an elongated papillary muscle. The tip of the papillary muscle is
shown (14E, yellow arrows), arriving till the mitral annular plane (which is categorically abnormal). The transthoracic
postoperative echo after mitral repair (mitral ring + suture and shortening of the papillary muscle), shows trivial resid‐
ual mitral regurgitation (14F).
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The proper diagnosis and thus the management of such a serious clinical condition as the acute
ischemic mitral regurgitation must rely on clear and robust echocardiographic concepts such
as mitral valve geometry and functional anatomy. As already said the normal mitral valve
geometry is the standard that guides both the evaluation of the various valve lesions and the
surgical treatment. The central feature of the normal mitral valve geometry is represented by
the triangle of coaptation (fig 4). The coaptation length (CL) and the coaptation height (CH)
are cornerstone elements used in order to fully describe the valve geometry and to assess the
result of the repair (Cerin 2012). It may be assumed that from a three dimensional geometrical
perspective the triangle of coaptation corresponds roughly to an asymmetrical tent. In the
course of perioperative echocardiographic study, the systematical analysis of the mitral valve
apparatus is done, focusing on whether the triangle of coaptation is present or not. This
geometrical concept of the mitral valve allows the repair to be performed even in some of the
serious cases of acute mitral regurgitation.
Nevertheless, it should be underlined that this condition, even if rare, is a very severe cardio‐
logical emergency, often characterized by low cardiac output and high early mortality; with
medical therapy about 90% of patients with acute ischemic mitral regurgitation will died in
the first two months. This is the reason why surgical correction must not be delayed. The
predictors of better survival are: early operation, short duration of shock and mild degree of
left/right ventricular impairment. For the management of these patients the use of intra-aortic
balloon pumping and / or ventricular assist device (fig 13), out of inotropic pharmacologic
support, is mandatory. Surgery might be delayed up to 2-3 weeks only when patient is stable;
in this setting, as noted, the surgery is performed with lower risk.
Figure 13. Acute heart failure due to ischemic mitral regurgitation. TEE intraoperative picture showing the assessment
of the right position of the ventricular assist device (Impella) into the left ventricular outflow tract.
4. Chronic ischemic mitral regurgitation
4.1. Physiopathological consideration
Largely, the chronic ischemic mitral regurgitation is considered a long-lasting developing
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infarction may develop an acute and dynamic process of ventricular remodeling involving the
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From this point of view, the classification of ischemic mitral regurgitation in acute and chronic
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following the same steps as the myocardial infarction. So, as the myocardial infarction
recognizes an acute period, a recent (sub-acute) and then a stable (chronic) phase, it seems
logical to use the same classification for ischemic mitral regurgitation. In the era of shorter
hospitalization of infarcted patients the acute ischemic mitral regurgitation, being a dynamic
phenomenon, may be missed at the first echo examinations and ‘discovered’ over time, as ‘late’
complication (Popa BA 2007) (fig 14); Thus, the echocardiographer has to be aware that the
classification in acute or chronic may reflect mainly the moment of diagnosis and less the true
period of time when the lesion occurred. This aspect is important as regard the prognosis of
ischemic mitral regurgitation, because, as noted, the acute and sub-acute ischemic mitral
regurgitation have a worse prognosis over a short period of time, respect of chronic ischemic
mitral regurgitation.
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cardial infarction. The clinical presentation of the patient was exertion dyspnea. Ten years before, at discharge from
the hospital the Echo exam has been normal. Note the elongation of the papillary muscle (14 A,C,E), causing loss of
leaflet coaptation (14 A,C), with marginal prolapse of A2 scallop (14B,C). Apparently the patient presents an A2 local‐
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The chronic ischemic mitral regurgitation, comparing with the acute one, is a much more
gradual and more complex process, because of the slow progression over time of the left heart
remodeling (fig 14). This clinical condition recognizes two main mechanisms: a structural
alteration of the subvalvular apparatus (papillary muscle and the corresponding LV wall),
alongside of the phenomenon of left ventricular cavity remodeling.
4.2. Left ventricle post infarction remodeling process
From the physiopathological point of view the left ventricular post myocardial infarction
remodeling is considered to be a phenomenon which can be divided in two parts: a regional
and a global process of remodeling.
Regional remodeling is more often found after the inferior infarction (but not only), and may
evolve over time in two different ways:
1. mainly a process of inferior wall remodeling with displacement of the papillary muscles.
This type is associated with overt systolic restriction of posterior mitral leaflet.
2. inferior wall remodeling and displacement of the papillary muscles, combined with post-
ischemic elongation of papillary muscles. In this kind of inferior post infarction remodeling
the systolic restriction of the posterior mitral leaflet may be less evident or even absent in
some cases. Respect of the first type, the geometry of mitral valve in this sort of ventricular
remodeling will be different.
Global left ventricular remodeling is generally seen after two heart attacks (multiple myo‐
cardial infarctions and in cases with ischemic dilated cardiomyopathy) and it is characterized
by restriction of both mitral leaflets, tethering of the mitral valve apparatus with mitral valve
tenting, due to progressive migration of the papillary muscles simultaneously with overall left
cavity dilatation.
In the patients with left ventricular remodeling and chronic ischemic mitral regurgitation,
these physiopathological concepts are expressed by two main echocardiographic patterns of
left heart remodeling:
a. the echocardiographic pattern of limited LV remodeling: inferior or lateral infarction scar,
mild left ventricular dilatation, mild systolic dysfunction and chronic ischemic mitral
regurgitation due to unambiguous systolic restriction of posterior leaflet (fig 15), and
b. the echocardiographic pattern of extensive LV remodeling: major left ventricular cavity
dilatation with dysfunction and distortion (by anterior and inferior myocardial infarc‐
tion), typically with poor systolic function, but also with a diastolic one and the tethering
of both mitral leaflets (fig 3).
Both types of chronic ischemic mitral regurgitation present a mitral annular dilatation, obvious‐
ly more evident in patients with double myocardial infarction. A form of symmetric remodeling
of the mitral valve apparatus  is present in patients with ischemic dilated cardiomyopathies
(‘extensive’ LV remodeling) due to bilateral migration of both the papillary muscle (scallops P1/
P2/P3). Conversely, a limitary process of mitral valve apparatus remodeling is present in patients
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with ‘limited’ LV remodeling (inferior infarction) and asymmetric mitral valve remodeling, due to
solitary migration of the postero-medial papillary muscle (scallops P3/P2).
These two main echocardiographic patterns of LV remodeling, when associated with chronic
ischemic mitral regurgitation, are easy to identify by transthoracic echocardiographic exam
and the transesophageal examination is not necessary. Sometimes, these configurations may
be less definite, as in patients with regional or global remodeling, combined with coincident
papillary muscle elongation. In these cases there is an additional phenomenon of migration of
the LV infarcted wall, associated with post ischemic elongation of the papillary muscle.
A geometrical analysis of the mitral apparatus, by use of the echocardiographic tool of triangle
of coaptation may identify these patients with regional or global remodeling, combined with
elongation of the papillary muscle. As already has been mentioned, the patients with papillary
muscle elongation present a distortion of the triangle of coaptation with progressive alteration
of the standard trilateral shape (fig 5), till the complete disappearance of it (fig.6). The mech‐
anism of mitral insufficiency in these patients is more complex and the surgical strategy has
to be tailored accordingly.
The elongation of the papillary muscle may often be unnoticed if the operator mostly focuses
the attention on the mitral leaflet, on the valve coaptation and on the degree of mitral regur‐
gitation. Moreover, the papillary muscles are difficult and rarely seen in the same plane with
the mitral valve leaflets, being sited distant from the coaptation valve plane; only a specific
and vigilant off axis assessment of them may reveal the muscularly post-ischemic remodeling.
When the papillary muscles elongation is obvious, the surgical strategy has to be adapted and
sometimes a shortening of them or use of the artificial chordae may be necessary to restore a
good plane of valve coaptation and valve geometry.
Therefore, as message for the everyday practice, in acute or in chronic ischemic mitral regurgita‐
tion, the marker of the papillary muscle elongation is the distorted coaptation triangle.
Consequently, in the analysis of ischemic mitral regurgitation the starting points are restricted
motion of the posterior mitral leaflet (type III° Carpentier’s classification), combined with
mitral annular dilatation, secondary to migration of the wall and left ventricular enlargement
Figure 15. Limited LV remodeling: TTE (left) and TEE 2-chamber view (right) showing systolic restriction of the posteri‐
or mitral leaflet and minimal leaflet coaptation. Necrosis of the inferior wall is evident, with mild left ventricular dilata‐
tion (EDVol 170ml), mild systolic dysfunction (EF 43%) and chronic ischemic mitral regurgitation due to clear systolic
restriction of posterior leaflet.
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motion of the posterior mitral leaflet (type III° Carpentier’s classification), combined with
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(fig 15). The consequent mitral regurgitation leads to left ventricular volume overload, closing
the vicious circle of ischemic mitral regurgitation and of left ventricular remodeling. The
echocardiographic examination will show the tethering of one or both mitral leaflets, which is
the ‘standard’ pattern of chronic ischemic mitral regurgitation. However, around 10% of
patients with chronic ischemic mitral regurgitation may show a different pattern of regurgi‐
tation with ‘false mitral prolapse’, by elongation of the papillary muscle due to local ischemia,
necrosis and/or fibrosis (false because the etiology is not degenerative, but ischemic one).
In these patients, from the echocardiographic point of view, there are three elements that may
suggest the suspicion of ischemic etiology of the prolapsed valve:
1. leaflets - prolapse limited to one of the mitral leaflets, often of the anterior one,
2. papillary muscle - specific appearance of the papillary muscle: elongated, hyperechogenic,
thinning and triangularly shaped; “thorny” papillary muscle (fig 16);
3. valve geometry - the abnormal mitral valve geometry, with distortion of the triangle of
coaptation, until its complete extinction (see also the Fig 5, 6)
16 A 16 B 16 C 16 D 
Figure 16. A,B,C,D. Four different cases with chronic post ischemic elongation of the papillary muscle: 2D transthora‐
cic exam (16B) and live 3D (A,C,D). Note the progressive thinning of the papillary muscle, with the sharp aspect of the
tip of it: so called ‘thorny papillary muscle’.
Chronic ischemic mitral regurgitation may also be synonymous with ruptured tendineous
chordae. Due to ischemia or necrosis the insertion place of the mitral chords on the tip of the
papillary muscle may become friable, and often a limited ‘ischemic flail’, may be apparent (fig 17).
17A 17B 17C 17D 
Figure 17. Loss of leaflet coaptation (B,C), with flail (B) and eccentric jet. The free ruptured chordae is visible in systole
(C) and also in diastole (D). The pictures belong to the same patient.
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Indication to surgery: With an ever increasing population of patients with coronary artery
disease complicated by chronic ischemic mitral regurgitation, the question whether to perform
a mitral valve repair in addition to CABG is one of the most common and controversial clinical
dilemmas faced by cardiac surgeons and cardiologists today. There is a general agreement
regarding the indication for surgery in patients with severe ischemic mitral regurgitation. The
problem arises for moderate ischemic mitral regurgitation. At present, there is no definitive
randomized, prospective trial that clarifies which approach should be taken. The 2011 ACCF/
AHA guidelines on CABG state that patients undergoing CABG who have severe ischemic
mitral valve regurgitation not likely to resolve with revascularization, should have concomi‐
tant mitral valve repair or replacement at the time of CABG (Class I, Level of evidence B)
(Gillinov 2001, Trichon BH 2003, Fattouch K 2009 & 2010, Zoghbi W 2003). Operative mortality
is considered to be around 10% (Rankin 1988, Cohn 1995, Grossi 2001). Some studies advocate
mitral valve repair to all patients that undergo CABG even when the degree of mitral regur‐
gitation is mild. This strategy seems to be reasonable if the chronic ischemic mitral regurgita‐
tion is considered to be expression of the LV deformation / remodeling process, which is not
still reversible in the chronic phase of the myocardial infarction. A careful echocardiographic
analysis focused mainly on the quality of leaflet coaptation and on the extension of LV
deformation (limited or extensive remodeling), may guide the surgeon.
5. Assessment of ischemic mitral regurgitation severity
Due to the hemodynamic conditions in ischemic heart disease and the particular shape of the
regurgitant orifice, assessment of the severity of mitral regurgitation may be challenging.
Mitral regurgitation in an ischemic setting has a profound impact on patient’s prognosis and
therefore its quantification plays a key role in the revascularization plan because moderate and
severe mitral regurgitation have indication to surgery. Given this special impact on prognosis,
the thresholds of defining a severe mitral regurgitation in ischemic patients are much lower
than in other contexts (see below the PISA method).
The qualitative method, based on regurgitant jet area, is not reliable. This is true especially
when an exact assessment of mitral regurgitation is need, because this approach is prone to
many biases, being so dependent upon loading conditions and on equipment settings (for
example color gain). The gradient between left ventricle and left atrium will highly influence
the size of the jet. In an acute mitral regurgitation, in which left atrium pressure is elevated
and the left ventricle-left atrium gradient is low, the regurgitant jet may be small, even though
the real regurgitant volume is important. Conversely, in a high blood pressure setting (i.e. a
high left ventricle-left atrium gradient) the regurgitant jet will be bigger. Last but not the least,
eccentric jets (like the ones found in posterior leaflet restriction), seem smaller than the central
ones due to Coandă effect (hugging of the adjacent wall of the left atrium).
The semi-quantitative (vena contracta) and quantitative methods (PISA) are therefore
advisable whenever their determination is possible.
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2. papillary muscle - specific appearance of the papillary muscle: elongated, hyperechogenic,
thinning and triangularly shaped; “thorny” papillary muscle (fig 16);
3. valve geometry - the abnormal mitral valve geometry, with distortion of the triangle of
coaptation, until its complete extinction (see also the Fig 5, 6)
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Figure 16. A,B,C,D. Four different cases with chronic post ischemic elongation of the papillary muscle: 2D transthora‐
cic exam (16B) and live 3D (A,C,D). Note the progressive thinning of the papillary muscle, with the sharp aspect of the
tip of it: so called ‘thorny papillary muscle’.
Chronic ischemic mitral regurgitation may also be synonymous with ruptured tendineous
chordae. Due to ischemia or necrosis the insertion place of the mitral chords on the tip of the
papillary muscle may become friable, and often a limited ‘ischemic flail’, may be apparent (fig 17).
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Figure 17. Loss of leaflet coaptation (B,C), with flail (B) and eccentric jet. The free ruptured chordae is visible in systole
(C) and also in diastole (D). The pictures belong to the same patient.
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Vena contracta is the narrowest region of the regurgitant jet, which is found not at the level of
the leaflets, but just below the regurgitant orifice (because the blood is still converging for a
few millimeters before re-expanding in left atrium) (fig 18). Its width is a marker of the
regurgitant orifice area. It should be measured in a window perpendicular to the coaptation
line, like parasternal long axis or four chambers views. A value of < 3mm is compatible with
a mild regurgitation, while a value of >7mm is indicative of severe regurgitation. Values in-
between are not diagnostic of a moderate mitral regurgitation, because of an important
overlap. In ischemic mitral regurgitation, the shape of the regurgitant orifice is not round, but
rather elliptic. For this reason, assessment of vena contracta width should be done in two
orthogonal planes (e.g. parasternal and apical four chambers) and an average of these two
should be reported. A value > 8 mm is diagnostic of severe regurgitation. The 3D echo can be
a solution for assessment of vena contracta in an ischemic setting.
Figure 18. Vena contracta depth measurement at the narrowest point of the regurgitant jet. The three components
of the jet are visible: convergence zone, vena contracta and the flow into the left atrium.
Quantitative approaches and especially PISA (proximal isovelocity surface area) are the most
indicated. PISA is based on the fact that near the regurgitant orifice, the blood (which should
pass throw a restricted area) is disposed in hemispheric layers, having the same velocity at a
certain distance from the orifice. Lowering the Nyquist limit at 15-40 cm/s (the velocity at which
aliasing is appearing), all the “layers” with a higher velocity will have the aliasing phenom‐
enon. Measuring the first aliasing hemisphere we’ll have a marker of regurgitation degree.
PISA method permits assessment of:
• the flow rate (FR) as FR= 2 x π x R 2 x Val
where R is the PISA radius and Val is the aliasing velocity
• effective regurgitant orifice area (ROA) as EROA=FR/V max
where FR is the flow rate and V max is the maximum velocity measured on mitral regurgitation
envelope in continuous Doppler
• regurgitant volume (RV) as RV=ROA x TVI, where EROA is effective regurgitant orifice area
and TVI is the time-velocity integral measured on mitral regurgitation envelope in contin‐
uous Doppler (fig 19).
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Figure 19. Assessment of mitral regurgitation severity according to PISA method (MR ERO, MR Flow). The baseline of
color Doppler is moved toward the regurgitant jet direction and the hemisphere radius is measured (left). On the mi‐
tral regurgitation envelope (continuous Doppler) maximum velocity and TVI are determined
In eccentric jets (posterior leaflet restriction) the largest PISA is to be found in the parasternal
long axis view, while in central jets the apical four chambers view should be used.
The elliptic shape of regurgitant orifice found in ischemic mitral regurgitation leads the PISA
method to underestimate the real regurgitant volume (PISA is bigger than a hemisphere).
Considering the profound deleterious effect of mitral regurgitation in an ischemic context, cut
off levels of severity are lower than in organic mitral regurgitation, i.e. an EROA more than
20mm2 (vs. >40mm2 in organic mitral regurgitation) and a regurgitant volume greater than
30ml (vs. >60ml) defines a severe ischemic mitral regurgitation.
Due to the dynamic characteristic of ischemic mitral regurgitation, PISA is not the same
throughout the whole systole, being usually smaller in mesosystole when the regurgitation
tends to decrease.
If hemispheric floor is not flat (i.e. 180º), an angle correction can be made. In this situation
EROA adjusted=EROA x α/180, where α is the angle of convergence.
In multiple jets, both vena contracta width and PISA method are not additives and cannot
be used.
Surgical approaches. Overview. The surgical treatment of acute or chronic ischemic mitral
regurgitation is strongly influenced by the echocardiographic assessment, which remains the
only tool for surgical planning and postoperative control. The complex mechanisms of
ischemic mitral regurgitation are analyzed by echo and the surgical planning is done after
transthoracic and usually elaborate after intraoperative transesophageal examination. Based
on echocardiographic analysis, various approaches have been proposed for the management
of ischemic mitral regurgitation. So far, both medical treatments and classical surgical
techniques are not always sufficient. Within the next paragraphs a rapid overview of some of
the various surgical techniques implied in the treatment of ischemic mitral regurgitation will
be done.
1. Undersized mitral valve annuloplasty. The strategy of over-reduction of mitral annulus,
combined with the coronary by-pass surgery is the most diffused surgical approach,
especially in patients with dilated heart and chronic ischemic mitral regurgitation. As
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Vena contracta is the narrowest region of the regurgitant jet, which is found not at the level of
the leaflets, but just below the regurgitant orifice (because the blood is still converging for a
few millimeters before re-expanding in left atrium) (fig 18). Its width is a marker of the
regurgitant orifice area. It should be measured in a window perpendicular to the coaptation
line, like parasternal long axis or four chambers views. A value of < 3mm is compatible with
a mild regurgitation, while a value of >7mm is indicative of severe regurgitation. Values in-
between are not diagnostic of a moderate mitral regurgitation, because of an important
overlap. In ischemic mitral regurgitation, the shape of the regurgitant orifice is not round, but
rather elliptic. For this reason, assessment of vena contracta width should be done in two
orthogonal planes (e.g. parasternal and apical four chambers) and an average of these two
should be reported. A value > 8 mm is diagnostic of severe regurgitation. The 3D echo can be
a solution for assessment of vena contracta in an ischemic setting.
Figure 18. Vena contracta depth measurement at the narrowest point of the regurgitant jet. The three components
of the jet are visible: convergence zone, vena contracta and the flow into the left atrium.
Quantitative approaches and especially PISA (proximal isovelocity surface area) are the most
indicated. PISA is based on the fact that near the regurgitant orifice, the blood (which should
pass throw a restricted area) is disposed in hemispheric layers, having the same velocity at a
certain distance from the orifice. Lowering the Nyquist limit at 15-40 cm/s (the velocity at which
aliasing is appearing), all the “layers” with a higher velocity will have the aliasing phenom‐
enon. Measuring the first aliasing hemisphere we’ll have a marker of regurgitation degree.
PISA method permits assessment of:
• the flow rate (FR) as FR= 2 x π x R 2 x Val
where R is the PISA radius and Val is the aliasing velocity
• effective regurgitant orifice area (ROA) as EROA=FR/V max
where FR is the flow rate and V max is the maximum velocity measured on mitral regurgitation
envelope in continuous Doppler
• regurgitant volume (RV) as RV=ROA x TVI, where EROA is effective regurgitant orifice area
and TVI is the time-velocity integral measured on mitral regurgitation envelope in contin‐
uous Doppler (fig 19).
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Figure 19. Assessment of mitral regurgitation severity according to PISA method (MR ERO, MR Flow). The baseline of
color Doppler is moved toward the regurgitant jet direction and the hemisphere radius is measured (left). On the mi‐
tral regurgitation envelope (continuous Doppler) maximum velocity and TVI are determined
In eccentric jets (posterior leaflet restriction) the largest PISA is to be found in the parasternal
long axis view, while in central jets the apical four chambers view should be used.
The elliptic shape of regurgitant orifice found in ischemic mitral regurgitation leads the PISA
method to underestimate the real regurgitant volume (PISA is bigger than a hemisphere).
Considering the profound deleterious effect of mitral regurgitation in an ischemic context, cut
off levels of severity are lower than in organic mitral regurgitation, i.e. an EROA more than
20mm2 (vs. >40mm2 in organic mitral regurgitation) and a regurgitant volume greater than
30ml (vs. >60ml) defines a severe ischemic mitral regurgitation.
Due to the dynamic characteristic of ischemic mitral regurgitation, PISA is not the same
throughout the whole systole, being usually smaller in mesosystole when the regurgitation
tends to decrease.
If hemispheric floor is not flat (i.e. 180º), an angle correction can be made. In this situation
EROA adjusted=EROA x α/180, where α is the angle of convergence.
In multiple jets, both vena contracta width and PISA method are not additives and cannot
be used.
Surgical approaches. Overview. The surgical treatment of acute or chronic ischemic mitral
regurgitation is strongly influenced by the echocardiographic assessment, which remains the
only tool for surgical planning and postoperative control. The complex mechanisms of
ischemic mitral regurgitation are analyzed by echo and the surgical planning is done after
transthoracic and usually elaborate after intraoperative transesophageal examination. Based
on echocardiographic analysis, various approaches have been proposed for the management
of ischemic mitral regurgitation. So far, both medical treatments and classical surgical
techniques are not always sufficient. Within the next paragraphs a rapid overview of some of
the various surgical techniques implied in the treatment of ischemic mitral regurgitation will
be done.
1. Undersized mitral valve annuloplasty. The strategy of over-reduction of mitral annulus,
combined with the coronary by-pass surgery is the most diffused surgical approach,
especially in patients with dilated heart and chronic ischemic mitral regurgitation. As
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noted, this technique addressed just the annular dilation. The echocardiographic exami‐
nation plays an essential role because it confirms the dilation of the mitral annulus, and
the subsequent reduced and/or loss of leaflet coaptation in case of advanced left ventric‐
ular and annular dilatation (‘extended’ LV remodeling pattern). As a rule, Echo indicates
the presence of tethering of the mitral leaflets, and also the systolic and, in cases with
advanced heart remodeling and ischemic dilative cardiomyopathy, the diastolic restric‐
tion of the posterior mitral leaflets.
Concomitant coronary revascularization and downsizing of the mitral annulus by prosthetic
rings, showed promising results with 80% good competence of the mitral valve at 2-years
follow-up, but only 50% at five years (McGee, 2004, Klein 2011). Better results were published
by Dion (2004) according to a proper algorithm. Patients treated with this technique showed
almost always the echocardiographic picture of the so-called “monoleaflet” mitral valve,
where the anterior leaflet covers the entire mitral orifice and the posterior leaflet remains
restricted in its diastolic position. At the time of surgery the preoperative TEE Echo assists the
surgical mitral repair by estimating the length of the medial scallop of the anterior mitral leaflet
(scallop A2). This is usually performed from the distal-esophageal 135° view (three chamber
view) and is essential in choosing the size of the annuloplasty ring. The choice of the size of
the prosthetic ring is still empirical, but usually a ring two to three sizes smaller than measured
is used.
The other determinant of the ischemic mitral regurgitation in the advanced stage of left
ventricular remodeling is the restricted motion of the posterior mitral leaflet and loss of the
anatomical and functional leaflet reserve both in systole and also in diastole. The existence of
the anatomical and functional reserve of posterior mitral leaflet is a key element for having a
competent mitral valve and, unfortunately, this aspect is not resolved by the over-reduction
technique alone. To overcome the leaflet restriction some authors cut a limited number of basal
chordae tendinae with the intent of reducing leaflet tethering and improving the coaptation.
This simple procedure reduced tenting without creating valve prolapse, and the consequence
is a decrease in mitral regurgitation (Messas 2001).
2. Because of these unsatisfactory results with the undersizing technique alone, the reposi‐
tioning of the posterior papillary muscle has been proposed, mainly in patients with
ischemic dilated cardiomyopathy, as adjunctive approach to the annuloplasty; the
outcome is currently under evaluation (Hvass 2010). The role of intraoperative TEE is to
define the deformation of the subvalvular apparatus from the geometrical point of view.
On one hand, it must preoperatively assess the distance between the base of the papillary
muscles (usually from the transgastric short axis view), and on the other hand it has to
evaluate the geometry of the left ventricle using the sphericity index.
3. Elongation of the posterior mitral leaflet with pericardial patch (LEX), represents a
relatively novel surgical approach to relief ischemic systolic restriction, despite some
controversy regarding this technique (fig 20). Some encouraging results of LEX were
reported but the number of treated patients is, so far, very limited (Dobre 2000, Langer
2006, de Varennes 2009). Surgical leaflet extension by autologous pericardial patch
addresses directly the problem of ischemic leaflet restriction and tethering (type III°b
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Carpentier classification). It is a physiologically coherent and relatively simple approach,
intended to increase the surface and the mobility of the posterior mitral leaflet, in order
to allow a better leaflet coaptation.
Figure 20. Posterior mitral leaflet after extension with pericardial patch (arrows) in a patient with ischemic dilated car‐
diomyopathy: extended LV remodeling (intraoperative view - left and TTE preoperative picture; right).
This technique allows the extension of the surface of the posterior leaflet, especially in the area
of the scallops P3 and P2, which is normally more restricted by the post-ischemic tethering.
Furthermore, this procedure provides an additional anatomical leaflet reserve: in case of
continuing left ventricular remodeling after surgery, which may be present in about 50% of
the patients, according to some authors. Leaflet extension by autologous pericardial patch has
been widely and successfully used in the reconstruction of other mitral valve pathologies such
as rheumatic disease and endocarditis, with acceptable long-term results (Zegdi, 2007). This
procedure can be performed within 15-20 extra minutes of aortic cross-clamping, and allows
implanting larger sizes mitral prosthetic rings, with minor diastolic gradient through the mitral
valve. Further studies with larger number of patients and adequate long-term follow-up are
needed to assess the efficiency of this simple and promising approach to the treatment of
ischemic mitral regurgitation, in case of ischemic dilated cardiomyopathy.
Once more the echo plays an essential role by identifying the patient candidates to LEX.
Typically the Echo aspect demonstrates small posterior mitral leaflets, systolic and, sometimes,
diastolic leaflets restriction, with significant mitral regurgitation due to reduced coaptation
and asymmetrical apposition of the anterior leaflet. Consequently, at the postoperative
examination Echo evaluates not only the mitral valve function as expressed by the degree of
residual regurgitation, but, more important, the anatomical (leaflet length) and functional
reserve (the coaptation length).
For every day practice three main situations will be considered:
1. Chronic ischemic mitral regurgitation determined by restriction of the posterior leaflet
and apical displacement of the papillary muscle in patients with inferior myocardial
infarction (or inferior and lateral myocardial infarction), mild left ventricular dilatation
and mild systolic dysfunction: so called ‘limited’ LV remodeling pattern.
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the anatomical and functional reserve of posterior mitral leaflet is a key element for having a
competent mitral valve and, unfortunately, this aspect is not resolved by the over-reduction
technique alone. To overcome the leaflet restriction some authors cut a limited number of basal
chordae tendinae with the intent of reducing leaflet tethering and improving the coaptation.
This simple procedure reduced tenting without creating valve prolapse, and the consequence
is a decrease in mitral regurgitation (Messas 2001).
2. Because of these unsatisfactory results with the undersizing technique alone, the reposi‐
tioning of the posterior papillary muscle has been proposed, mainly in patients with
ischemic dilated cardiomyopathy, as adjunctive approach to the annuloplasty; the
outcome is currently under evaluation (Hvass 2010). The role of intraoperative TEE is to
define the deformation of the subvalvular apparatus from the geometrical point of view.
On one hand, it must preoperatively assess the distance between the base of the papillary
muscles (usually from the transgastric short axis view), and on the other hand it has to
evaluate the geometry of the left ventricle using the sphericity index.
3. Elongation of the posterior mitral leaflet with pericardial patch (LEX), represents a
relatively novel surgical approach to relief ischemic systolic restriction, despite some
controversy regarding this technique (fig 20). Some encouraging results of LEX were
reported but the number of treated patients is, so far, very limited (Dobre 2000, Langer
2006, de Varennes 2009). Surgical leaflet extension by autologous pericardial patch
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Carpentier classification). It is a physiologically coherent and relatively simple approach,
intended to increase the surface and the mobility of the posterior mitral leaflet, in order
to allow a better leaflet coaptation.
Figure 20. Posterior mitral leaflet after extension with pericardial patch (arrows) in a patient with ischemic dilated car‐
diomyopathy: extended LV remodeling (intraoperative view - left and TTE preoperative picture; right).
This technique allows the extension of the surface of the posterior leaflet, especially in the area
of the scallops P3 and P2, which is normally more restricted by the post-ischemic tethering.
Furthermore, this procedure provides an additional anatomical leaflet reserve: in case of
continuing left ventricular remodeling after surgery, which may be present in about 50% of
the patients, according to some authors. Leaflet extension by autologous pericardial patch has
been widely and successfully used in the reconstruction of other mitral valve pathologies such
as rheumatic disease and endocarditis, with acceptable long-term results (Zegdi, 2007). This
procedure can be performed within 15-20 extra minutes of aortic cross-clamping, and allows
implanting larger sizes mitral prosthetic rings, with minor diastolic gradient through the mitral
valve. Further studies with larger number of patients and adequate long-term follow-up are
needed to assess the efficiency of this simple and promising approach to the treatment of
ischemic mitral regurgitation, in case of ischemic dilated cardiomyopathy.
Once more the echo plays an essential role by identifying the patient candidates to LEX.
Typically the Echo aspect demonstrates small posterior mitral leaflets, systolic and, sometimes,
diastolic leaflets restriction, with significant mitral regurgitation due to reduced coaptation
and asymmetrical apposition of the anterior leaflet. Consequently, at the postoperative
examination Echo evaluates not only the mitral valve function as expressed by the degree of
residual regurgitation, but, more important, the anatomical (leaflet length) and functional
reserve (the coaptation length).
For every day practice three main situations will be considered:
1. Chronic ischemic mitral regurgitation determined by restriction of the posterior leaflet
and apical displacement of the papillary muscle in patients with inferior myocardial
infarction (or inferior and lateral myocardial infarction), mild left ventricular dilatation
and mild systolic dysfunction: so called ‘limited’ LV remodeling pattern.
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2. Chronic ischemic mitral regurgitation by systolic (and sometimes diastolic) restriction of
mitral leaflets motion (tethering of mitral leaflets) in patients with history of double or
multiple infarction, overt left ventricular dilatation and depression of systolic function
(ischemic cardiomyopathy): ‘extended’ LV remodeling pattern.
3. Chronic ischemic mitral regurgitation by papillary muscle elongation (with various
degree of false prolapse of the mitral leaflets) (Hashim 2012); usually patients with inferior
myocardial infarction, chronic ischemic mitral regurgitation and distortion of the coaptation
triangle.
5.1. Chronic ischemic mitral regurgitation due to restriction
Chronic ischemic mitral regurgitation due to restriction of the posterior mitral leaflet and
asymmetrical apposition of the anterior one, by apical displacement of the posterior papillary
muscle and left ventricular wall. Fig 21.
Figure 21. Systolic restriction of posterior papillary muscle; 3D and 2D transthoracic echocardiography and drawing.
Background. This is the most common type of ischemic mitral regurgitation (about 2/3 of all
cases of chronic ischemic mitral regurgitation), belongs to the Carpantier’s type III°b classifi‐
cation and has been extensively described. The valve leakage is here the result of alteration of
subvalvular apparatus secondary to left ventricle remodeling following myocardial infarction.
Frequently, they present with a myocardial scar caused by a previous myocardial infarction
and the remodeling process of the left heart is less expressed, with mild systolic dysfunction.
Respect of patients with ischemic dilated cardiomyopathy, this category of patients has less
dilatation of the left ventricular cavity, and, as a rule, history of inferior (or lateral) myocardial
infarction: echocardiographic pattern of limited LV remodeling. An infarction at the basal side
of the left ventricle, involving the postero-medial papillary muscle will lead to a posterior and
apical displacement of the papillary muscle, which will pull the posterior leaflet toward the
posterior wall, impeding it to arrive to the normal coaptation plane during systole (figure
22). The postero-medial papillary muscle is more prone to ischemic remodeling than the
antero-lateral one, having only a vascular source (from circumflex or right coronary), while
the latter has a double vascularization (from both left anterior descending and circumflex) –
see also the fig 7.
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Geometrical echocardiographic analysis. As already mentioned, the echocardiographic
presentation of systolic restriction of the posterior mitral leaflet is typical: in presence of an
inferior and/or lateral myocardial infarction, the posterior leaflet appears fixed in systole (and
sometimes also in diastole), instead of the normal thickness of it and of the absence of fibrosis
and/or calcification. The anterior leaflet is overlapping the posterior restricted leaflet (asym‐
metrical apposition), due to the deficit of a supporting surface in systole. The transthoracic
exam is sufficient to identify the mechanism of mitral regurgitation and, equally important, to
evaluate the degree of mitral regurgitation (Monin JL, 2005). The algorithm of evaluation of
mitral valve geometry should be focused on the assessment of the triangle of coaptation and
coaptation length (normally >6mm). In this specific condition there is an insufficient leaflet
coaptation due to systolic restriction of the posterior leaflet, asymmetric apposition of the
anterior leaflet and annular dilatation.
Figure 22. Restriction of posterior leaflet with typical asymmetric apposition of the anterior one (2DE and 3DE TT pic‐
tures) in a patient with inferior MI. The tip of the anterior mitral leaflet is heading towards the left atrium due to
chronic loss of the systolic resistance plane.
The evaluation of the anatomical and functional reserve of the posterior mitral leaflet plays an
essential role for those patients who will undergo reconstructive surgery. For example, when
the posterior leaflet is too small (<1mm of length) and particularly restricted (fixed leaflet), it
is a clear sign of reduced anatomical reserve. This key point will indicate the need of a more
aggressive surgical approach where reductive annuloplasty should be associated to leaflet
extension as discussed before.
Echo-surgical messages: As general rule, in coronary patients undergoing revascularization,
the assessment of the severity of valve regurgitation (and so of decision to treat the regurgi‐
tation), should be done by transthoracic exam, as general anesthesia may significantly decrease
the severity of regurgitation. When necessary, in the operating room, a preload and/or
afterload test provides an additional estimation of the severity of mitral regurgitation (Aklog
2001, Gisbert A, 2006). Intraoperative transesophageal echocardiography is routinely per‐
formed in order to confirm the mechanism of mitral regurgitation and mainly to control the
outcome of repair.
Ischemic Mitral Regurgitation: From Echo Assessment to Surgical Strategy and Technique
http://dx.doi.org/10.5772/56062
89
2. Chronic ischemic mitral regurgitation by systolic (and sometimes diastolic) restriction of
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3. Chronic ischemic mitral regurgitation by papillary muscle elongation (with various
degree of false prolapse of the mitral leaflets) (Hashim 2012); usually patients with inferior
myocardial infarction, chronic ischemic mitral regurgitation and distortion of the coaptation
triangle.
5.1. Chronic ischemic mitral regurgitation due to restriction
Chronic ischemic mitral regurgitation due to restriction of the posterior mitral leaflet and
asymmetrical apposition of the anterior one, by apical displacement of the posterior papillary
muscle and left ventricular wall. Fig 21.
Figure 21. Systolic restriction of posterior papillary muscle; 3D and 2D transthoracic echocardiography and drawing.
Background. This is the most common type of ischemic mitral regurgitation (about 2/3 of all
cases of chronic ischemic mitral regurgitation), belongs to the Carpantier’s type III°b classifi‐
cation and has been extensively described. The valve leakage is here the result of alteration of
subvalvular apparatus secondary to left ventricle remodeling following myocardial infarction.
Frequently, they present with a myocardial scar caused by a previous myocardial infarction
and the remodeling process of the left heart is less expressed, with mild systolic dysfunction.
Respect of patients with ischemic dilated cardiomyopathy, this category of patients has less
dilatation of the left ventricular cavity, and, as a rule, history of inferior (or lateral) myocardial
infarction: echocardiographic pattern of limited LV remodeling. An infarction at the basal side
of the left ventricle, involving the postero-medial papillary muscle will lead to a posterior and
apical displacement of the papillary muscle, which will pull the posterior leaflet toward the
posterior wall, impeding it to arrive to the normal coaptation plane during systole (figure
22). The postero-medial papillary muscle is more prone to ischemic remodeling than the
antero-lateral one, having only a vascular source (from circumflex or right coronary), while
the latter has a double vascularization (from both left anterior descending and circumflex) –
see also the fig 7.
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Geometrical echocardiographic analysis. As already mentioned, the echocardiographic
presentation of systolic restriction of the posterior mitral leaflet is typical: in presence of an
inferior and/or lateral myocardial infarction, the posterior leaflet appears fixed in systole (and
sometimes also in diastole), instead of the normal thickness of it and of the absence of fibrosis
and/or calcification. The anterior leaflet is overlapping the posterior restricted leaflet (asym‐
metrical apposition), due to the deficit of a supporting surface in systole. The transthoracic
exam is sufficient to identify the mechanism of mitral regurgitation and, equally important, to
evaluate the degree of mitral regurgitation (Monin JL, 2005). The algorithm of evaluation of
mitral valve geometry should be focused on the assessment of the triangle of coaptation and
coaptation length (normally >6mm). In this specific condition there is an insufficient leaflet
coaptation due to systolic restriction of the posterior leaflet, asymmetric apposition of the
anterior leaflet and annular dilatation.
Figure 22. Restriction of posterior leaflet with typical asymmetric apposition of the anterior one (2DE and 3DE TT pic‐
tures) in a patient with inferior MI. The tip of the anterior mitral leaflet is heading towards the left atrium due to
chronic loss of the systolic resistance plane.
The evaluation of the anatomical and functional reserve of the posterior mitral leaflet plays an
essential role for those patients who will undergo reconstructive surgery. For example, when
the posterior leaflet is too small (<1mm of length) and particularly restricted (fixed leaflet), it
is a clear sign of reduced anatomical reserve. This key point will indicate the need of a more
aggressive surgical approach where reductive annuloplasty should be associated to leaflet
extension as discussed before.
Echo-surgical messages: As general rule, in coronary patients undergoing revascularization,
the assessment of the severity of valve regurgitation (and so of decision to treat the regurgi‐
tation), should be done by transthoracic exam, as general anesthesia may significantly decrease
the severity of regurgitation. When necessary, in the operating room, a preload and/or
afterload test provides an additional estimation of the severity of mitral regurgitation (Aklog
2001, Gisbert A, 2006). Intraoperative transesophageal echocardiography is routinely per‐
formed in order to confirm the mechanism of mitral regurgitation and mainly to control the
outcome of repair.
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Surgical planning and management. Most of the times, the surgical technique consists in
mitral annuloplasty using an undersized complete prosthetic ring or in alternative only a
posterior prosthetic ring which should reduce the annular dilation especially in the region of
the medial scallops (P3). Depending on the functional and anatomical reserve of the posterior
leaflet, cusp extension using a pericardial patch may be taken into consideration. The newly
inserted pericardial patch should be as large as possible because, by sewing usually it remains
smaller and also because it has a natural tendency to shrink overtime.
5.2. Ischemic dilatative cardiomyopathy (fig 23)
Background. This situation is the final stage of an unfavorable evolution of ischemic heart
disease. Usually, in anamnesis, there are more than one myocardial infarction and a long story
of percutaneous interventions and/or surgical treatments.
Mechanism. This category of patients presents the phenomenon of “mitral – ventricular
mismatch”. Due to progressive dilatation of the left cavity, the rightly balance between the
mitral valve apparatus and the dimension of the multiinfarcted left ventricle will be lost, and
in this condition, the mitral valve will become insufficient. Any tentative to repair the mitral
valve has to take into consideration this aspect. More remodeled and dilated the left cavity
will be, more difficult will be to accomplish the valve repair and the plasty will be less stable
over time. Some elements as diameter of the LV cavity, the volumes, dilatation of the mitral
annulus and migration of the papillary muscle, may be documented by a series of echocar‐
diographic parameters. So, the remodeling of the left heart will be expressed by a series of
factor as: tenting area, coaptation distance, left ventricular diameter and volume, the interpa‐
pillary distance. Some studies showed negative correlation between these parameters and the
feasibility of mitral repair.
Figure 23. Ischemic dilated cardiomyopathy with chronic mitral regurgitation due to important dilatation of the LV
cavity, annular dilatation and loss of leaflet coaptation (arrow). TEE transgastric short and long axis views. Notice also
the systolic restriction of the posterior leaflet (right picture).
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6. Unfavorable characteristics for mitral valve repair (table 2, fig 24)
When the global remodeling of the left ventricle is too advanced, with loss of the normal shape
and important dilatation of the LV cavity, overt tethering of the mitral leaflet and important
annular dilatation, the mitral valve repair may be difficult to accomplish (Troubil 2010). A
remodeled, dilated ventricle, with an interpapillary muscle distance more than 20mm, is a
marker of poor scenario for mitral valve repair. A left ventricular cavity remodeled and dilated
with a value above 65mm for LV end diastolic diameter (EDD) and above 51mm for end systolic
diameter (ESD), corresponding to an end systolic volume above 140ml, are also considered
unfavorable characteristics for valve repair.
• Coaptation distance ≥ 1 cm
• Tenting area > 2,5 – 3 cm2
• Complex jets
• Posterolateral angle > 45°
• Interpapillary muscle distance > 20 mm
• EDD > 65 mm, ESD > 51 mm (ESV > 140 mL)
EDD - end diastolic diameter,
ESD - end systolic diameter,
ESV - end systolic volume.
Table 2. Unfavorable characteristics for mitral valve repair.
Figure 24. Assessment of the tenting area (5,74cm2, left) and of the coaptation distance (13mm, right) in a coronary
patient with chronic ischemic mitral insufficiency; both criteria suggest low probability for mitral valve repair.
Due to the deteriorated contractile status of the LV, the diminish force of closing contributes
to the generation of mitral insufficiency, but this phenomenon alone is not enough. There are
indeed forms of dilated cardiomyopathy with very large ventricle and severely reduced
ejection fraction without an important mitral regurgitation, or even without any mitral
regurgitation. Important in this situation is the impairment of the geometry at the papillary
muscles level. Asymmetrical and symmetrical pattern can coexist in the same patient.
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diameter (ESD), corresponding to an end systolic volume above 140ml, are also considered
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indeed forms of dilated cardiomyopathy with very large ventricle and severely reduced
ejection fraction without an important mitral regurgitation, or even without any mitral
regurgitation. Important in this situation is the impairment of the geometry at the papillary
muscles level. Asymmetrical and symmetrical pattern can coexist in the same patient.
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Geometrical echocardiographic analysis. These patients have a high degree of tenting in both
leaflets (papillary far from each other), a very dilated annulus and a large defect of coaptation
in the central part of the valve conditioning a severe mitral regurgitation, with a large vena
contracta. They also present a larger area than normal of the coaptation triangle, express by a
larger tenting area and a higher coaptation distance (fig 24).
Surgery. Given the seriousness of this clinical condition, the surgical management of this
syndrome requires the most aggressive approach. Restrictive and undersized annuloplasty
usually with a complete rigid is often combined with other surgical techniques as leaflet
extension and/or papillary muscle repositioning. There are some techniques used in these
situations, like re-approaching the papillary muscles with a Gore-Tex band (Hvass 2010) thus
decreasing the degree of tenting or the use of an external mesh for preventing further dilatation.
Even if the immediate outcome could be satisfactory medium and long term results are to be
evaluated.
7. Chronic ischemic mitral regurgitation due to elongation of papillary
muscle (fig 24)
Background. This type of ischemic mitral regurgitation is considered to be rare (about 2%
of all cases of ischemic mitral regurgitation), belonging to the Carpantier’s type II classifica‐
tion. Nevertheless, it is possible that this type of regurgitation is indeed more frequent and
in every day practice  but  also  underestimated.  The valve  leakage is,  here,  the  result  of
alteration of subvalvular apparatus secondary to ischemic elongation of the papillary muscle
following myocardial necrosis, chronic ischemia and mechanical stress. The papillary muscle
elongation is  never  solitary,  being an associated process  in  the  general  context  of  post-
infarction remodeling.
Mechanism. The partially infarcted and/or ischemic posterior papillary muscle suffers a
chronic remodeling with elongation that expresses itself at the level of the mitral leaflets by
alteration of the coaptation triangle and valve geometry.
Geometrical echocardiographic analysis: in this specific condition there is an insufficient
leaflet coaptation due to various degree of ischemic prolapse of the posterior and/or anterior
mitral leaflet. Often the echocardiographic aspect is an unusual anterior leaflet prolapse or that
of a prolapse of more corresponding scallops (e.g. A2/P2 and A3/P3). The papillary muscle
appears elongated, triangular shaped, with the tip very close to the mitral annulus. As a
consequence, the normal configuration of mitral valve, defined by the coaptation triangle, will
suffer various degree of alteration, till the complete disappearance (see also fig 5, 6). An annular
dilation is often associated, depending on the extension of myocardial infarction. All these
elements will lead to a complex holosystolic regurgitant jet. This entity may be caused by a
limited infarction at the papillary muscle level, which lead to fibrosis and elongation of the
muscle. The papillary muscle will develop a thin and sharp appearance, like a thorn, and will
be more hyperechogenic.
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The clue of the diagnosis is the visualization of the papillary muscles, which can be done
transthoracic in parasternal or apical long axis views, modified for the exposure of the
papillary, or transoesophageal at 60º (bicommissural view) or transgastric view at 90º. The
prolapse at the level of one scallop can coexist with the restriction of another scallop, hence
the importance to visualize the entire valve prior to surgery.
Surgical planning and management: In these cases a rebuilding of the triangle of coaptation
is performed by means of PTFE Gore-Tex neochords which will correct the normal mitral
geometry. Depending on the intraoperative finding and surgical exposition and access,
plication of the elongated papillary muscle may be performed. Annuloplasty is always
performed in order to stabilize the repair.
Dyssynchrony as a cause of chronic ischemic mitral regurgitation. Due to the high prevalence
of left bundle branch block in the ischemic heart disease, the assyncronism of contraction is a
frequent cause of mitral regurgitation. Significant mitral regurgitation is twice more often in
patients with a QRS duration longer than 130 msec. The delayed activation of the antero-lateral
papillary muscle leads to a misalignment of the leaflets during systole. The resynchronization
therapy has good results in this type of mitral regurgitation. The pacing wires are better
attached intraoperatively, the surgeon having the possibility to choose the place without the
restriction imposed by the anatomy of the cardiac veins.
On one hand, though, the currently available techniques still need validation and, on the other,
the optimal therapy /combination of therapies needs clarification.
8. Conclusions
Ischemic mitral regurgitation has important prognosis implications in patients with coronary
heart disease. It should not be underestimated and this underlines the need for a complete
evaluation in which the 2DE and the Doppler echocardiography plays a major role, but should
be interpreted specifically, in particular as regards quantification of the regurgitation.
Figure 25. Several patients with chronic ischemic regurgitation and papillary muscle elongation. The papillary muscle
appears elongated, thinly and sharply, like a thorn, with a hyperechogenic tip, which is very close to the mitral valve
annulus plane (so called “thorny papillary muscle”).
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A complete assessment of left ventricular geometry and function and of the mitral valve
configuration prior to surgery may help improve patient risk stratification and better indi‐
vidualize the surgical strategy based on the patient's specific characteristics.
The acute ischemic mitral regurgitation is a rare mechanical complication after myocardial
infarction, due to elongation, partial or complete rupture of papillary muscle but has a poor
prognosis and it needs urgent diagnosis and surgery. A careful echocardiographic exam,
performed in ICU, is mandatory in acute patients with myocardial infarction, focusing the
attention on the presence of mitral regurgitation. In case of any suspicion of structural acute
ischemic mitral regurgitation the transesophageal exam must be done, to avoid the transfor‐
mation of partial rupture of papillary muscle in a complete one. The complete rupture of
papillary muscle is often fatal and has to be considered a too late clinical and echocardiographic
diagnosis; these patients need an emergent operation and very intensive perioperative
pharmacologic and mechanical support.
From a conceptual point of view, chronic ischemic mitral regurgitation witnesses the loss of
contractile myocardial tissue parallel with the presence of the post-infarction remodeling
process. As known, ischemic mitral insufficiency develops on normally mitral leaflets. As the
myocardial mass loss is larger, the remodeling processes and regurgitation become greater.
Recognizing the mechanism of valve incompetence is an essential point for the surgical
planning and for a good result of the mitral repair. In the patient’s candidates to surgery, the
role of the echocardiographic exam is to identify the mechanisms of valve regurgitation and
to quantify it. As noted, in most cases of chronic ischemic mitral regurgitation the mechanism
is the restriction of one or both leaflets, caused by the tethering exercised by the displaced
papillary muscle.
The transthoracic exam is commonly enough to clarify the mechanism of the chronic ischemic
mitral regurgitation. Only patients with papillary muscle elongation may raise difficulties in
diagnosis. Loss of the normal shape of the ‘triangle of coaptation’ is one of the key character‐
istics of chronic ischemic mitral regurgitation. In case of post-ischemic elongation of the
papillary muscle, the clue of the diagnosis is obtained by looking not only to the mitral valve,
but by focusing the exam on the papillary muscles, particularly when the patient presents a
deformation of the ‘coaptation triangle’. In patients with type II° Carpentier’s classifications
(elongated papillary muscle and leaflets prolapse), alongside of ring annuloplasty use of PTFE
Gore-Tex chordae is often required.
In patients with chronic ischemic mitral insufficiency the echocardiography may identify two
different patterns of post infarction remodeling: a limited process of post infarction remodeling
and an extensive one. The mitral repair is usually more challenging in patients with extensive
pattern of post infarction remodeling, where, due to left heart cavity enlargement a phenom‐
enon of “mitral valve – LV chamber mismatch” is present.
Although the mechanisms of ischemic mitral regurgitation are often complex, currently,
undersized annuloplasty is considered the standard approach to reducing mitral insufficiency.
Unfortunately this technique does not resolve the real mechanism of disease, the remodeled
and sphericalized left ventricle. By this technique the persistence of ischemic mitral regurgi‐
Hot Topics in Echocardiography94
tation is considered to range between 10 to 20% of the cases, and, at five years of follow up,
half of the patient may develop recurrence.
Thus, in advanced stage of left ventricular post infarction remodeling with over dilatation and
important mitral valve tethering, the ring annuloplasty has to be completed with leaflet
extension. This approach seems coherent with the mechanism of mitral regurgitation, with the
echocardiographic data and with the concept of “mitral valve – LV chamber mismatch”.
The major challenge for cardiologists and surgeons is how to integrate data from different
imaging techniques that assess mitral valve geometry and left ventricular size, geometry,
function and potential functional recovery. This in order to tailor and optimize the surgical
approach to patients with chronic ischemic mitral regurgitation.
Even today, we have no reliable predictors of recurrent and persistent mitral regurgitation.
However, the surgical treatment of ischemic mitral insufficiency continues to evolve and new
methods addressing ventricular structures are being introduced: left ventricular restoration,
papillary muscle’s relocation, sling, imbrication or reapproximation, chordal cutting or
translocation. Despite remarkable progress in reparative surgery, further investigation is still
necessary to find the best approach to treat ischemic mitral regurgitation.
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performed in ICU, is mandatory in acute patients with myocardial infarction, focusing the
attention on the presence of mitral regurgitation. In case of any suspicion of structural acute
ischemic mitral regurgitation the transesophageal exam must be done, to avoid the transfor‐
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is the restriction of one or both leaflets, caused by the tethering exercised by the displaced
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1. Introduction
Since Dr Kanji Inoue introduced the Inoue balloon catheter in 1984, percutaneous balloon
valvuloplasty (PBMV) has become the treatment of choice for patients with symptomatic mitral
valve stenosis and favorable valve morphology. PBMV is the preferred treatment for mitral
stenosis as it is less invasive and provides longer-lasting results than closed commissurotomy.
1 PMBV is not suited for patients with mitral stenosis due to severe annular calcification or
markedly degenerated valves. PBMV can be performed either an in antegrade fashion through
a transseptal puncture or retrograde from the aorta to the mitral valve. Serial balloon dila‐
tions of the mitral valve using the self-centering Inoue balloon catheter (or alternatively, a
standard valvuloplasty balloon catheter) are performed to physically split the mitral valve
leaflet commissures and subsequently improve leaflet motion and hemodynamics. In success‐
ful cases, percutaneous balloon mitral valvuloplasty typically doubles the mitral valve area and
decreases the mitral valve gradient by half.  Splitting of the commissures is the principle
mechanism that leads to improvement of hemodynamics and patient symptomatology.
The anatomy of the mitral valve is complex, and echocardiographic imaging plays a critical
role in both the diagnosis and guidance of management of patients with mitral stenosis.
Although Doppler hemodynamics and 2D transthoracic echocardiography are a mainstay in
the echocardiographic assessment of mitral stenosis (Figure 1), real-time three-dimensional
echocardiography (RT3DE) is an emerging imaging tool for not only the diagnosis of mitral
stenosis (Figure 2), but also for the guidance of percutaneous balloon mitral valvuloplasty
procedures in the catheterization laboratory.
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RV: right ventricle; LV: left ventricle; RA: right atrium; LA: left atrium
Figure 1. Two dimensional and Doppler echocardiography in mitral stenosis. Traditionally 2D echocardiography has
provided structural information regarding the morphology of the mitral valve in mitral stenosis. In addition chamber
size, and ventricular function is assessed by echocardiography. Doppler methods provide hemodynamic functional in‐
formation regarding the mitral valve in mitral stenosis. Peak and mean mitral valve gradients, pressure half time de‐
rived mitral valve area and systolic pulmonary pressure are usually recorded in these patients.
2. Diagnosis
Diagnosis of mitral valve stenosis commonly involves the use of 2D transthoracic echocar‐
diography (2DE) to assess the severity of mitral disease, including mitral leaflet mobility,
thickening, calcification and sub-valvular stenosis; as well as to exclude any contraindications
to treatment, such us left atrial thrombus or significant mitral regurgitation.
Normal mitral valve area (MVA) is approximately 4-6 cm2. Patients with symptomatic mitral
stenosis typically have a valve area of less than 2.0 cm2 and have severe mitral stenosis if the
valve area is less than 1.0 cm2.[2] (Figure 3) The narrowing of the mitral orifice creates a left
atrioventricular pressure gradient (the hemodynamic hallmark of mitral stenosis), which in a
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normal functioning mitral valve is near zero. In the setting of hemodynamically significant
mitral stenosis, patients can present with a constellation of symptoms that may include
dyspnea, orthopnea, paroxysmal nocturnal dyspnea, lower extremity edema, poor exercise
tolerance and/or palpitations.
3. Modalities used to evaluate the mitral valve
Various echocardiographic techniques can be used to measure mitral valve area, including
pressure half-time (PHT), planimetry, continuity equation and proximal iso-velocity surface
area (PISA). Each method has its own advantages and disadvantages.
Planimetry has shown to be more accurate when measuring MVA post PBMV compared to
PHT, PISA or the continuity equation method.[3],[4] Planimetry involves the direct measure‐
ment of the mitral valve orifice and has correlated well with invasive anatomic measurement.
[1] This method requires a considerable amount of expertise for reliability.
RV: right ventricle; LV: left ventricle; RA: right atrium; LA: left atrium; Ao: Aorta
Figure 2. Comparison of 2D and 3D transthoracic echocardiography in mitral stenosis. The most useful views to evalu‐
ate patients with mitral stenosis include the apical 4 chamber view as well as the parasternal long and short axis views.
This figure illustrates the added value of 3D imaging in better characterizing the mitral valve apparatus. The third di‐
mension increases the anatomic detail of the leaflets, commissures and subvalvular tissue.
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The PHT method is easily performed, but is influenced by other concomitant valvular disease,
such as aortic or mitral regurgitation, or by the dynamic hemodynamics seen post-PBMV.[4],
[6],[7] In contrast, planimetry is not affected by hemodynamic variability, but is difficult
because it requires technically challenging imaging views of the mitral orifice.
The PISA method requires many different imaging planes and variables to accurately calculate
MVA and thus is very laborious. It can be however, used in the presence of mitral regurgitation
dynamic flow changes.[7]
The continuity equation also involves the measurements of many variables, including size of
the left ventricular outflow tract and mitral annulus. It also cannot be used in patients with
atrial fibrillation or significant aortic or mitral regurgitation.
Planimetry has become the most reliable method for calculating mitral valve area and has been
compared to the invasively derived Gorlin’s formula, which by some is considered the gold
standard for mitral valve area calculation.[2] However, real-time 3D echocardiography
(RT3DE) may be a more accurate and feasible method for calculating MVA in patients being
evaluated for PBMV.[6] Planimetry with 2DE relies on good echocardiographic technique and
Figure 3. Normal mitral valve compared to mitral valves with moderate and severe mitral stenosis.The mitral valve ori‐
fice is seen from the left atrial side (LA view-white asterisk) and the left ventricular side (LV View- green asterisk) in a
patient with a normal mitral valve (valve area 4cm2, a patient with moderate mitral stenosis ( valve area of 1.2 cm2),
and in a patient with severe mitral stenosis ( valve area of 0.8 cm2).
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imaging windows in the parasternal short-axis plane to directly measure the mitral valve
orifice. In contrast, RT3DE is not limited to a specific imaging plane and can image the mitral
valve in several different planes, allowing for a recreation of a 3D image for precise tracing of
the mitral valve orifice.(Figure 4) Even though poor imaging windows can affect both 2D and
3D echocardiography, RT3DE has been less affected by poor imaging windows compared to
2D.[8],[9] Real-time 3D echocardiography has been shown to be more accurate and reliable
than 2DE planimetry for assessing MVA, severity of commissural fusion and extent of sub-
valvular disease.[8],[10] Real-time 3D echocardiography has also been shown to provide a
more accurate and reliable MVA measurement in inexperienced echocardiographers using
RT3DE compared to 2D echocardiography and nominally affected by mitral valve morphology
and post-PBMV hemodynamic changes.[6],[8],[10]-[11]
The asterisks represent the mitral valve orifice from each of the 3 orthogonal planes. RV: right ventricle; LV: left ventri‐
cle; RA: right atrium; LA: left atrium
Figure 4. Multiplane reconstruction of the mitral valve apparatus in mitral stenosis. 3D echocardiography can be pre‐
sented in a volume rendition form (panel D) or in a simultaneous multiplane rendition (panels A, B and C). From the
long axis plane (panel A) one can choose the tips of the leaflets to obtain the true minimal mitral valve orifice area, as
depicted in panel B. Panel C represents an orthogonal view at the bi-commissural level, a view that is not obtainable
from 2D echo alone.
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Favorable  patients  for  percutaneous balloon mitral  valvuloplasty are  typically  evaluated
through calculation of the echocardiographic Wilkin’s score (Figure 5). It is the most widely
used prognostic score to determine a favorable PBMV outcome. It is derived non-invasively by
echocardiography using four variables, valve leaflet mobility, thickening, calcification and
degree of sub-valvular thickening. The Wilkin’s score assigns a value from 1 to 4 for each
category, with a higher value indicating more extensive disease. A patient is considered a good
candidate for PBMV if they have a total score of ≤ 8 and the absence of severe mitral regurgita‐
tion. An optimal patient is associated with a high level of procedural success and low compli‐
cation rate. Patients with scores > 8 have an increased risk for adverse outcomes and should be
considered for surgical management.[12] However, even in unfavorable candidates percutane‐
ous balloon valvuloplasty is often still the first treatment of choice in experienced centers.
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Table 1. Mitral Valve Anatomy Scoring Using the Wilkin’s Score
Iung and Cormier also developed a scoring system to evaluate mitral valve anatomy in a less
complex way. In addition, the Cormier scoring system also factors in chordae length, a feature
not included in the more traditional Wilkins score. Interestingly, however, neither the Wilkins
or Cormier scoring systems address the issue of commissure disease, such as fusion and extent
of calcification. Inadequate leaflet splitting and the development of mitral regurgitation can
be related to severe commissural disease.[14]-[16] Identifying the degree of commissural
disease can help to predict poor patient outcomes. Because of the potential importance of
commissural disease in PBMV outcomes, there is interest in incorporating this variable into a
new, RT3DE-derived mitral stenosis scoring system.[9]
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RV: right ventricle; LV: left ventricle; RA: right atrium; LA: left atrium; Ao: Aorta
Figure 5. Splitability scores obtained in three patients with mitral stenosis. Diastolic frames are depicted to the left
and systolic frames to the right. The upper panels are from a patient with a Splitability score of 4, which would make
him a good balloon valvuloplasty candidate. The middle panels are from a patient with a score of 9 which would make
him a borderline candidate for valvuloplasty. The lower panels are from a poor candidate for balloon valvuloplasty
with a score of 13.
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Echocardiographic Grade Mitral valve anatomy
1
Pliable non-calcified anterior mitral leaflet and mild subvalvular disease (i.e., thin chordae
10mm long)
2
Pliable non-calcified anterior mitral leaflet and severe subvalvular disease (i.e., thickened
chordae < 10mm long)
3
Calcification of mitral valve of any extent, as assessed by fluoroscopy, whatever state of the
subvalvular apparatus.
Adapted by Iung B et al.[13]
Table 2. Cormier Score
When compared to 2DE, real-time 3D echocardiography allows for superior visualization of
the mitral valve and sub-valvular anatomy. (Figure 2) Specifically, real-time 3D echocardiog‐
raphy allows for better resolution of mitral leaflet thickening and annular calcification and
enhanced anatomic detail of chordal thickening and separation.[9] Commissural separation,
a key determinate of PBMV success is also better assessed by RT3DE.[10] Finally, leaflet
calcification, including distribution of calcium is better visualized with RT3DE. This is
important because leaflet calcification is a strong predictor of commissural splitting. The
presence of calcification also can help predict adverse outcomes such as embolic stroke or
conduction abnormalities.[9]
1. Persistent left atrial or left atrial appendage thrombus
2. Severe mitral regurgitation
3. Massive or bicommissural calcification
4. Severe concomitant aortic valve or severe tricuspid regurgitation or stenosis
5. Severe concomitant coronary artery disease requiring bypass surgery
Adapted from ACC/AHA 2006 Guidelines for the management of valvular heart disease.[17]
Table 3. Contraindications to percutaneous balloon mitral valvuloplasty
Contraindications to PBMV are listed in Table 3. However, with the advancement of technique
and imaging, even “unfavorable” candidates are often considered for PBMV as first line
treatment in experienced centers. Other patient factors such as age, presence of severe
pulmonary hypertension, atrial arrhythmia, history of prior commissurotomy, smaller valve
area, presence of mitral regurgitation, NYHA class IV and surgical risk help determine those
patients best suited for PBMV.[13],[18],[19]
5. Immediate and late results
The successful splitting of the commissures is the primary determinant of procedural success.
A mitral valve gradient that decreases to 50% pre-PBMV gradient and a mitral valve area that
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roughly increases by 100% or > 1.5cm² without significant mitral regurgitation are hemody‐
namic criteria used to gauge success.[20] Other, often unmeasured variables such as exercise
capacity, pulmonary pressures, left atrial pressure and cardiac output also increase respec‐
tively.
At the time of the procedure), we rely heavily on echo evidence of bicommissural splitting,
which is best seen with RT 3D TEE (Figure 6). The reason for this is that patients undergoing
PMBV are usually under general anesthesia, or heavily sedated, which dramatically impacts
the hemodynamics through the valve. An anatomic endpoint, as opposed to a hemodynamic
endpoint, is what is generally used to assess the efficacy of the PMBV.
Yellow asterisk: lateral commissure; red asterisk: medial commissure.
Figure 6. Panels A and D depict the mitral valve orifice as seen from the LV. Note the commissural fusion and the small
mitral orifice in the pre procedure image (Panel A). In panel D, were the commissures are now split and the arealof the
mitral orifice has increased. Panels B and E illustrate the 2D TEE views of the mitral valve pre and post procedure. Note
the increased leaflet distance post procedure. Panels C and F illustrate the transmitral Doppler gradients pre and post
procedure. The pre-procedure gradients had already diminished under general anesthesia and the post procedure
gradients showed only a mild drop despite good bi-commissural splitting. This is not uncommon to see in the immedi‐
ate post procedure studies and is probably related to decreased left atrial compliance, therefore to gage procedural
success; we rely mostly on the 3D visualization of the mitral orifice size and commissural splitting.
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Late re-stenosis is defined as a valve area < 1.5cm² or a > 50% decrease of initial increase in
valve area post- PBMV.[21] Patients with optimal anatomy (Wilkin’s score ≤ 8) have a re-
stenosis rate nearly 15% less for the same time frame of those with non-optimal anatomy.[20]
Favorable long-term results are directly correlated to desirable baseline valve anatomy and
good immediate results of PBMV.[18] Favorable patients with Wilkin’s scores < 8 have less re-
stenosis as those with scores > 8.[20],[22] In addition, several clinical factors have been shown
to influence late PBMV results: NYHA functional class III-IV, age ≥ 70 years atrial fibrillation,
and suboptimal valve morphology after the procedure.[18] Unsuccessful balloon commissur‐
otomy (Figure 7) and incomplete commissural splitting is associated with a higher post-
procedure mitral gradient and smaller post-PBMV valve area.
Yellow asterisk: lateral commissure; red asterisk: medial commissure
AL: anterior leaflet; PL: posterior leaflet
Figure 7. Panels A and D depict the mitral valve orifice as seen from the LA. Note the commissural fusion and the small
mitral orifice in the pre procedure image. In panel D, post procedure, the commissures are not splitted and the area of
the mitral orifice has not increased. Panels B and E illustrate the views of the mitral valve from the left ventricle with
similar findings.. Panels C and F illustrate the transmitral Doppler gradients pre and post procedure showing no signifi‐
cant drop in mean transmitral pressures
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Event-free survival; Table 4, has been shown to be as high as 90% in 5 years or longer after the
procedure.[23]
Study (n) patients Age (yrs) Follow-up (yrs)
Event –free
Survival (%)
Fawzy et al.[24] 520 31 17 31±
Iung et al.[18] 1024 49 10 56±
Palacios et al.[26] 879 55 12 33±
Ben-Farhat et al.[25] 654 34 10 72±
Song et al.[23] 402 44 9 90*
Fawzy [28] 547 31 10 88
Cohen [27] 136 59 5 51*
*Survival without intervention
± Survival without intervention in NYHA I or II
Table 4. Event Free Survival
6. Procedural complications
Rates of success of PBMV can exceed 95% in experienced centers to less than 60% in patients
with unfavorable mitral valve anatomy.[20] A direct relationship exists between the experience
of the interventional cardiologist performing the procedure and the incidence of procedural
complications.[29] Most of the complications of the procedure including, mitral regurgitation,
tamponade and a suboptimal improvement in mitral valve gradient are most often related to
unfavorable mitral valve anatomy (represented by elevated Wilkin’s scores).[7],[12] In
contrast, patients with Wilkin’s scores < 8 have a low rate of complications (< 2%), less re-
stenosis and more than a 90% chance of procedure success.[20]
7. Mitral regurgitation
While mild mitral regurgitation is a common outcome following PBMV and is an under‐
standable consequence of commissurotomy, acute severe mitral regurgitation is fortunate‐
ly a rare complication that develops when the balloon commissurotomy produces a leaflet(s)
tear,  damages  the  sub-valvular  compartment  and/or  causes  chordae  rupture.  This  may
require emergent surgical correction.[19],[27] Severe mitral regurgitation is most often seen
in patients  with severe  orifice  narrowing,  severely  diseased leaflets  and significant  sub-
valvular disease.[20]
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The Brockenbrough procedure creates an iatrogenic inter-atrial septal defect, which usually
carries no hemodynamic significance. However, hemo-pericardium can occur with perforation
of adjacent structures by the Brockenbrough needle with an incidence of 2.0 %.[20] Manipu‐
lation of the catheter in the mitral valve position can lead to an unintended perforation of the
left atrium, left atrial appendage, pulmonary veins, ventricular wall or apex, or aortic root.
These complications can be readily avoided using real-time 3D echocardiography, which can
promptly identify a pericardial effusion and help guide catheterization equipment in intra-
cardiac structures.
8. Procedural guidance and assessment of results
Currently, real-time 3D trans-esophageal echocardiography (RT3DTEE) is often used in the
catheterization laboratory to guide the various steps involved in performing a PBMV proce‐
dure,[30] (Figures 8 and 9) as the guide-wires, catheters and devices used during the procedure
may not be readily apparent when using 2D trans-esophageal echocardiography. RT3DTEE,
LA: left atrium; RA: right atrium; SVC: superior vena cava; AV: aortic valve
Figure 8. transeptal puncture is usually the first step in the mitral valve balloon valvuloplasty. Transesophageal echo‐
cardiography now plays a central role for guiding this procedure. Simultaneous biplane imaging is the preferred TEE
guiding mode. Panel A depicts a bicaval view with the Brockenbrough needle tenting (red arrow) the interatrial sep‐
tum at the level of the fossa ovalis. In panel B the same is illustrated from an orthogonal view at the level of the aortic
valve.
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particularly presented in the x plane format, can effectively visualize the precise location of
the tenting of the septum during septal puncture, thereby increasing the safety of this critical
step.[31] Moreover, real-time 3DTEE can more accurately assess MVA and mitral regurgitation
before and after valvuloplasty, compared to 2DE. RT3DTEE allows for imaging the valve
during balloon dilation, “en face” and possibly avoiding leaflet damage by stepwise balloon
over-dilatation by visualizing commissural splitting and leaflet tears immediately after balloon
dilation.[31] 3D TEE is also useful to help determine whether the balloon is free of the chordal
stuctures prior to inflation. RT3DTEE can accurately determine when optimal MVA balloon
dilatation has been achieved and the procedure can be successfully completed.
Figure 9. Three D TEE guidance is now commonly used to assist with all the phases of mitral balloon valvuloplasty. In
panels A, B and C septal puncture is accomplished and the catheter is advanced through the inter-atrial septum (S)
from the right atrium (RA) to the left atrium (LA). In panels D, E and F the balloon is guided to the mitral orifice and
finally through the mitral valve into the left ventricle. In panels G and H the balloon is aligned to the long axis of the
left ventricle (LV) and in panel I the balloon is inflated.
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Percutaneous balloon mitral valvuloplasty has become the first line of treatment in individuals
with symptomatic rheumatic mitral stenosis.
Echocardiographic imaging plays a pivotal role in both the diagnosis of mitral stenosis as well
as the guidance of catheter-based procedures (e.g., PBMV) used in treatment. With the
advancement of ultrasound imaging real-time 3D echocardiography supplements current 2D
technology and offers an advantage over conventional echocardiography for the evaluation
of patients being considered for percutaneous balloon mitral valvuloplasty. With the large
number of factors that play a role in determining patients suitability for PBMV as well the risk
for poor outcomes, further defining patient anatomy with advanced imaging such as real-time
3D echocardiography should improve both short and long-term outcomes.
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as the guidance of catheter-based procedures (e.g., PBMV) used in treatment. With the
advancement of ultrasound imaging real-time 3D echocardiography supplements current 2D
technology and offers an advantage over conventional echocardiography for the evaluation
of patients being considered for percutaneous balloon mitral valvuloplasty. With the large
number of factors that play a role in determining patients suitability for PBMV as well the risk
for poor outcomes, further defining patient anatomy with advanced imaging such as real-time
3D echocardiography should improve both short and long-term outcomes.
Author details
Mark A. Navarro, Michael Kim and Ernesto E. Salcedo
*Address all correspondence to: ernesto.e.salcedo@ucdenver.edu
University of Colorado, Hospital Anschutz Medical Campus, USA
References
[1] Dean, L. S. Percutaneous transvenous mitral commissurotomy: a comparison to the
closed and open surgical techniques. Cathet Cardiovasc Diagn.(1994). suppl 2):76-81.
[2] Baumgartner, H, Hung, J, Bermejo, J, et al. Echocardiographic assessment of valve
stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr.
(2009). , 22, 1-23.
[3] Leopold, P, Casanova, C, Almeria, C, et al. Which method should be the reference
method to evaluate the severity of rheumatic mitral stenosis? Gorlin’s method versus
3D-echo. Eur J Echocardiography.(2007). , 8, 470-473.
[4] Thomas, J, Wilkins, G, Choong, C, et al. Inaccuracy of mitral pressure half-time im‐
mediately after percutaneous mitral valvotomy: dependence on transmitral gradient
and left atrial and ventricular compliance. Circulation.(1988). , 78, 980-93.
[5] Perez de Isla LCasanova C, Almeria C, et al. Which method should be the reference
method to evaluate the severity of rheumatic mitral stenosis? Gorlin’s method versus
3D-echo.Eur J Echocardiography.(2007). , 8, 470-473.
Hot Topics in Echocardiography114
[6] Zamorano, J. Perez de Isla L, Sugeng L et al. Non-invasive assessment of mitral valve
area during percutaneous balloon mitral valvuloplasty: role of real-time 3D echocar‐
diography. European heart journal (2004). , 25, 2086-91.
[7] Messika-zeitoun, D, Iung, B, Brochet, E, et al. Evaluation of mitral stenosis in (2008).
Archives of Cardiovascular Disease.2008; , 101, 653-663.
[8] Binder, T. M, Risenhek, R, Porenta, G, Maurer, G, & Baumgartner, H. Improved As‐
sessment of Mitral Valve Stenosis by Volumetric Real-Time Three-Dimensional Echo‐
cardiography. Jounral of the American College of Cardiology.(2000). , 36, 1355-61.
[9] Anwar, A. M, Attia, W. M, Nosir, Y. F, et al. Validation of a new score for the assess‐
ment of mitral stenosis using real-time three-dimensional echocardiography. Journal
of the American Society of Echocardiography : official publication of the American
Society of Echocardiography.(2010). , 23, 13-22.
[10] Messika-zeitoun, D, Brochet, E, Holmin, C, et al. Three-dimensional evaluation of the
mitral valve area and commissural opening before and after percutaneous mitral
commissurotomy in patients with mitral stenosis. European heart journal.(2007). , 28,
72-79.
[11] Dreyfus, J, Brochet, E, Lepage, L, et al. Real-time 3D transoesophageal measurement
of the mitral valve area in patients with mitral stenosis. European journal of echocar‐
diography : the journal of the Working Group on Echocardiography of the European
Society of Cardiology (2011). , 12, 750-5.
[12] Wilkin, G. T, Weyman, A. E, Abascal, V. M, et al. Percutaneous balloon dilatation of
the mitral valve: an analysis of echocardiographic variables realted to outcome and
the mechanism of dilitation. Br Heart J. (1998). , 60, 299-308.
[13] Iung, B, Cormier, B, Ducimetiere, P, et al. Immediate results of percutaneous mitral
commissurotomy. A predictive model on a series of 1514 patients. Circulation.
(1996). , 94, 2124-2130.
[14] Padial, L. R, Freitas, N, Sagie, A, et al. Echocardiography can predict which patients
will develop severe mitral regurgitation after percutaneous mitral balloon valvuloto‐
my. J Am Coll Cardiol.(1996). , 27, 1225-1231.
[15] Cannan, C. R, Nishimura, R. A, Reeder, G. S, et al. Echocardiographic assessment of
commissural calcium: a simple predictor of outcome after percutaneous mitral bal‐
loon valvotomy. J Am Coll Cardiol. (1997). , 29, 175-180.
[16] Sutaria, N, Northridge, D. B, & Shaw, T. R. Significance of commissural calcium on
outcome of mitral balloon valvotomy. Heart.(2000). , 84, 398-402.
[17] Bonow, R. O, Carabello, B. A, Chatterjee, K, et al. ACC/AHA (2006). guidelines for
the management of patients with valvular heart disease: a report of the American
College of Cardiology/American Heart Association Task Force on Practice Guide‐
lines. J Am Coll Cardiol.2006;48:ee148., 1.
Real-Time 3D Echocardiography in Percutaneous Balloon Mitral Valvuloplasty
http://dx.doi.org/10.5772/56433
115
[18] Iung, B, Garbarz, E, Michaud, P, et al. Late results of percutaneous mitral commis‐
sure in a series of 1024 patients. Circulation.(1999). , 99, 3272-3278.
[19] Iung, B, & Vahanian, A. The Long-term Outcome of Balloon Valvuloplasty for Mitral
Stenosis. Current Cardiology Reports.(2002). , 4, 118-124.
[20] Nobuyoshi, M, Arita, T, Shirai, S, et al. Percutaneous balloon mitral valvuloplasty: a
review. Circulation.(2009). e , 211-9.
[21] Hernandez, R, Banuelos, C, Alfonso, F, et al. Long-term clinical and echocardio‐
graphic follow-up after percutaneous mitral valvuloplasty with the Inoue balloon.
Circulation. (1999). , 99, 1580-1586.
[22] Chmielak, Z, Klopotowski, M, Kruk, M, et al. Repeat percutaneous mitral balloon
valvuloplasty for patients with mitral valve restenosis. Cathet. Cardiovasc. Intervent.
(2010).
[23] Song, J. K, Song, J. M, Kang, D. M, et al. Restenosis and adverse clinical events after
unsuccessful percutaneous mitral valvuloplasty: immediate post-procedural mitral
valve area as an important prognostic factor. Eur Heart J. (2009). , 30, 1254-1262.
[24] Fawzy, M. E, Shoukri, H. K, Al-buraki, J, et al. Seventeen years’ clinical and echocar‐
diographic follow up of mitral balloon valvuloplasty in 520 patients and predictors
of long-term outcome. J Heart Valve Dis.(2007). , 16, 454-460.
[25] Ben-farhat, M, Betbout, F, Gamra, H, et al. Predictors of long-term event free survival
and freedom from restenosis after percutaneous balloon mitral commissurotomy.
AM Heart J. (2001). , 142, 1072-1079.
[26] Palacios, I. F, Sanchez, P. L, Harrell, L. C, et al. Which patients benefit from percuta‐
neous mitral balloon valvuloplasty? Prevalvuloplasty and postvalvuloplasty varia‐
bles that predict long-term outcome. Circulation.(2002). , 105, 1465-1471.
[27] Cohen, D, Kuntz, R, Gordon, S, et al. Predictors of Long-term Outcome After Percu‐
taneous Balloon Mitral Valvuloplasty. N Engl J Med. (1992). , 327, 1329-1335.
[28] Fawzy, M. E. Long-Term Results up to 19 Years of Mitral Balloon Valvuloplasty.
Asian Cardiovascular & Thoracic Annals.(2009). , 17, 627-633.
[29] Complications and mortality of percutaneous mitral balloon commissurotomyA re‐
port from the National Heart, Lung and Blood Institute Balloon Valvuloplasty Regis‐
try. Circulation.(1992). , 85, 2014-2024.
[30] Eng, M. H, Salcedo, E. E, Quaife, R, et al. Implementation of Real Time Three-Dimen‐
sional Transesophageal Echocardiography in Percutaneous Mitral Balloon Valvulo‐
plasty and Structural Heart Disease Interventions. Echocardiography.(2009). , 26,
958-966.
Hot Topics in Echocardiography116
[31] Applebaum, R. M, Ksaliwal, R. R, Kanojia, A, et al. Utility of three-dimensional echo‐
cardiography during balloon mitral valvuloplasty. J Am Coll Cardiol. (1998). , 32,
1405-1409.
Real-Time 3D Echocardiography in Percutaneous Balloon Mitral Valvuloplasty
http://dx.doi.org/10.5772/56433
117
[18] Iung, B, Garbarz, E, Michaud, P, et al. Late results of percutaneous mitral commis‐
sure in a series of 1024 patients. Circulation.(1999). , 99, 3272-3278.
[19] Iung, B, & Vahanian, A. The Long-term Outcome of Balloon Valvuloplasty for Mitral
Stenosis. Current Cardiology Reports.(2002). , 4, 118-124.
[20] Nobuyoshi, M, Arita, T, Shirai, S, et al. Percutaneous balloon mitral valvuloplasty: a
review. Circulation.(2009). e , 211-9.
[21] Hernandez, R, Banuelos, C, Alfonso, F, et al. Long-term clinical and echocardio‐
graphic follow-up after percutaneous mitral valvuloplasty with the Inoue balloon.
Circulation. (1999). , 99, 1580-1586.
[22] Chmielak, Z, Klopotowski, M, Kruk, M, et al. Repeat percutaneous mitral balloon
valvuloplasty for patients with mitral valve restenosis. Cathet. Cardiovasc. Intervent.
(2010).
[23] Song, J. K, Song, J. M, Kang, D. M, et al. Restenosis and adverse clinical events after
unsuccessful percutaneous mitral valvuloplasty: immediate post-procedural mitral
valve area as an important prognostic factor. Eur Heart J. (2009). , 30, 1254-1262.
[24] Fawzy, M. E, Shoukri, H. K, Al-buraki, J, et al. Seventeen years’ clinical and echocar‐
diographic follow up of mitral balloon valvuloplasty in 520 patients and predictors
of long-term outcome. J Heart Valve Dis.(2007). , 16, 454-460.
[25] Ben-farhat, M, Betbout, F, Gamra, H, et al. Predictors of long-term event free survival
and freedom from restenosis after percutaneous balloon mitral commissurotomy.
AM Heart J. (2001). , 142, 1072-1079.
[26] Palacios, I. F, Sanchez, P. L, Harrell, L. C, et al. Which patients benefit from percuta‐
neous mitral balloon valvuloplasty? Prevalvuloplasty and postvalvuloplasty varia‐
bles that predict long-term outcome. Circulation.(2002). , 105, 1465-1471.
[27] Cohen, D, Kuntz, R, Gordon, S, et al. Predictors of Long-term Outcome After Percu‐
taneous Balloon Mitral Valvuloplasty. N Engl J Med. (1992). , 327, 1329-1335.
[28] Fawzy, M. E. Long-Term Results up to 19 Years of Mitral Balloon Valvuloplasty.
Asian Cardiovascular & Thoracic Annals.(2009). , 17, 627-633.
[29] Complications and mortality of percutaneous mitral balloon commissurotomyA re‐
port from the National Heart, Lung and Blood Institute Balloon Valvuloplasty Regis‐
try. Circulation.(1992). , 85, 2014-2024.
[30] Eng, M. H, Salcedo, E. E, Quaife, R, et al. Implementation of Real Time Three-Dimen‐
sional Transesophageal Echocardiography in Percutaneous Mitral Balloon Valvulo‐
plasty and Structural Heart Disease Interventions. Echocardiography.(2009). , 26,
958-966.
Hot Topics in Echocardiography116
[31] Applebaum, R. M, Ksaliwal, R. R, Kanojia, A, et al. Utility of three-dimensional echo‐
cardiography during balloon mitral valvuloplasty. J Am Coll Cardiol. (1998). , 32,
1405-1409.




A Framework for the Systematic Characterization
of the Aortic Valve Complex by Real-Time
Three Dimensional Echocardiography: Implications
for Transcatheter Aortic Valve Replacement
Daniel Zalkind, Michael Kim and Ernesto E. Salcedo
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/56021
1. Introduction
Transcatheter aortic valve replacement (TAVR) has become a viable alternative to surgical
aortic valve replacement in both high-risk and inoperable patients with symptomatic severe
aortic stenosis [1]. A successful TAVR procedure is heavily dependent on appropriate patient
selection and detailed morphologic characterization of the aortic valve complex to prevent
device migration, coronary artery compromise and paravalvular leak. Two-dimensional
echocardiography (2DE) and Doppler methods have traditionally been used to characterize
the presence and severity of aortic stenosis [2]; however the detailed structural analysis of the
aortic valve complex required for successful TAVR demands a more precise analysis of not
only the aortic leaflets, but of the left ventricular outflow tract dimensions, aortic valve
annulus, and the aortic root. Computed tomography (CT) [3, 4, 5, 6] and two dimensional
transesophageal echocardiography (2D TEE) [7] are traditionally used to obtain this informa‐
tion. Although transthoracic and transesophageal three-dimensional echocardiography (3D
Echo) provide detailed characterization of the aortic valve complex, these advanced modalities
are not currently being routinely used in the evaluation of patients considered for TAVR. The
purpose of this chapter is to provide a framework for the 3D echocardiographic evaluation of
the aortic valve complex and its implications for TAVR.
1.1. The aortic valve complex
The aortic valve complex includes the aortic valve leaflets and surrounding structures defining
a functional unit that allows, under normal circumstances, unidirectional and unobstructed
© 2013 Zalkind et al.; licensee InTech. This is a paper distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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1. Introduction
Transcatheter aortic valve replacement (TAVR) has become a viable alternative to surgical
aortic valve replacement in both high-risk and inoperable patients with symptomatic severe
aortic stenosis [1]. A successful TAVR procedure is heavily dependent on appropriate patient
selection and detailed morphologic characterization of the aortic valve complex to prevent
device migration, coronary artery compromise and paravalvular leak. Two-dimensional
echocardiography (2DE) and Doppler methods have traditionally been used to characterize
the presence and severity of aortic stenosis [2]; however the detailed structural analysis of the
aortic valve complex required for successful TAVR demands a more precise analysis of not
only the aortic leaflets, but of the left ventricular outflow tract dimensions, aortic valve
annulus, and the aortic root. Computed tomography (CT) [3, 4, 5, 6] and two dimensional
transesophageal echocardiography (2D TEE) [7] are traditionally used to obtain this informa‐
tion. Although transthoracic and transesophageal three-dimensional echocardiography (3D
Echo) provide detailed characterization of the aortic valve complex, these advanced modalities
are not currently being routinely used in the evaluation of patients considered for TAVR. The
purpose of this chapter is to provide a framework for the 3D echocardiographic evaluation of
the aortic valve complex and its implications for TAVR.
1.1. The aortic valve complex
The aortic valve complex includes the aortic valve leaflets and surrounding structures defining
a functional unit that allows, under normal circumstances, unidirectional and unobstructed
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blood flow to exit the left ventricle and to enter the ascending aorta. The clinical anatomy of
the aortic root has been well characterized in other publications [8, 9] and is summarized below.
More recently, the anatomy of the aortic valve complex and its implications in TAVR have
been elegantly reviewed by Piazza [10]. The components of the aortic valve complex are
illustrated in (Figure 1).
2. Anatomy and clinical application
2.1. General anatomical landmarks
As described above, the aortic annulus is one part of the aortic valve complex that is comprised
of the muscular ventricular LVOT, the aortic valve, aortic leaflets, sinuses of Valsalva, the
sinotubular junction and the ascending aorta [11]. The aortic annulus diameter and general
geometry, which is crucial for pre-procedural planning, valve implantation and post-proce‐
dural follow-up can be considered to be a virtual ring joining the basal attachments of all three
aortic valve cusps, representing the inlet from the left ventricular outflow tract into the aortic
root [12]. The annulus described by surgeons is usually the semilunar crown-like structure
demarcated by the hinges of the leaflets. There is also the true ring, comprised of the sinotub‐
ular junction, demarcated by the sinus ridge and the related sites of attachment of the periph‐
eral zones of apposition between the aortic valve leaflets. This forms the outlet of the aortic
root into the ascending aorta.
Figure 1. Aortic valve complex with virtual and anatomical rings.
The larger part of the noncoronary leaflet  of the valve,  along with part of the left  coro‐
nary leaflet, is in fibrous continuity with the aortic or anterior leaflet of the mitral valve,
Hot Topics in Echocardiography120
with the ends of this area of fibrous continuity being thickened to form the so-called fibrous
trigones. It is these trigones that anchor the aortic-mitral valvular unit to the roof of the left
ventricle.  The  valvular  complex  is  a  dynamic  structure,  with  the  geometric  parameters
changing continuously during the phases of the cardiac cycle and in relation to changes in
pressure within the aortic root. From diastole to systole, the change in the diameter at the
level of the outlet and at the base of the valve has been noted to increase more than 10%,
according  to  several  earlier  publications.  Proper  functioning  of  the  native  aortic  valve
depends on the proper relationship between the leaflets within the aortic root. Not only do
variations exist among individuals in the dimensions of the root, but in the same individu‐
al, marked variations can exist in all aspects of the dimensions of the individual leaflets,
including the height, width, surface area, and volume of each of the supporting sinuses of
Valsalva.
2.2. Application of echocardiography
Transthoracic echocardiography (TTE) is a critical portion of patient selection for TAVR and
complements the clinical criteria for TAVR due to its robust ability to provide both anatomical
and hemodynamic data. According to the latest European Association of Echocardiography
and the ASE 2011 consensus document [13], the role of TTE is to specifically assess the annular
dimension and detailed anatomic characteristics of the aortic valve, including the number,
mobility, and thickness of cusps, as well as the extent and distribution of calcification.
Patients being considered for TAVR should undergo a pre-TAVR 2D/Doppler TTE evaluation
to serve as a baseline for post-TAVR comparison. In addition 3D TTE should be performed to
more precisely delineate the aortic valve complex in order to better determine patient suita‐
bility for TAVR. Transthoracic echo plays a key role in establishing the presence of severe AS
with Doppler assessment of peak and mean transaortic gradients as well as AVA calculation
by the continuity equation. Per the current ACC/AHA guidelines, severe AS is defined by an
AVA of <1cm2 (<0.6 cm2/m2) or a mean aortic valve gradient of >40 mmHg. The aortic valvular
dimension must be assessed with echocardiography, as the current guidelines recommend a
23 mm prosthesis for transverse aortic annular diameters of 18–21 mm (measured at the level
of aortic cusp insertion) and a 26 mm prosthesis for aortic annular diameters of 22–25 mm.
There is also a larger 29mm SAPIEN valve which is currently available outside of the United
States which can accommodate 26-29mm annular diameters.
Using TTE, assessing the annular dimension and detailed anatomic characteristics of the aortic
valve, including the number, mobility, and thickness of cusps, as well as the extent and
distribution of calcification should be described. LV and right ventricular dimensions and
function, aortic regurgitation, and the structure and function of the other valves should be
evaluated. Other valvular disease such as severity of valvular regurgitation or presence of
bioprothetic valves in other positions must also be closely evaluated as such findings may
preclude TAVR. Left ventricular thrombus and valvular vegetations must be ruled out due to
the risk of embolization during sheath manipulation prior to or during deployment. LVOT
obstruction and calcification should also be evaluated as it can interfere with device deploy‐
ment and can lead to migration of the valve. Pericardial fibrosis or pericardial patch should
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blood flow to exit the left ventricle and to enter the ascending aorta. The clinical anatomy of
the aortic root has been well characterized in other publications [8, 9] and is summarized below.
More recently, the anatomy of the aortic valve complex and its implications in TAVR have
been elegantly reviewed by Piazza [10]. The components of the aortic valve complex are
illustrated in (Figure 1).
2. Anatomy and clinical application
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sinotubular junction and the ascending aorta [11]. The aortic annulus diameter and general
geometry, which is crucial for pre-procedural planning, valve implantation and post-proce‐
dural follow-up can be considered to be a virtual ring joining the basal attachments of all three
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root [12]. The annulus described by surgeons is usually the semilunar crown-like structure
demarcated by the hinges of the leaflets. There is also the true ring, comprised of the sinotub‐
ular junction, demarcated by the sinus ridge and the related sites of attachment of the periph‐
eral zones of apposition between the aortic valve leaflets. This forms the outlet of the aortic
root into the ascending aorta.
Figure 1. Aortic valve complex with virtual and anatomical rings.
The larger part of the noncoronary leaflet  of the valve,  along with part of the left  coro‐
nary leaflet, is in fibrous continuity with the aortic or anterior leaflet of the mitral valve,
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with the ends of this area of fibrous continuity being thickened to form the so-called fibrous
trigones. It is these trigones that anchor the aortic-mitral valvular unit to the roof of the left
ventricle.  The  valvular  complex  is  a  dynamic  structure,  with  the  geometric  parameters
changing continuously during the phases of the cardiac cycle and in relation to changes in
pressure within the aortic root. From diastole to systole, the change in the diameter at the
level of the outlet and at the base of the valve has been noted to increase more than 10%,
according  to  several  earlier  publications.  Proper  functioning  of  the  native  aortic  valve
depends on the proper relationship between the leaflets within the aortic root. Not only do
variations exist among individuals in the dimensions of the root, but in the same individu‐
al, marked variations can exist in all aspects of the dimensions of the individual leaflets,
including the height, width, surface area, and volume of each of the supporting sinuses of
Valsalva.
2.2. Application of echocardiography
Transthoracic echocardiography (TTE) is a critical portion of patient selection for TAVR and
complements the clinical criteria for TAVR due to its robust ability to provide both anatomical
and hemodynamic data. According to the latest European Association of Echocardiography
and the ASE 2011 consensus document [13], the role of TTE is to specifically assess the annular
dimension and detailed anatomic characteristics of the aortic valve, including the number,
mobility, and thickness of cusps, as well as the extent and distribution of calcification.
Patients being considered for TAVR should undergo a pre-TAVR 2D/Doppler TTE evaluation
to serve as a baseline for post-TAVR comparison. In addition 3D TTE should be performed to
more precisely delineate the aortic valve complex in order to better determine patient suita‐
bility for TAVR. Transthoracic echo plays a key role in establishing the presence of severe AS
with Doppler assessment of peak and mean transaortic gradients as well as AVA calculation
by the continuity equation. Per the current ACC/AHA guidelines, severe AS is defined by an
AVA of <1cm2 (<0.6 cm2/m2) or a mean aortic valve gradient of >40 mmHg. The aortic valvular
dimension must be assessed with echocardiography, as the current guidelines recommend a
23 mm prosthesis for transverse aortic annular diameters of 18–21 mm (measured at the level
of aortic cusp insertion) and a 26 mm prosthesis for aortic annular diameters of 22–25 mm.
There is also a larger 29mm SAPIEN valve which is currently available outside of the United
States which can accommodate 26-29mm annular diameters.
Using TTE, assessing the annular dimension and detailed anatomic characteristics of the aortic
valve, including the number, mobility, and thickness of cusps, as well as the extent and
distribution of calcification should be described. LV and right ventricular dimensions and
function, aortic regurgitation, and the structure and function of the other valves should be
evaluated. Other valvular disease such as severity of valvular regurgitation or presence of
bioprothetic valves in other positions must also be closely evaluated as such findings may
preclude TAVR. Left ventricular thrombus and valvular vegetations must be ruled out due to
the risk of embolization during sheath manipulation prior to or during deployment. LVOT
obstruction and calcification should also be evaluated as it can interfere with device deploy‐
ment and can lead to migration of the valve. Pericardial fibrosis or pericardial patch should
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be evaluated with either echocardiography or CT as the transapical approach requires a
thoracotomy and pericardioctemy.
During the implantation of a transcatheter aortic valve, contact between the valve struts or
between the mechanically dilated and moved native calcifications can skirt the membranous
septum, potentially instigating high-degree atrioventricular heart block caused by the
compression of the left bundle. This phenomenon is of particular concern in patients with pre-
existing right bundle branch block (RBBB).
Currently, bicuspid aortic valve is an exclusion criterion for TAVR because an elliptical
valvular orifice may predispose to an increased risk of incomplete and incorrect deployment
of the aortic prosthesis, predisposing to a risk of paravalvular leak or valve embolization post
implantation. Moreover, the risk of aortic complications in patients with bicuspid aortic valves,
such as spontaneous aortic dissection, may be increased due to abnormal arterial wall
structure.
2.3. Aortic and mitral valve interaction
Although difficult to study and to characterize with traditional 2D echocardiography, the
interaction between the mitral and aortic valves can vary in intensity and may have subtle
effects on the success or failure of TAVR. A study of this interaction from Veronesi and
colleagues demonstrated that the interaction between the mitral annulus surface area and
aortic annulus projected area changed reciprocally over time due to the physical interaction
through this fibrous continuity [14]. The aortic annulus projected area increased 17% from end
diastole to early systole and decreased to a minimum during isovolumic relaxation. The angle
between the mitral and aortic annuli decreased by 5% from diastole to systole. It is reasonable
to infer that valve undersizing, resulting in more frequent and/or severe perivalvular aortic
regurgitation, may result if the coupling between the aortic and mitral valves is not appreci‐
ated. Other work in mitral-aortic valve coupling was presented at the ACC conference in 2012
and described that aortic stenosis patients have reduced mitral annular size and displacement.
After TAVR, mitral annular size remains reduced due to the presence of the calcified aortic
valve, which is compressed along the aortic root by the TAVR valve struts. This may also
contribute to the increase in aortic-mitral angle post-TAVI [15].
2.4. General Description of the Sinuses of Valsalva and coronary artery ostia
The aortic root is a geometrically complicated structure that includes the sinuses of Valsalva
which are in direct communication with the coronary cusp insertion points. The coronary
artery ostia are in the sinuses and thus give name to the sinuses (left, right and non-coronary)
[16]. The height of the sinuses and the proximity to the aortic valve cusps in systole are two
important parameters to consider in the pre-TAVR planning
For pre-TAVR planning, the LVOT view (110-140 degrees of omni-plane) should be used to
visualize the height of the sinus, defined as the distance from the aortic annulus to the
sinotubular junction (tapering of the sinuses to the ascending aorta diameter) [17]. We have
found success in visualizing the sinuses of Valsalva with transthoracic 3D by using multi-plane
Hot Topics in Echocardiography122
reconstruction (MPR) [18] and measuring the longest diameter and area. MPR can also be used
to assess the height of the sinuses, best visualized with our technique from the “Full Volume”
acquisition from the parasternal long window as shown in figures 2-4. Alternatively, CT
imaging can also be used with a similar MPR technique.
Figure 2. LVOT view from parasternal long MPR
Figure 3. Aortic annular dimension from parasternal long MPR
2.5. Fibrous interleaflet triangles
The portion of the aortic wall that is beneath the apices formed by the attachment of the aortic
leaflets straddles the ventricular and aortic sides of the aortic valve. This region of the heart is
exposed to the ventricular hemodynamic forces. Also known as trigones, these structures help
to support the integrity of the aortic valve [19]. Some authors have made the analogy to a
suspension bridge where the collagenous thickening at the zone of coaptation and the hinges
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be evaluated with either echocardiography or CT as the transapical approach requires a
thoracotomy and pericardioctemy.
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between the mechanically dilated and moved native calcifications can skirt the membranous
septum, potentially instigating high-degree atrioventricular heart block caused by the
compression of the left bundle. This phenomenon is of particular concern in patients with pre-
existing right bundle branch block (RBBB).
Currently, bicuspid aortic valve is an exclusion criterion for TAVR because an elliptical
valvular orifice may predispose to an increased risk of incomplete and incorrect deployment
of the aortic prosthesis, predisposing to a risk of paravalvular leak or valve embolization post
implantation. Moreover, the risk of aortic complications in patients with bicuspid aortic valves,
such as spontaneous aortic dissection, may be increased due to abnormal arterial wall
structure.
2.3. Aortic and mitral valve interaction
Although difficult to study and to characterize with traditional 2D echocardiography, the
interaction between the mitral and aortic valves can vary in intensity and may have subtle
effects on the success or failure of TAVR. A study of this interaction from Veronesi and
colleagues demonstrated that the interaction between the mitral annulus surface area and
aortic annulus projected area changed reciprocally over time due to the physical interaction
through this fibrous continuity [14]. The aortic annulus projected area increased 17% from end
diastole to early systole and decreased to a minimum during isovolumic relaxation. The angle
between the mitral and aortic annuli decreased by 5% from diastole to systole. It is reasonable
to infer that valve undersizing, resulting in more frequent and/or severe perivalvular aortic
regurgitation, may result if the coupling between the aortic and mitral valves is not appreci‐
ated. Other work in mitral-aortic valve coupling was presented at the ACC conference in 2012
and described that aortic stenosis patients have reduced mitral annular size and displacement.
After TAVR, mitral annular size remains reduced due to the presence of the calcified aortic
valve, which is compressed along the aortic root by the TAVR valve struts. This may also
contribute to the increase in aortic-mitral angle post-TAVI [15].
2.4. General Description of the Sinuses of Valsalva and coronary artery ostia
The aortic root is a geometrically complicated structure that includes the sinuses of Valsalva
which are in direct communication with the coronary cusp insertion points. The coronary
artery ostia are in the sinuses and thus give name to the sinuses (left, right and non-coronary)
[16]. The height of the sinuses and the proximity to the aortic valve cusps in systole are two
important parameters to consider in the pre-TAVR planning
For pre-TAVR planning, the LVOT view (110-140 degrees of omni-plane) should be used to
visualize the height of the sinus, defined as the distance from the aortic annulus to the
sinotubular junction (tapering of the sinuses to the ascending aorta diameter) [17]. We have
found success in visualizing the sinuses of Valsalva with transthoracic 3D by using multi-plane
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reconstruction (MPR) [18] and measuring the longest diameter and area. MPR can also be used
to assess the height of the sinuses, best visualized with our technique from the “Full Volume”
acquisition from the parasternal long window as shown in figures 2-4. Alternatively, CT
imaging can also be used with a similar MPR technique.
Figure 2. LVOT view from parasternal long MPR
Figure 3. Aortic annular dimension from parasternal long MPR
2.5. Fibrous interleaflet triangles
The portion of the aortic wall that is beneath the apices formed by the attachment of the aortic
leaflets straddles the ventricular and aortic sides of the aortic valve. This region of the heart is
exposed to the ventricular hemodynamic forces. Also known as trigones, these structures help
to support the integrity of the aortic valve [19]. Some authors have made the analogy to a
suspension bridge where the collagenous thickening at the zone of coaptation and the hinges
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of the leaflets correspond to support cables. These interleaflet triangles are crucial for proper
valvular function. When one or more of them are vestigial, or very small, the valve can become
stenotic due to a change in the geometry. It is challenging to view these structures with
transthoracic echocardiography but TEE can sometime be used to identify them if the valvular
motion is slowed down during the post-processing stage and they are identified in mid systole
or possibly mid diastole, depending on the plane of imaging that is used. Three-dimensional
echocardiography does not quite have the resolution to discriminate between these thin
structures and the valve leaflets. These triangles are currently not part of the TAVR planning
protocols at most institutions at this time.
2.6. Tubular portion of ascending aorta
Aortic valvular disease such as aortic stenosis and aortic regurgitation can often be accompa‐
nied by ascending aortic dilatation. In a recent, large case series from Baylor Medical Center,
of the 1385 patients who had isolated aortic valve replacement, 59 also had aortic root resection
[20]. The largest ascending aortic diameter (multiple imaging modalities were included)
ranged from 4.5 to 6.7 cm (mean, 5.3+-0.5 cm): these diameters were larger in the men than in
the women (mean, 5.4 cm versus mean, 4.9 cm). Although the association between bicuspid
valve and aortopathy is well known, occasionally patient with severe AS may be referred for
TAVR and the valve is so heavily calcified that the diagnosis of bicuspid valve (and thus their
ineligibility for TAVR) is not known. Wide-sector acquisition in the left parasternal long axis
can be used to visualize the ascending aorta and thus help to identify dilatation of the ascending
aorta that may, in itself, warrant surgical correction. Alternatively, CT with contrast can be
used to assess the ascending aorta.
2.7. Aorto-mitral fibrosa
The aorto-mitral fibrosa is usually a thin piece of fibrous tissue that lies between the mitral and
aortic annuli. Best visualized in the parasternal long view on TTE, the fibrosa is usually thin [21].
Alternations to the geometry of the left ventricular inflow and outflow regions can lead to
variations in the length of this fibrosa, such as in transposition of the great vessels, endocardi‐
tis or heavy calcification of either or both annuli. From parasternal short axis window, acquisi‐
tion can be performed in “Live 3D Zoom” modality to examine the left ventricular outflow tract
and mitral valve region. More detailed pictures can, of course, be obtained with TEE as well.
Figure 4. Sinus of valsva (left), sinotubular junction (center) and ascending aorta (right). MPR from parasternal long
view.
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2.8. Pathology including subvalvular stenosis and HCM
Echocardiography has been used to assess all of the structures mentioned above as well as
hypertrophic cardiomyopathy (HCM) with substantial validation. In a thorough study of 77
pediatric patients with subaortic stenosis from the University of Michigan from 1983 to 1991,
echocardiography was used to evaluate patients before and after surgical repair as well as
follow them longitudinally as their gradients increased. In the 36 patients who underwent
surgery, the pre-operative LVOT gradient decreased from 63 to 14mmHg [22]. TTE examina‐
tions were crucial in this patient population due to the complexity of the lesions. A discrete
fibrous membrane or fibromuscular collar can frequently encircle the LVOT just beneath the
aortic valve. Occasionally the long fibromuscular obstruction narrows the LVOT for several
centimeters forming a tunnel. Accompanying aortic regurgitation can also be present and has
been used as an indicator for urgent surgical correction. Three dimensional echocardiography
can be especially useful in such cases as the aortic valvular pathology can be differentiated
from the subaortic pathology and the aortic regurgitation can be fully described (eccentricity,
vena contracta width and PISA) using 2D, 3D, pulsed doppler and color-flow doppler.
Subaortic stenosis is a contraindication to CoreValve implantation. Additionally, the high
incidence of concominant atrial and ventricular septal defects increases the utility of echocar‐
diography as those defects can be readily visualized.
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy with a
prevalence of approximately 0.2%. The clinical presentation is quite diverse but the sentinel
findings of either concentric basal hypertrophy (with septal involvement), arrhythmias and
sudden cardiac death can be recognized late in the disease process [23]. According to the 2011
American Society of Echocardiography guidelines for HCM, ventricular volumes, discrete
wall thickness and LV geometry (apical vs. septal hypertrophy) can be defined. Dynamic
obstruction of the LVOT during stress can be assessed but due to the need for continuous wave
Doppler, can be confused with severe aortic stenosis. In the evaluation of patients with
suspected concominant aortic stenosis and a dynamic LVOT obstruction from HCM, TEE
imaging is crucial to separate the two pathologies. Additionally, papillary muscle hypertro‐
phy/remodeling can also lead to the elongation of the mitral leaflet area and lead to further
increases in the LVOT gradient due to the venture effect in the hypertrophied and/or hyper‐
dynamic LVOT. These dynamic processes must be evaluated prior to any consideration of
transcatheter treatment of aortic stenosis.
3. Three dimensional echocardiography of the aortic valve complex
3.1. Background, physics and validation
Two dimensional echocardiography has numerous limitations in assessing the volumes and
geometry of complex cardiac structures such as the left ventricular cavity (for the purposes of
LVEF assessment) as described above and include geometric assumptions, image plane
positioning errors and imprecise endocardial boundary demarcation [24]. Over the last twenty
years, numerous advances in ultrasound transducer technology and parallel computer
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of the leaflets correspond to support cables. These interleaflet triangles are crucial for proper
valvular function. When one or more of them are vestigial, or very small, the valve can become
stenotic due to a change in the geometry. It is challenging to view these structures with
transthoracic echocardiography but TEE can sometime be used to identify them if the valvular
motion is slowed down during the post-processing stage and they are identified in mid systole
or possibly mid diastole, depending on the plane of imaging that is used. Three-dimensional
echocardiography does not quite have the resolution to discriminate between these thin
structures and the valve leaflets. These triangles are currently not part of the TAVR planning
protocols at most institutions at this time.
2.6. Tubular portion of ascending aorta
Aortic valvular disease such as aortic stenosis and aortic regurgitation can often be accompa‐
nied by ascending aortic dilatation. In a recent, large case series from Baylor Medical Center,
of the 1385 patients who had isolated aortic valve replacement, 59 also had aortic root resection
[20]. The largest ascending aortic diameter (multiple imaging modalities were included)
ranged from 4.5 to 6.7 cm (mean, 5.3+-0.5 cm): these diameters were larger in the men than in
the women (mean, 5.4 cm versus mean, 4.9 cm). Although the association between bicuspid
valve and aortopathy is well known, occasionally patient with severe AS may be referred for
TAVR and the valve is so heavily calcified that the diagnosis of bicuspid valve (and thus their
ineligibility for TAVR) is not known. Wide-sector acquisition in the left parasternal long axis
can be used to visualize the ascending aorta and thus help to identify dilatation of the ascending
aorta that may, in itself, warrant surgical correction. Alternatively, CT with contrast can be
used to assess the ascending aorta.
2.7. Aorto-mitral fibrosa
The aorto-mitral fibrosa is usually a thin piece of fibrous tissue that lies between the mitral and
aortic annuli. Best visualized in the parasternal long view on TTE, the fibrosa is usually thin [21].
Alternations to the geometry of the left ventricular inflow and outflow regions can lead to
variations in the length of this fibrosa, such as in transposition of the great vessels, endocardi‐
tis or heavy calcification of either or both annuli. From parasternal short axis window, acquisi‐
tion can be performed in “Live 3D Zoom” modality to examine the left ventricular outflow tract
and mitral valve region. More detailed pictures can, of course, be obtained with TEE as well.
Figure 4. Sinus of valsva (left), sinotubular junction (center) and ascending aorta (right). MPR from parasternal long
view.
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2.8. Pathology including subvalvular stenosis and HCM
Echocardiography has been used to assess all of the structures mentioned above as well as
hypertrophic cardiomyopathy (HCM) with substantial validation. In a thorough study of 77
pediatric patients with subaortic stenosis from the University of Michigan from 1983 to 1991,
echocardiography was used to evaluate patients before and after surgical repair as well as
follow them longitudinally as their gradients increased. In the 36 patients who underwent
surgery, the pre-operative LVOT gradient decreased from 63 to 14mmHg [22]. TTE examina‐
tions were crucial in this patient population due to the complexity of the lesions. A discrete
fibrous membrane or fibromuscular collar can frequently encircle the LVOT just beneath the
aortic valve. Occasionally the long fibromuscular obstruction narrows the LVOT for several
centimeters forming a tunnel. Accompanying aortic regurgitation can also be present and has
been used as an indicator for urgent surgical correction. Three dimensional echocardiography
can be especially useful in such cases as the aortic valvular pathology can be differentiated
from the subaortic pathology and the aortic regurgitation can be fully described (eccentricity,
vena contracta width and PISA) using 2D, 3D, pulsed doppler and color-flow doppler.
Subaortic stenosis is a contraindication to CoreValve implantation. Additionally, the high
incidence of concominant atrial and ventricular septal defects increases the utility of echocar‐
diography as those defects can be readily visualized.
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy with a
prevalence of approximately 0.2%. The clinical presentation is quite diverse but the sentinel
findings of either concentric basal hypertrophy (with septal involvement), arrhythmias and
sudden cardiac death can be recognized late in the disease process [23]. According to the 2011
American Society of Echocardiography guidelines for HCM, ventricular volumes, discrete
wall thickness and LV geometry (apical vs. septal hypertrophy) can be defined. Dynamic
obstruction of the LVOT during stress can be assessed but due to the need for continuous wave
Doppler, can be confused with severe aortic stenosis. In the evaluation of patients with
suspected concominant aortic stenosis and a dynamic LVOT obstruction from HCM, TEE
imaging is crucial to separate the two pathologies. Additionally, papillary muscle hypertro‐
phy/remodeling can also lead to the elongation of the mitral leaflet area and lead to further
increases in the LVOT gradient due to the venture effect in the hypertrophied and/or hyper‐
dynamic LVOT. These dynamic processes must be evaluated prior to any consideration of
transcatheter treatment of aortic stenosis.
3. Three dimensional echocardiography of the aortic valve complex
3.1. Background, physics and validation
Two dimensional echocardiography has numerous limitations in assessing the volumes and
geometry of complex cardiac structures such as the left ventricular cavity (for the purposes of
LVEF assessment) as described above and include geometric assumptions, image plane
positioning errors and imprecise endocardial boundary demarcation [24]. Over the last twenty
years, numerous advances in ultrasound transducer technology and parallel computer
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processing has made the acquisition of 3D echocardiographic volumes possible using multiple
formats (in the Philips Healthcare system but similar modes in the other manufacturers as
well) including large sector (“Full Volume”), narrow sector format (“Live 3D”), wide sector
focused (“Zoom 3D”), simultaneous biplane (“X-plane”) modes. The different formats are
provided because 3D echocardiography is a technically demanding technique with temporal
and spatial resolution limitations. Each one of the formats or modes has strengths and
weaknesses.
One of the first clinical studies documenting real-time 3D echocardiography was published in
1998. The phased-array volumetric 3D system was developed in the Duke University Center
for Emerging Cardiovascular Technology and initially operated with 2.5- or 3.4-MHz trans‐
ducers (both 14 mm in diameter) [25]. A 2D array and the pyramid-shaped volumetric scan
composed of 43x 43 square elements, each measuring 0.3x0.3 mm. The volume was scanned
rapidly with 16-to-1 parallel processing in the receive system. Consequently, the overall
scanned pyramidal volume was composed
of 256 small pyramids stacked side by side. Since then the transducer technology has increased
substantially and current systems are solid state devices that operate at 5-7 MHz and are
composed of more than 3000 array elements with the ability to acquire in the multiple modes
above as well as to perform other advanced functions such as 3D color Doppler and color M-
mode. This technology has been validated against nuclear magnetic resonance [26] and SPECT
imaging [27].
Large sector acquisition (“Full Volume” on the Philips Healthcare system) is a technique for
acquiring large volume sets such as the entire left ventricle over multiple cardiac cycles to
allow the transducer/processor to sample small sectors of the entire volume during each cycle.
The sectors are then “stitched” together by software algorithms into one large volume. This
technique allows for large volumes to be imaged but relies on a regular heart rhythm that
produces constant R-R intervals. Respiratory artifact can also be introduced if the ultrasound
probe is affected leading to slightly different cardiac geometry to be sampled in the various
sectors leading to “stitch” artifact. This technique has been used in our laboratory to define LV
geometry as well to define the aortic annulus and the entirety of the aortic valve complex and
proximal ascending aorta in one acquisition step. Apical and parasternal long positions are
favored for this approach.
Narrow sector format (“Live 3D”) is a technique which focuses on a narrow sector such as the
aortic leaflets at the level of the Sinuses of Valsalva with high temporal resolution and frame
rates above 30Hz for visualization of rapidly moving structures such as fenestrations, vege‐
tations or thrombi. Temporal resolution is now sufficient to visualize valvular motion as seen
in figure 5.
Wide sector focused (“Zoom 3D”) allows for large acquisition fields that are relatively shallow
which can be obtained anywhere along the long axis of the field of view. For example, the
entire aortic valve annulus, leaflets and possibly the coronary ostia can be visualized. This
approach is often coupled with the simultaneous orthogonal view format known as “X-plane”.
This 2D technique allows the sonographer to visualize complex structures in their traditional
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2D view and concurrently, in a split window format, visualize the orthogonal 2D plane.
Especially useful in the identification of the coronary ostia and left atrial appendage thrombi
and the aortic annular diameter.
3.2. Role for 3D echo from EAE and ASE guidelines
Since the development of the matrix-array transducer and real-time 3D echocardiography, the
application to clinical practice has increased substantially due to improves accuracy and ease
of use. Direct measurements of cardiac chambers without geometrical assumptions, non-
invasive views of valvular structure and function as well as color Doppler assessment of
regurgitation and stenosis are all improving and are gradually becoming well accepted and
strongly recommended in the ASE guidelines [28].
Specifically 3D LV chamber quantification is now recommended as the best technique for
evaluating LV end-diastolic and end-systolic volumes, leading to accurate quantification of
LV ejection fraction. Several studies have now directly compared the accuracy of 3D meas‐
urements of LV volumes and EF have shown the superiority of the 3D approach over the 2D
methodology, which was shown to consistently underestimate LV volumes.
Valvular heart disease has been studied as a possible application for RT3D as well. The most
experience comes in mitral disease where the hyperbolic paraboloid (“saddle-shaped”)
geometry of the valve is better evaluated from multiple planes that are possible with 3D
imaging. The current TAVR recommendations recommend that the aortic valve is imaged with
3D but the sizing of the valve still be performed with 2D echo in the LVOT view, usually
accomplished at the mid-esophageal position at 120 degrees of omni tilt. LVOT measurements
performed on the 3D dataset require multi-planar reconstruction (see below).
3.3. Wide-sector acquisition and advances in post processing
Although not currently endorsed for the pre-procedural evaluation for TAVR, transthoracic
3D imaging may have a special niche. Similar 3D capabilities as transesophageal echocardiog‐
raphy are available to the sonographer including RT3D with high-frame rate imaging (Live
3D) as well as breath-hold, large sector acquisition. The off-line processing software is currently
aimed for LV ejection fraction quantification but, in the authors’ experience, can be applied to
the LVOT, aortic annulus and possibly the ascending aorta.
Figure 5. Aortic valve in diastole and systole with transthoracic 3D MPR reconstruction.
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processing has made the acquisition of 3D echocardiographic volumes possible using multiple
formats (in the Philips Healthcare system but similar modes in the other manufacturers as
well) including large sector (“Full Volume”), narrow sector format (“Live 3D”), wide sector
focused (“Zoom 3D”), simultaneous biplane (“X-plane”) modes. The different formats are
provided because 3D echocardiography is a technically demanding technique with temporal
and spatial resolution limitations. Each one of the formats or modes has strengths and
weaknesses.
One of the first clinical studies documenting real-time 3D echocardiography was published in
1998. The phased-array volumetric 3D system was developed in the Duke University Center
for Emerging Cardiovascular Technology and initially operated with 2.5- or 3.4-MHz trans‐
ducers (both 14 mm in diameter) [25]. A 2D array and the pyramid-shaped volumetric scan
composed of 43x 43 square elements, each measuring 0.3x0.3 mm. The volume was scanned
rapidly with 16-to-1 parallel processing in the receive system. Consequently, the overall
scanned pyramidal volume was composed
of 256 small pyramids stacked side by side. Since then the transducer technology has increased
substantially and current systems are solid state devices that operate at 5-7 MHz and are
composed of more than 3000 array elements with the ability to acquire in the multiple modes
above as well as to perform other advanced functions such as 3D color Doppler and color M-
mode. This technology has been validated against nuclear magnetic resonance [26] and SPECT
imaging [27].
Large sector acquisition (“Full Volume” on the Philips Healthcare system) is a technique for
acquiring large volume sets such as the entire left ventricle over multiple cardiac cycles to
allow the transducer/processor to sample small sectors of the entire volume during each cycle.
The sectors are then “stitched” together by software algorithms into one large volume. This
technique allows for large volumes to be imaged but relies on a regular heart rhythm that
produces constant R-R intervals. Respiratory artifact can also be introduced if the ultrasound
probe is affected leading to slightly different cardiac geometry to be sampled in the various
sectors leading to “stitch” artifact. This technique has been used in our laboratory to define LV
geometry as well to define the aortic annulus and the entirety of the aortic valve complex and
proximal ascending aorta in one acquisition step. Apical and parasternal long positions are
favored for this approach.
Narrow sector format (“Live 3D”) is a technique which focuses on a narrow sector such as the
aortic leaflets at the level of the Sinuses of Valsalva with high temporal resolution and frame
rates above 30Hz for visualization of rapidly moving structures such as fenestrations, vege‐
tations or thrombi. Temporal resolution is now sufficient to visualize valvular motion as seen
in figure 5.
Wide sector focused (“Zoom 3D”) allows for large acquisition fields that are relatively shallow
which can be obtained anywhere along the long axis of the field of view. For example, the
entire aortic valve annulus, leaflets and possibly the coronary ostia can be visualized. This
approach is often coupled with the simultaneous orthogonal view format known as “X-plane”.
This 2D technique allows the sonographer to visualize complex structures in their traditional
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2D view and concurrently, in a split window format, visualize the orthogonal 2D plane.
Especially useful in the identification of the coronary ostia and left atrial appendage thrombi
and the aortic annular diameter.
3.2. Role for 3D echo from EAE and ASE guidelines
Since the development of the matrix-array transducer and real-time 3D echocardiography, the
application to clinical practice has increased substantially due to improves accuracy and ease
of use. Direct measurements of cardiac chambers without geometrical assumptions, non-
invasive views of valvular structure and function as well as color Doppler assessment of
regurgitation and stenosis are all improving and are gradually becoming well accepted and
strongly recommended in the ASE guidelines [28].
Specifically 3D LV chamber quantification is now recommended as the best technique for
evaluating LV end-diastolic and end-systolic volumes, leading to accurate quantification of
LV ejection fraction. Several studies have now directly compared the accuracy of 3D meas‐
urements of LV volumes and EF have shown the superiority of the 3D approach over the 2D
methodology, which was shown to consistently underestimate LV volumes.
Valvular heart disease has been studied as a possible application for RT3D as well. The most
experience comes in mitral disease where the hyperbolic paraboloid (“saddle-shaped”)
geometry of the valve is better evaluated from multiple planes that are possible with 3D
imaging. The current TAVR recommendations recommend that the aortic valve is imaged with
3D but the sizing of the valve still be performed with 2D echo in the LVOT view, usually
accomplished at the mid-esophageal position at 120 degrees of omni tilt. LVOT measurements
performed on the 3D dataset require multi-planar reconstruction (see below).
3.3. Wide-sector acquisition and advances in post processing
Although not currently endorsed for the pre-procedural evaluation for TAVR, transthoracic
3D imaging may have a special niche. Similar 3D capabilities as transesophageal echocardiog‐
raphy are available to the sonographer including RT3D with high-frame rate imaging (Live
3D) as well as breath-hold, large sector acquisition. The off-line processing software is currently
aimed for LV ejection fraction quantification but, in the authors’ experience, can be applied to
the LVOT, aortic annulus and possibly the ascending aorta.
Figure 5. Aortic valve in diastole and systole with transthoracic 3D MPR reconstruction.
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Three-dimensional imaging requires optimal patient positioning to minimize the lung space
between the thoracic wall and the myocardium (extreme left decubitus) along with minimal
subcutaneous fat layer. For example we typically perform apical 3D imaging on dedicated
echocardiography tables with fold-out windows to allow for proper transducer alignment with
the long-axis of the LV. This is crucial for 3D imaging of the LVOT [29] as the focus is more on
the imaginary line drawn through the proximal ascending aorta into the LV cavity as we have
found that the acquisition volume needs to be positioned over the aortic valvular complex and
the ascending aorta.
Often the increased calcium in the aortic annulus and on the leaflets causes shadowing of the
aortic valve and ascending aorta. We have found that parasternal long 3D imaging with both
Live3D and Full-Volume acquisition produces easily interpretable and physiologic images
[30]. This view is crucial for highly calcified aortic valves or for HCM patient with substantially
hypertrophied septum which can be calcified and can obstruct the aortic annulus.
Once the 3D sample volume is acquired in either the “Full Volume” or “Zoom 3D” formats,
multi-plane reconstruction can be used to visualize the aortic valve complex in any plane. Most
useful for the assessment of the aortic annular diameter as well as the diameter of the sino‐
tubular junction, MPR allows the echocardiographer to solve the issue of “oblique” planes
through round structures that can lead to under or overestimation of the annular diameter. In
a recent retrospective analysis in the Journal of the American College of Cardiology, Wilson
and colleagues suggested that CT imaging of the aortic annulus is more accurate and can lead
to better sizing for TAVR, presumably leading to less perivalvular regurgitation (See below
for the unique benefits of 3D echocardiography in perivalvular regurgitation).
An off-line processing feature on the Philips workstation known as “I-Slice” is an automatic
software feature that isolates multiple segments of the LV and allows for separate evaluation.
Mostly designed for the evaluation of LV function throughout different segments of the
chamber, this feature can also be applied to the transthoracic evaluation of the aortic valve
complex and the ascending aorta by applying it along the LVOT-to-ascending aorta axis.
Orthogonal 2D slices at multiple levels of this area of interest can be displayed simultaneously
and thus can help to identify calcium, maximal and minimal diameters and areas of supra-
aortic and sub-aortic stenosis without the need for multi-plane reconstruction (Fig. 6).
4. Clinical application in aortic stenosis
The publication of the PARTNER trial ushered in a new era in interventional cardiology
and  highlights  the  improved  outcomes  of  TAVR  vs.  medical  treatment.  As  originally
reported  by  Braunwald  and  colleagues  and  recently  further  explored  by  Carabello  and
colleagues, aortic stenosis had a 2% incidence in the Cardiovascular Health Study and has
a high mortality rate (especially with symptoms) when medical treatment alone is initiat‐
ed.  As  per  the  2008  EAE/ASE  valvular  guidelines,  echocardiography  has  become  the
standard means for evaluation of aortic stenosis (AS) severity [31]. Cardiac catheterization
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is no longer recommended except in rare cases when echocardiography is non-diagnostic
or discrepant with clinical data [32].
As mentioned above, non-invasive imaging including echocardiography is important and
plays a central role in TAVR because accurate preoperative measurements of aortic annular
sizes are crucial for selection of appropriate prosthesis sizes. One of the possible imaging
modalities, 2D echocardiography underestimates aortic annular and LVOT dimensions
compared when compared with multislice computed tomography (MSCT) and 3D echocar‐
diography [33]. Three dimensional TEE has been promoted for more accurate diameter
measurements. A study by Ng and colleagues, from the Netherlands, showed marked
differences in the aortic annular dimension measurement between 2D TEE, 3D TEE circular
annular assumption and 3D TEE with planimetry measurements based on overall valve area
although all of the modalities were consistent when eccentricity was measured post TAVR
(circular valve prosthesis). Using CT planimetered areas as “gold standard,” 3D TEE plani‐
Figure 6. Philips “I-Slice” mode applied to the aortic valve complex.
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Three-dimensional imaging requires optimal patient positioning to minimize the lung space
between the thoracic wall and the myocardium (extreme left decubitus) along with minimal
subcutaneous fat layer. For example we typically perform apical 3D imaging on dedicated
echocardiography tables with fold-out windows to allow for proper transducer alignment with
the long-axis of the LV. This is crucial for 3D imaging of the LVOT [29] as the focus is more on
the imaginary line drawn through the proximal ascending aorta into the LV cavity as we have
found that the acquisition volume needs to be positioned over the aortic valvular complex and
the ascending aorta.
Often the increased calcium in the aortic annulus and on the leaflets causes shadowing of the
aortic valve and ascending aorta. We have found that parasternal long 3D imaging with both
Live3D and Full-Volume acquisition produces easily interpretable and physiologic images
[30]. This view is crucial for highly calcified aortic valves or for HCM patient with substantially
hypertrophied septum which can be calcified and can obstruct the aortic annulus.
Once the 3D sample volume is acquired in either the “Full Volume” or “Zoom 3D” formats,
multi-plane reconstruction can be used to visualize the aortic valve complex in any plane. Most
useful for the assessment of the aortic annular diameter as well as the diameter of the sino‐
tubular junction, MPR allows the echocardiographer to solve the issue of “oblique” planes
through round structures that can lead to under or overestimation of the annular diameter. In
a recent retrospective analysis in the Journal of the American College of Cardiology, Wilson
and colleagues suggested that CT imaging of the aortic annulus is more accurate and can lead
to better sizing for TAVR, presumably leading to less perivalvular regurgitation (See below
for the unique benefits of 3D echocardiography in perivalvular regurgitation).
An off-line processing feature on the Philips workstation known as “I-Slice” is an automatic
software feature that isolates multiple segments of the LV and allows for separate evaluation.
Mostly designed for the evaluation of LV function throughout different segments of the
chamber, this feature can also be applied to the transthoracic evaluation of the aortic valve
complex and the ascending aorta by applying it along the LVOT-to-ascending aorta axis.
Orthogonal 2D slices at multiple levels of this area of interest can be displayed simultaneously
and thus can help to identify calcium, maximal and minimal diameters and areas of supra-
aortic and sub-aortic stenosis without the need for multi-plane reconstruction (Fig. 6).
4. Clinical application in aortic stenosis
The publication of the PARTNER trial ushered in a new era in interventional cardiology
and  highlights  the  improved  outcomes  of  TAVR  vs.  medical  treatment.  As  originally
reported  by  Braunwald  and  colleagues  and  recently  further  explored  by  Carabello  and
colleagues, aortic stenosis had a 2% incidence in the Cardiovascular Health Study and has
a high mortality rate (especially with symptoms) when medical treatment alone is initiat‐
ed.  As  per  the  2008  EAE/ASE  valvular  guidelines,  echocardiography  has  become  the
standard means for evaluation of aortic stenosis (AS) severity [31]. Cardiac catheterization
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is no longer recommended except in rare cases when echocardiography is non-diagnostic
or discrepant with clinical data [32].
As mentioned above, non-invasive imaging including echocardiography is important and
plays a central role in TAVR because accurate preoperative measurements of aortic annular
sizes are crucial for selection of appropriate prosthesis sizes. One of the possible imaging
modalities, 2D echocardiography underestimates aortic annular and LVOT dimensions
compared when compared with multislice computed tomography (MSCT) and 3D echocar‐
diography [33]. Three dimensional TEE has been promoted for more accurate diameter
measurements. A study by Ng and colleagues, from the Netherlands, showed marked
differences in the aortic annular dimension measurement between 2D TEE, 3D TEE circular
annular assumption and 3D TEE with planimetry measurements based on overall valve area
although all of the modalities were consistent when eccentricity was measured post TAVR
(circular valve prosthesis). Using CT planimetered areas as “gold standard,” 3D TEE plani‐
Figure 6. Philips “I-Slice” mode applied to the aortic valve complex.
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metered aortic annular and LVOT areas showed the least underestimation and narrowest
limits of agreements compared with their respective calculated circular areas. After TAVR,
both 3D TEE and CT demonstrated a decrease in the annular dimension and area due to the
thickness of the valve stent thickness [34]. In contrast, the planimetered LVOT areas increased
by both modalities due to a more circular geometry after TAVR.
Three dimensional TEE has another niche in aortic stenosis. Obstructions in the LVOT or post-
procedural complications such as pannus formation in surgical valves can be visualized with
real time 3D TEE [35]. A pannus that formed on a mitral valve that could be visualized only
with 3D TEE was reported by Ozkan and colleagues in 2009. The same technology technique
could be transferred to the aortic valve with the caveat that shadowing can often complicate
visualization of intra-valvular pathology, based on our experience.
Finally, two dimensional echocardiography has recently been used to estimate effective orifice
area after TAVR and the measurement of the LVOT diameter immediately proximal to the
valve stent struts produced the most likely true effective orifice area with the minimal false
negative prosthesis-patient-mismatch (AVA <0.65cm/m2) [36].
4.1. Aortic insufficiency and perivalvular leaks
Periprocedural complications of device deployment may limit the short-term and long-term
results that have been reported. One common problem is perivalvular aortic regurgitation. Two
dimensional [37, 38] and three dimensional echo has been validated in native valve regurgita‐
tion in previous studies [39, 40, 41]. Based on the previous experience in surgically-implanted
valves, periprosthetic leak severity is defined as severe when greater than 25% of the ring
circumference is involved by color Doppler [42]. While predictors for left ventricular function‐
al recovery or survival following valve replacement have been investigated, predictors for
paravalvular  aortic  regurgitations  after  TAVR are  less  established.  Postprocedural  aortic
regurgitation grade 2/4 has been noted in about 12–20% of patients. In a recent study by Koos
and colleagues [43], pre-TAVR CT scans were performed to calculate the Agastson calcium score
and the routine echocardiographical protocol was used for pre and post-TAVR [44]. There was
a correlation between very high Agastson scores (over 3000) and aortic insufficiency ¾ and
higher. In a recent retrospective study, Sherif and colleagues [45] performed a univariate
regression analysis on 50 successful CoreValve deployments and found that the LVOT-Ao angle,
oval LVOT shape and prior AI all contributed significantly to the development of ¾ or 4/4 aortic
insufficiency. Three dimensional TEE is helpful in these cases as the geometry of the LV and the
acuity of the differences in the LV axis and the LVOT-Ao axis, the shape of the LVOT and the
amount of AI can all be assessed with 2D and 3D echocardiography. In a recent review of
PARTNER I 2-year follow-up data, perivalvular regurgitation has been associated with increased
mortality (Hazard ratio 2.11 for mild to moderate in severity). [46]
4.2. Echocardiography during deployment [47, 48, 49, 50, 51, 52]
The imaging modalities that have described previously in this text for the pre-procedural
evaluation of the aortic valve complex have been compared to the Hegar dilator technique in the
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work of Dashkevich and colleagues. Two dimensional TEE often underestimates the size of the
aortic annulus when compared to CT that correlated well to the anatomical measurement.
Whichever technique is used for sizing, the utility of live two and three dimensional echocardiog‐
raphy during the procedure is well accepted and outlined by Lerakis and colleagues.
The first step in the deployment of the Edwards-Sapien valve is achieving coaxiality of the delivery
catheter with the LVOT-Aorta. This is best accomplished in the TEE probe in the high esopha‐
geal position, LVOT view, at 110-140 degrees of omniposition. Other authors have also recom‐
mended 3D TEE imaging with the use of “Zoom 3D” mode at 135, which allows a more precise
positioning of the tip of the catheter and the prosthesis in relation to the aortic Annulus [53].
The next step is to align the aortic end of the THV with the tips of the native aortic valve leaflets.
Fluoroscopy is used simultaneously and is discussed elsewhere [54]. After deployment, the 3-
dimensional transesophageal echocardiography short-axis view of the THV can be used to
show a successful outcome with normal valve function and color Doppler can be used to assess
possible valvular or perivalvular regurgitation. Mild to moderate perivalvular regurgitation
is common after TAVR with the CoreValve. Sizing based on mean annulus diameter may help
to reduce according to one recent retrospective review of 50 patients [55].
In clinical practice, optimal positioning of the CoreValve 5-10mm proximal to the native aortic
annulus occurs only 50% of the time by fluoroscopy. Non-optimal positioning has been found
to have an inverse relationship to patient-prosthesis mismatch [56]. In our experience, the
utility of TEE during deployment is greatest for recapturable valves such as the CoreValve as
live evidence of perivalvular regurgitation can be useful before repositioning is performed.
For Edwards-Sapien valves this is less crucial as the valve is deployed and cannot be recap‐
tured. In very rare circumstances, the THV is deployed with the wrong orientation, thus
producing severe, open valvular regurgitation. This can be assessed quickly with either 2D or
3D echo. Another valve is subsequently deployed within the inproperly deployed valve.
Positioning of the valve is critical as is the surveillance of the aortic valve complex and ascend‐
ing aorta for any atheromas or loose calcium that can contribute to cerebrovascular accidents.
There is no currently well-accepted description of the etiology of peri-procedural CVA.
Patient follow-up at three days post-procedure as well as months out is routine at our center.
As with surgical aortic valve replacement, TTE is the imaging modality of choice for evaluation
of prosthesis function during follow-up. Post-implantation gradients should be followed.
There is flow acceleration at the valve stent as well as in the bioprosthetic valvular insertion
point in the stent. This can lead to an overestimation of the trans-valvular gradients if the
sample volume is placed inside the stent in the “subvalvular” position. As described above,
the most proximal point of the stent should be used as the LVOT diameter and the sample
volume should be placed there in the Doppler interrogation of the Edwards-Sapien valves [57].
Left ventricular hypertrophy should also be assessed. In fact, left ventricular hypertrophy that
has been well described to be associated with clinically important aortic stenosis can be
followed with transthoracic echocardiography and the Devereux formula in combination with
the relative wall thickness has been used to evaluate the regression of increased ventricular
wall thickness.
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catheter with the LVOT-Aorta. This is best accomplished in the TEE probe in the high esopha‐
geal position, LVOT view, at 110-140 degrees of omniposition. Other authors have also recom‐
mended 3D TEE imaging with the use of “Zoom 3D” mode at 135, which allows a more precise
positioning of the tip of the catheter and the prosthesis in relation to the aortic Annulus [53].
The next step is to align the aortic end of the THV with the tips of the native aortic valve leaflets.
Fluoroscopy is used simultaneously and is discussed elsewhere [54]. After deployment, the 3-
dimensional transesophageal echocardiography short-axis view of the THV can be used to
show a successful outcome with normal valve function and color Doppler can be used to assess
possible valvular or perivalvular regurgitation. Mild to moderate perivalvular regurgitation
is common after TAVR with the CoreValve. Sizing based on mean annulus diameter may help
to reduce according to one recent retrospective review of 50 patients [55].
In clinical practice, optimal positioning of the CoreValve 5-10mm proximal to the native aortic
annulus occurs only 50% of the time by fluoroscopy. Non-optimal positioning has been found
to have an inverse relationship to patient-prosthesis mismatch [56]. In our experience, the
utility of TEE during deployment is greatest for recapturable valves such as the CoreValve as
live evidence of perivalvular regurgitation can be useful before repositioning is performed.
For Edwards-Sapien valves this is less crucial as the valve is deployed and cannot be recap‐
tured. In very rare circumstances, the THV is deployed with the wrong orientation, thus
producing severe, open valvular regurgitation. This can be assessed quickly with either 2D or
3D echo. Another valve is subsequently deployed within the inproperly deployed valve.
Positioning of the valve is critical as is the surveillance of the aortic valve complex and ascend‐
ing aorta for any atheromas or loose calcium that can contribute to cerebrovascular accidents.
There is no currently well-accepted description of the etiology of peri-procedural CVA.
Patient follow-up at three days post-procedure as well as months out is routine at our center.
As with surgical aortic valve replacement, TTE is the imaging modality of choice for evaluation
of prosthesis function during follow-up. Post-implantation gradients should be followed.
There is flow acceleration at the valve stent as well as in the bioprosthetic valvular insertion
point in the stent. This can lead to an overestimation of the trans-valvular gradients if the
sample volume is placed inside the stent in the “subvalvular” position. As described above,
the most proximal point of the stent should be used as the LVOT diameter and the sample
volume should be placed there in the Doppler interrogation of the Edwards-Sapien valves [57].
Left ventricular hypertrophy should also be assessed. In fact, left ventricular hypertrophy that
has been well described to be associated with clinically important aortic stenosis can be
followed with transthoracic echocardiography and the Devereux formula in combination with
the relative wall thickness has been used to evaluate the regression of increased ventricular
wall thickness.
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4.3. Limitations and alternative approaches
4.3.1. Cardiac computed tomography [58, 59, 60]
As with other cardiac structures, the cardiologist and cardiac surgeon has multiple imaging
modalities available for the evaluation of the aortic valve complex for TAVR planning. As
described by Bloomfield and colleagues in a recent review paper, multi-detector CT, cardiac
MRI and, of course, fluoroscopy can all be used to assess the area of interest. There are
numerous advantages and disadvantages to each technique [61]. Fluoroscopy and CT are
discussed elsewhere in this chapter. Although cardiac CT can provide a MFR image for
multiple measurements, the most reproducible MDCT measurements of the annulus are the
area-derived diameter and basal ring average diameter, with derived values generally larger
than those obtained with echocardiography. More recently, the annular circumference has
begun to emerge as the gold standard [62].
4.3.2. Cardiac magnetic resonance imaging [63, 64]
Cardiac magnetic resonance allows for an anatomic and functional assessment of the aortic
valve and aortic root. However, most CMR sequences are two-dimensional with the plane of
imaging chosen at the time of the examination. Whole heart, echo-gated 3D cardiac MR can
provide isotropic images for multiplanar reconstruction and shows the oval shape of the
annulus with maximal and minimal diameters. Planimetric calculations can be made using
steady-state free precession cine sequences. Limitations due to Gadollium contrast and long
acquisition times are two reasons why it is less desirable and not routinely used in clinical
practice.
5. Future directions
5.1. Single cardiac cycle imaging [65]
Although current limitations of 3D echo includes frame rate, acquisition volume and resolution
there are both hardware and software advances coming in the future. Improvements in
transducer design, parallel-processing and automated edge-detection and LV volume calcu‐
lations will enable the sonographer to acquire higher quality images and the physician to
answer clinical questions faster. Off-line processing will become simpler and less time
consuming as well. Additional advances in the miniaturization of the probe and the echocar‐
diogram machine itself will allow for wider use in the clinical setting.
6. Conclusions
Three dimensional echocardiography has emerged as a crucial imaging modality for TAVR
planning and followup. With advanced post-processing techniques such as multi-plane
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reconstruction, I-slice and excellent temporal resolution of narrow-sector acquisition with the
anatomical definition of wide-sector acquisition, the multi-disciplinary TAVR team is now able
to perform this important procedure with great precision and with minimal risk.
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